Healthcare rotation as AI selloff hedge · Thesis · Arbora ↑

As AI and technology stocks sold off sharply on June 5, investors rotated into healthcare names as a defensive alternative, with one article explicitly noting healthcare stocks gaining traction as investors move away from volatile AI and technology names. Amgen received European Commission approval for a new therapy, AbbVie secured EU approval for another drug, and Merck announced detailed results from a Moderna collaboration — a cluster of positive clinical and regulatory catalysts arriving simultaneously. The combination of defensive rotation demand and pipeline execution makes diversified biopharma an attractive hedge against AI valuation compression.

Published 2026-06-06 Updated 2026-09-27

Causal chain

AI and technology valuations compress under selling pressure → risk-off sentiment drives institutional and retail capital out of high-multiple growth names → investors seek sectors with lower beta, more predictable cash flows, and near-term fundamental catalysts → healthcare and biopharma absorb rotation inflows, as explicitly evidenced by UnitedHealth and Eli Lilly leading a sector rebound → simultaneously, Amgen, AbbVie, and Merck deliver a cluster of positive regulatory and clinical newsflow (EC approvals for IMDYLLTRA® and AQUIPTA®, plus Merck-Moderna collaboration data) → pipeline execution validates the fundamental case independent of macro sentiment → combined demand from defensive rotation and stock-specific catalysts creates a dual-engine bid for the sector → sector multiple expansion and relative outperformance versus AI/tech names follow. The bear interruption point sits between steps two and three: if the AI selloff proves shallow or reverses quickly, the rotation impulse dissipates before it fully accretes into healthcare prices, leaving the thesis dependent solely on the regulatory catalysts.

Key drivers

Defensive rotation demand: The AI/tech selloff on June 5 was sharp enough to prompt explicit sector rotation into healthcare, with UnitedHealth and Eli Lilly named as direct beneficiaries, suggesting institutional-level repositioning rather than retail noise.
Regulatory catalyst cluster: Three member tickers — AMGN, ABBV, and MRK — received or announced material regulatory and clinical milestones within days of each other, reducing idiosyncratic risk and reinforcing the sector-wide narrative.
EU market access expansion: EC approvals for IMDYLLTRA® (Amgen) and AQUIPTA® (AbbVie) open new revenue streams in a major regulated market, providing tangible near-term commercial upside beyond the US pipeline.
Merck-Moderna collaboration data: Detailed results from the Merck-Moderna collaboration add a forward-looking innovation signal, suggesting MRK's pipeline is progressing on multiple fronts simultaneously.
Valuation relativity: With AI/tech names under valuation compression, large-cap biopharma with visible earnings and dividend support becomes relatively more attractive on a risk-adjusted basis, drawing capital that would otherwise sit in growth names.
Breadth of coverage: The thesis spans five diversified large-cap names (LLY, NVO, AMGN, ABBV, MRK), reducing single-stock concentration risk and making the trade accessible via sector-level positioning.

Risks and counter-case

AI/tech reversal: If the June 5 selloff proves transient and AI/tech names recover quickly, the rotation impulse fades and healthcare loses its relative bid, leaving the sector without a macro catalyst.
Regulatory approval already priced in: EC approvals for IMDYLLTRA® and AQUIPTA® may have been anticipated by the market; if so, the newsflow represents a "sell the news" event rather than incremental upside.
Pipeline execution risk: Positive early-stage or collaboration data (Merck-Moderna) does not guarantee commercial success; late-stage failures or label restrictions could reverse sentiment rapidly.
Sector-specific policy headwinds: Large-cap biopharma remains exposed to drug pricing legislation and regulatory scrutiny; any adverse policy development could overwhelm the rotation tailwind.
Concentration in GLP-1 names: LLY and NVO carry significant GLP-1 exposure; any clinical safety signal, competitive entrant, or reimbursement setback in that category would disproportionately impact the thesis basket.
Correlation breakdown: In a broad risk-off event (rather than a sector rotation), healthcare may not decouple from equities generally, limiting its hedging utility against a deeper market drawdown.
Short duration of catalyst window: Regulatory and clinical catalysts are point-in-time events; without a sustained pipeline of upcoming newsflow, the fundamental support for the thesis may erode within weeks.

What to watch

Relative sector performance (XLV vs. QQQ): Sustained outperformance of healthcare versus the Nasdaq is the primary confirmation signal that rotation is structural rather than a one-day reaction.
AI/tech volatility regime: Monitor whether the June 5 selloff extends or reverses; a continued downtrend in high-multiple tech names is a necessary condition for sustained rotation inflows into healthcare.
Commercial uptake guidance for IMDYLLTRA® and AQUIPTA®: Early launch metrics or management commentary on EU market penetration will indicate whether the regulatory approvals translate into revenue acceleration.
Merck-Moderna collaboration milestones: Watch for subsequent data readouts, trial enrollment updates, or partnership expansions that would confirm the collaboration is progressing toward commercialization.
Institutional fund flow data: Sector fund flow reports (e.g., weekly ETF inflows into XLV, IBB) will confirm whether the rotation is being sustained by institutional reallocation or was a single-session event.
Earnings guidance revisions for LLY and NVO: Given their GLP-1 weight in the basket, any upward or downward revision to volume and pricing guidance is a high-impact signal for the thesis.
Drug pricing legislative developments: Any movement on Medicare negotiation scope or international reference pricing proposals could rapidly shift the risk/reward calculus for the entire basket.

Sources

UnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stability 2026-06-05
Explicit statement that healthcare stocks gain traction as investors rotate from AI/tech
Amgen Inc. (AMGN) Announces EC’s Grant of Marketing Authorization for IMDYLLTRA® 2026-06-05
Amgen receives European Commission approval for new therapy, positive pipeline catalyst
AbbVie (ABBV) Announces European Commission’s Approval of AQUIPTA® 2026-06-05
AbbVie receives European Commission approval for another drug on June 2
Is Merck & Co. (MRK) One of the Best Cheap Stocks to Buy for Beginners? 2026-06-05
Merck and Moderna announce detailed results from collaboration on June 1
Yahoo Finance 2026-06-05
Novo Nordisk's investigational zenagamtide shows significant A1C reductions with up to 14.6% weight loss in adults with type 2 diabetes--presented at ADA 2026
Yahoo Finance 2026-06-05
AbbVie (ABBV) Ascends While Market Falls: Some Facts to Note
Yahoo Finance 2026-06-05
Novo And Lilly Push Beyond US As Only 1%-2% Use Obesity Drugs Globally
Yahoo Finance 2026-06-05
AGEN Early Access Revenues Signal a New Path Ahead of Approval
Yahoo Finance 2026-06-05
Is Agenus Stock a Hold Amid Valuation and Funding Risks?
Yahoo Finance 2026-06-05
AGEN BOT+BAL: What the BATTMAN Trial Means for mCRC
Yahoo Finance 2026-06-05
GLP-1 Sales Forecast Jumps To $150 Billion By 2030
Yahoo Finance 2026-06-05
Here’s Why Eli Lilly (LLY) is Among the 10 Best American Stocks to Buy and Hold for the Next Decade
Yahoo Finance 2026-06-05
Erasca Inc. (ERAS) Inspiring Confidence Through Commercial Collaborations
Yahoo Finance 2026-06-05
Why Health Care's Seasonal Tailwind Looks Especially Compelling This Year
Yahoo Finance 2026-06-06
Assessing Whether Amgen (AMGN) Is Slightly Undervalued After Recent Share Price Gains
Yahoo Finance 2026-06-06
Eli Lilly Broadens Beyond Obesity Drugs With Vaccine And Genetic Bets
Yahoo Finance 2026-06-06
Assessing Merck (MRK) Valuation After Recent Share Price Momentum And Earnings Growth
Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Sto 2026-06-06
Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?
Yahoo Finance 2026-06-06
People with type 2 diabetes who were increased to semaglutide 2 mg were as likely to achieve an HbA1c less than 7% and more likely to achieve greater than 5% weight loss than those who were switched t
Yahoo Finance 2026-06-06
Novo Nordisk Eyes Next GLP 1 Wave With Amycretin Trial Results
Yahoo Finance 2026-06-06
Jim Cramer Says Eli Lilly CEO Is a “Terrific Steward of His Shareholders’ Capital”
Eli Lilly makes surprising retreat from major market 2026-06-06
Eli Lilly makes surprising retreat from major market
Yahoo Finance 2026-06-06
Eli Lilly shares phase 3 data on triple agonist weight loss drug retatrutide
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing 2026-06-06
Eli Lilly's $3.8 Billion Vaccine Bets: Here's the Big Story Many Investors Are Missing
Yahoo Finance 2026-06-06
Is It Too Late To Consider Eli Lilly (LLY) After Its 48% One-Year Surge?
Yahoo Finance 2026-06-06
Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and i
Yahoo Finance 2026-06-06
AbbVie (ABBV) Valuation Check After New Cancer And Migraine Drug Approvals
Yahoo Finance 2026-06-06
Novo Nordisk to present new data on Wegovy® across a wide range of cardiometabolic conditions at the American Diabetes Association's 2026 Scientific Sessions
Yahoo Finance 2026-06-07
Eli Lilly Expands Beyond Obesity With US$4b Vaccine And Genetic Bets
Yahoo Finance 2026-06-07
How Investors May Respond To Moderna (MRNA) mRNA Advances in Personalized Cancer and Emerging Infectious Diseases
Yahoo Finance 2026-06-07
Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk unveils new data at ADA 2026
Yahoo Finance 2026-06-07
Lilly's Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage of menopause
Yahoo Finance 2026-06-07
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
Wall Street sees huge upside as Novo Nordisk backs biotech company 2026-06-08
Wall Street sees huge upside as Novo Nordisk backs biotech company
Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO) 2026-06-08
Novo Nordisk shares retreat after ADA conference updates fail to excite investors (NVO)
Yahoo Finance 2026-06-08
Eli Lilly Obesity Wins Recast Retatrutide And Foundayo As Cardiometabolic Story
Yahoo Finance 2026-06-08
Q1 Earnings Review: Branded Pharmaceuticals Stocks Led by Eli Lilly (NYSE:LLY)
Yahoo Finance 2026-06-08
Big Pharma Stock Eli Lilly Concocts New Buy Zone
Yahoo Finance 2026-06-08
Zacks Investment Ideas feature highlights: Eli Lilly and Merck
Yahoo Finance 2026-06-08
Novo Nordisk Real-World Data Supports Ozempic Against LLY's Mounjaro
Yahoo Finance 2026-06-08
Can Wegovy Pill's Rapid Uptake Give Novo Nordisk an Edge Over LLY?
Yahoo Finance 2026-06-08
Novo Nordisk Explores Wegovy Combination And Wider Semaglutide Benefits As Shares Fall
Yahoo Finance 2026-06-08
Eli Lilly Shares Rise Pre-Bell After Additional Retatrutide Data Shows Improvements in Obesity-Related Conditions
LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials 2026-06-08
LLY Stock Climbs As Oral GLP-1 Pill Beats Novo Nordisk, AstraZeneca’s Therapies In Diabetes Trials
Yahoo Finance 2026-06-08
Gilead and Merck Announce Positive Topline Results From Two Phase 3 Studies Evaluating Islatravir/Lenacapavir, an Oral Once-Weekly HIV Treatment
Yahoo Finance 2026-06-08
Why Eli Lilly, In A Buy Zone, Is Still The 'Clear Winner' Of The 'Weight Loss Olympics'
Yahoo Finance 2026-06-08
Eli Lilly's Weight-Loss Pill Clears Its Toughest Hormonal Test Yet
Yahoo Finance 2026-06-08
Lilly Rises on Retatrutide Data
Yahoo Finance 2026-06-08
Lilly's oral GLP-1 Foundayo (orforglipron) delivered superior A1C control and weight loss in three pivotal type 2 diabetes trials
Yahoo Finance 2026-06-08
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
Yahoo Finance 2026-06-08
Novo Drops 3.2% As CEO Eyes Longevity And Aesthetics
Yahoo Finance 2026-06-08
Alcohol Use Disorder Market Set to Expand at a 12.1% CAGR During the Forecast Period (2026–2036), Owing to the Emergence of Novel Mechanisms Such as 5-HT3 Pathway, NOP Receptor, mGluR5 NAM, and Other
Yahoo Finance 2026-06-09
Goldman Sachs Trims Amgen (AMGN) Valuation but Sticks with Buy Rating
Yahoo Finance 2026-06-09
Why Eli Lilly (LLY) Stock Is Up Today
Yahoo Finance 2026-06-09
Will HIV Win and Lung Cancer Loss in Trials Recast Merck’s (MRK) Risk Reward Narrative?
Yahoo Finance 2026-06-09
The Hashgraph Group and Merck Introduce EU Digital Product Passport on Hedera for Regulated Supply Chains
Yahoo Finance 2026-06-09
Pentagon Accuses Alibaba, Baidu of Aiding China’s Military
Yahoo Finance 2026-06-09
AlzeCure Pharma Enters Into A Collaboration And Out-Licensing Agreement With Lilly For Alzheimer's Project
Yahoo Finance 2026-06-09
Global Chromatography Market to Reach $21.50 Billion by 2031, Fueled by Biologic Purification Needs
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure 2026-06-09
Amgen Eyes 2026 ‘Springboard’ as Growth Drugs Offset Patent Pressure
Yahoo Finance 2026-06-09
Can Eli Lilly's Clinical Momentum Keep the Stock at Record Highs?
Yahoo Finance 2026-06-09
Lexaria's Animal Study Examining Next-Generation GLP-1 drugs is Underway
Yahoo Finance 2026-06-09
EVERSANA Strengthens Commitment to Driving Market Access Growth with Addition of Industry Expert Jen Norton
Novo Nordisk puts AI at the centre of its clinical strategy 2026-06-09
Novo Nordisk puts AI at the centre of its clinical strategy
Yahoo Finance 2026-06-09
Novo Wegovy Pill Tops 3M Prescriptions
Yahoo Finance 2026-06-09
Sector Update: Healthcare Stocks Rise Late Afternoon
Yahoo Finance 2026-06-09
Gilead, Merck Report Positive Phase III HIV Study Data, End NSCLC Study
Yahoo Finance 2026-06-09
Eli Lilly Expands Alzheimer’s Pipeline With AlzeCure Deal And Valuation Upside
Yahoo Finance 2026-06-09
Gilead’s Mixed Trial News Puts HIV Progress And Oncology Risks In Focus
Yahoo Finance 2026-06-09
Eli Lilly (LLY) Reports Positive Foundayo Weight Loss Data for Menopausal Women
LLY’s EBGLYSS Gets FDA Nod For Every-8-Weeks Dosing, Cutting Treatment To Six Injections Per Year 2026-06-09
LLY’s EBGLYSS Gets FDA Nod For Every-8-Weeks Dosing, Cutting Treatment To Six Injections Per Year
Yahoo Finance 2026-06-09
FDA approves Lilly's EBGLYSS® (lebrikizumab-lbkz) for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
Yahoo Finance 2026-06-09
Assessing Novo Nordisk (CPSE:NOVO B) Valuation As Share Price Weakness Follows A Tough Year
Yahoo Finance 2026-06-09
Lilly Makes a New Alzheimer's Pipeline Move
Yahoo Finance 2026-06-09
What's Driving Amneal's 2026 Growth Outlook?
Yahoo Finance 2026-06-10
Is Eli Lilly and Company (LLY) One of the 10 Best Dividend Stocks to Buy According to D. E. Shaw?
Yahoo Finance 2026-06-10
Planisware unveils latest AI innovations at its annual Exchange26 EMEA conference
Yahoo Finance 2026-06-10
Merck Expands EU Traceability Push And Targets Bundibugyo Ebola Response
Yahoo Finance 2026-06-10
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Yahoo Finance 2026-06-10
Eli Lilly Wins FDA Nod for Extended Ebglyss Dosing in Eczema Care
Yahoo Finance 2026-06-10
Zepbound (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable
Yahoo Finance 2026-06-10
Merck Stock Moves Above 50-Day SMA: Assessing Its Investment Case
Yahoo Finance 2026-06-10
Allergan Aesthetics Releases 'The Aesthetics Evolution: What Consumers Really Want' Highlighting Consumer Motivations and Expectations in Aesthetics
Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement 2026-06-10
Eli Lilly continues dealmaking roll with $1bn AlzeCure agreement
Yahoo Finance 2026-06-10
FDA Ebglyss Decision Adds New Thread To Eli Lilly Growth Story
Yahoo Finance 2026-06-10
Top Research Reports for Merck, Southern Company & Lumentum
Yahoo Finance 2026-06-10
Analysts See Nearly 3X Upside in Pyxis Oncology (PYXS)
Yahoo Finance 2026-06-10
Coastal Financial And 2 Additional Stocks Estimated To Be Priced Below Intrinsic Value
Yahoo Finance 2026-06-10
ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push
Yahoo Finance 2026-06-10
Amgen (AMGN) Registers a Bigger Fall Than the Market: Important Facts to Note
Yahoo Finance 2026-06-10
Can Gilead Sciences HIV Franchise Drive Long-Term Growth?
Yahoo Finance 2026-06-10
ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine 2026-06-10
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
Yahoo Finance 2026-06-11
Novo Nordisk hit by cyber incident, probes data breach
Yahoo Finance 2026-06-11
Novo Nordisk A/S: IT Security incident at Novo Nordisk
Yahoo Finance 2026-06-11
Novo Nordisk: Wegovy® pill (semaglutide tablets) becomes first daily GLP-1 weight-loss pill approved in the UK
Yahoo Finance 2026-06-11
Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?
Yahoo Finance 2026-06-11
Is PAHC Undervalued at 10x Earnings vs Peers?
Yahoo Finance 2026-06-11
Novo Nordisk (NVO): Top 10 Large Cap Value Stocks to Buy Now
Yahoo Finance 2026-06-11
Here is Why Amgen (AMGN) is One of the Top Large Cap Value Stocks to Buy Now
Yahoo Finance 2026-06-11
Is Gilead (GILD) One of the Top Large Cap Value Stocks to Buy Now?
Yahoo Finance 2026-06-11
Sector Update: Healthcare Stocks Higher Late Afternoon
Yahoo Finance 2026-06-11
Abridge wants to be the operating system for medicine—and NVIDIA and Eli Lilly are helping build it
NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News 2026-06-11
NVO Stock Gains As UK Clears First Daily GLP-1 Weight-Loss Pill, Offsetting Security Breach News
Yahoo Finance 2026-06-11
Novo Nordisk Cybersecurity Breach Puts Data Controls And Investor Confidence In Focus
Yahoo Finance 2026-06-11
Novo Nordisk (NVO) Outpaces Stock Market Gains: What You Should Know
Yahoo Finance 2026-06-12
Eli Lilly and Company (LLY)’s Foundayo Hits New Weight Loss Milestone among Menopause Ladies
Yahoo Finance 2026-06-12
Oral Wegovy FDA Win Reframes Novo Nordisk Growth And Longevity Story
Yahoo Finance 2026-06-12
AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Result
Yahoo Finance 2026-06-12
Merck TARGAN Deal Highlights Poultry Tech Push And Undervalued Share Price
UK gives Wegovy GLP-1 pill first European approval 2026-06-12
UK gives Wegovy GLP-1 pill first European approval
Yahoo Finance 2026-06-12
Is It Worth Investing in Merck (MRK) Based on Wall Street's Bullish Views?
Yahoo Finance 2026-06-12
Goldman Sachs Maintains a Buy Rating on Eli Lilly (LLY), Cites Encouraging Obesity Treatment Pipeline — Eli Lilly and Company (NYSE:LLY) rose around 12% in May 2026, primarily driven by strong FQ1 2026 earnings beat and FDA approval for Foundayo and expansion of insurance coverage of obesity treatment.
Yahoo Finance 2026-06-12
Amgen's $500 Million Tavneos Faces FDA Withdrawal Fight
Yahoo Finance 2026-06-12
Novo Nordisk Stock Up as UK Wegovy Pill Nod Eclipses Security Breach — NVO stock gains 3% as the United Kingdom becomes Europe's first country to approve the daily GLP-1 Wegovy weight-loss pill, overshadowing an IT security breach.
Yahoo Finance 2026-06-12
PAHC Stock: What's Driving Phibro's Animal Health Growth — Phibro Animal Health unit drove 74% of fiscal 2025 revenue, fueled by MFA, vaccines and global expansion, helping offset pressure in other businesses.
Yahoo Finance 2026-06-12
Merck (MRK) Stock After 53% One-Year Gain Is DCF Signaling Further Upside Potential — For investors considering whether Merck at around US$120.76 still offers value or whether most of the upside is already reflected in the price, this article walks through the key checks investors often rely on.
Yahoo Finance 2026-06-12
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With WELIREG® (belzutifan), for Adjuvant Treatment of Certain Patients With Clear Cell R
Yahoo Finance 2026-06-12
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo Finance 2026-06-12
Eli Lilly’s Abridge Bet Links Healthcare AI To Valuation And Growth
Yahoo Finance 2026-06-12
Eli Lilly Stock Hits Buy Zone As Earnings Soar 156%. Funds Are Loading Up. — Eli Lilly is committed to innovation and reinvests 20%-25% of its sales back into developing new treatments.
Yahoo Finance 2026-06-12
Eli Lilly (LLY) Moves to Enforce 340B Claims Data Reporting Compliance
Yahoo Finance 2026-06-12
AbbVie (ABBV) Rises Higher Than Market: Key Facts — AbbVie (ABBV) closed at $227.73 in the latest trading session, marking a +1.32% move from the prior day.
Novo Nordisk comeback stirs as Wegovy pill wins UK approval 2026-06-12
Novo Nordisk comeback stirs as Wegovy pill wins UK approval
Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion 2026-06-12
Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion
Yahoo Finance 2026-06-12
2 Cash-Producing Stocks on Our Buy List and 1 That Underwhelm
Yahoo Finance 2026-06-13
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
Yahoo Finance 2026-06-13
Jim Cramer Wasn’t Selling Eli Lilly (LLY)
Yahoo Finance 2026-06-13
Novo Nordisk (NVO) Reports Positive Phase 3 Reimagine Trial Results
Yahoo Finance 2026-06-13
Here’s Why Amgen (AMGN) is Among the 7 Best Longevity Stocks to Buy Now
Yahoo Finance 2026-06-13
Is Eli Lilly (LLY) One Of The Most Profitable Blue Chip Stocks To Buy According To Hedge Funds? — With a profit margin of 34.99% and net income of $20.64 billion (FY25), Eli Lilly and Company (NYSE:LLY) ranks among the most profitable blue chip stocks to buy according to hedge funds. Meanwhile, analysts see 9.20% upside for the stock.
Yahoo Finance 2026-06-13
Novo Nordisk’s Wegovy Pill Wins UK Nod And Expands Obesity Toolkit
Yahoo Finance 2026-06-14
Oral Wegovy Win In UK Puts Focus On Novo Nordisk Valuation Gap — Novo Nordisk, trading at $43.88, is adding another product to its obesity portfolio with this UK approval of oral Wegovy. The stock is up 2.1% over the past week,...
Yahoo Finance 2026-06-14
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
Yahoo Finance 2026-06-14
Morgan Stanley Raises Amgen (AMGN) Price Target Following a Strong Start for Uplizna — With an annual dividend yield of 2.85%, Amgen Inc.
Yahoo Finance 2026-06-14
Amgen Faces Dual Turning Point With IMDYLLTRA Gain And Tavneos Risk
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow 2026-06-14
3 Reasons to Buy Eli Lilly Stock Like There's No Tomorrow
Yahoo Finance 2026-06-15
Eli Lilly JAK2 Data Highlights Pipeline Beyond Obesity And Valuation Upside
Yahoo Finance 2026-06-15
Harbour BioMed Secures Landmark Victory in U.S. Patent Infringement Case Against Amgen, Reshaping the Global Antibody Patent Landscape
Yahoo Finance 2026-06-15
India's Electronics Mart eyes new markets as tech hubs fear job losses — The retailer gets ‌about 60% of its revenue from Hyderabad, which hosts offices of global companies such as JPMorgan Chase and Eli Lilly, and Indian IT majors Wipro and Infosys.
Yahoo Finance 2026-06-15
Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock? — NVO stock jumps 7% in a week on U.K. approval of oral Wegovy and positive commercial updates, but competition and 2026 pressure cloud near-term outlook.
Yahoo Finance 2026-06-15
ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)
Yahoo Finance 2026-06-15
Immuneering Appoints Andrew Gengos as Chief Financial Officer
Yahoo Finance 2026-06-15
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Lilly scores early positive data for new JAK drug 2026-06-15
Lilly scores early positive data for new JAK drug
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? 2026-06-15
HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout? — In April, the stock faced resistance near $30 and saw selling pressure in the following weeks.
Yahoo Finance 2026-06-16
Market Chatter: Novo Nordisk to Seek China Approval for Oral Wegovy as Obesity Drug
Yahoo Finance 2026-06-16
Medincell Reports FY 2025-26 Annual Results
Yahoo Finance 2026-06-16
European Stocks Higher in Tuesday Trading; Markets Buoyed by US, Iran Peace Deal; Inflation Remains a Concern
Yahoo Finance 2026-06-16
Eli Lilly (LLY) Buys 4E Therapeutics As Jaypirca Hits Key Leukemia Milestone
Yahoo Finance 2026-06-16
Jetstream Venture Fund Secures Position in Rejuvenate Bio, Investing Alongside Industry Giant Merck
Yahoo Finance 2026-06-16
4E Therapeutics Acquired by Lilly to Advance Non-Opioid Approach to Chronic Pain
Yahoo Finance 2026-06-16
Nivi, Inc. and MSD Collaborate to Expand HPV Disease Awareness and Cervical Cancer Prevention Through AI-Powered Platform
Yahoo Finance 2026-06-16
Novo Nordisk (CPSE:NOVO B) Prepares China Filing For Oral Wegovy Pill
Yahoo Finance 2026-06-16
Eli Lilly Takes Another Stab at the Market for Painkillers. This Attempt Might Work.
Yahoo Finance 2026-06-16
Can Retatrutide Extend Eli Lilly and Co (LLY)’s Lead in Weight Loss Market? — In the past month, Lilly shares have gained more than 18%. The shares have soared almost 50% over the past year.
Yahoo Finance 2026-06-16
FDA Accepts Gilead's Filing for Weekly Oral Yeztugo for HIV Prevention
Yahoo Finance 2026-06-16
Sector Update: Healthcare Stocks Advance in Afternoon Trading
Eli Lilly’s hottest drugs face a quiet new threat 2026-06-16
Eli Lilly’s hottest drugs face a quiet new threat — Eli Lilly (LLY) became the first pharmaceutical company to cross a $1 trillion market valuation in November last year, carried largely by its highly lucrative obesity and diabetes medications, such as Mounjaro and Zepbound.
Yahoo Finance 2026-06-16
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
Lilly buys non-opioid pain drugmaker 4E 2026-06-16
Lilly buys non-opioid pain drugmaker 4E — It’s the latest in a string of deals for Lilly, which has sunk more than $18 billion into acquisitions over the past few years.
Yahoo Finance 2026-06-16
Protillion Biosciences Announces Drug Discovery Collaboration with Merck
Yahoo Finance 2026-06-16
Verge Labs Unveils vBx: A Breakthrough Foundation Model for Precision Neurology
Yahoo Finance 2026-06-16
Allergan Aesthetics Receives U.S. FDA Approval for SKINVIVE by JUVÉDERM® for the Improvement of Neck Appearance
Yahoo Finance 2026-06-17
Novo Nordisk (NYSE:NVO) Discloses Clinical Trial Data Breach As GLP 1 Supply Strain Continues
Yahoo Finance 2026-06-17
The Zacks Analyst Blog Highlights Gilead Sciences, Merck and GSK
Novo Nordisk hack: FulcrumSec claims $25M extortion attempt 2026-06-17
Novo Nordisk hack: FulcrumSec claims $25M extortion attempt — A hacker group says it walked away with more than a terabyte of sensitive data after the pharmaceutical company refused to pay a $25 million ransom
Yahoo Finance 2026-06-17
Nectin Therapeutics Reports Encouraging Phase 1 Results for NTX1088 in Combination with Keytruda® (pembrolizumab) at ASCO 2026
Yahoo Finance 2026-06-17
Study Reveals Dog Owners and Veterinarians See Challenges in Treating Allergic Skin Disease, Highlighting a Need for a Targeted Rapid Onset Treatment for Dogs of All Ages
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership 2026-06-17
HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo Partnership
Yahoo Finance 2026-06-17
Sector Update: Healthcare Stocks Retreat Late Afternoon — Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index falling 1.3% and
Yahoo Finance 2026-06-17
Merck (MRK) Taps Protillion For AI Drug Discovery And Expands HPV Outreach
Yahoo Finance 2026-06-17
Here’s Why Merck (MRK) is Among the 10 Undervalued Counter Cyclical Stocks to Buy Now
Yahoo Finance 2026-06-17
AbbVie Inc. (ABBV) Presents Data on Fixed-Duration Venetoclax-Based Combination
Yahoo Finance 2026-06-17
Gilead Sciences (GILD) Donates Remdesivir to Uganda — (NASDAQ:GILD) announced a donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda to support response efforts for the current outbreak of Ebola Bundibugyo virus […]
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts 2026-06-17
MLTX Stock Moves Higher As Traders Position For Late-Stage Trial Catalysts
Vedana debuts with $46m to progress migraine therapies 2026-06-17
Vedana debuts with $46m to progress migraine therapies
Yahoo Finance 2026-06-17
Amgen (AMGN) Sees a More Significant Dip Than Broader Market: Some Facts to Know — The latest trading day saw Amgen (AMGN) settling at $341.66, representing a -1.78% change from its previous close.
Yahoo Finance 2026-06-17
Eli Lilly (LLY) Halves $2.7 Billion Germany Investment Over Europe Drug Pricing — Eli Lilly (NYSE:LLY) plans to reduce its previously announced €2.7b investment in Germany by half.
Yahoo Finance 2026-06-18
What’s Happening at Eli Lilly and Company (LLY)’s Pipeline? Early Signals Emerge
Yahoo Finance 2026-06-18
Axcelead DDP Joins Lilly TuneLab to Advance AI Drug Discovery
Yahoo Finance 2026-06-18
Biogen to Strengthen Immunology Pipeline With $1B RayThera Buyout — BIIB is set to acquire RayThera for up to $1 billion, adding anti-inflammatory candidates that could expand its immunology pipeline and future growth.
Yahoo Finance 2026-06-18
Chai Discovery Collaborates with Lilly TuneLab to Offer AI Capabilities to Select Biotechs
Yahoo Finance 2026-06-18
Charles River Joins Lilly TuneLab to Optimize AI/ML Platform through Nonclinical Testing Expertise
Yahoo Finance 2026-06-18
AbbVie (ABBV) Lands New SKINVIVE Approval As CLL Trial Results Impress
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate 2026-06-18
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate
Yahoo Finance 2026-06-18
U.S. FDA Approves an Additional Indication for CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in Children and Adolescents Aged 2 through 17 at Increased Risk for Pneumococcal Disease
Yahoo Finance 2026-06-18
Eli Lilly and Company (LLY) is one of the Best Growth Stocks to Buy According Ray Dalio
Yahoo Finance 2026-06-18
Taking Advantage Of Short-Term Rotation With Eli Lilly Stock — From the end of 2019 through July 2024, Eli Lilly gained more than 600% with a compound annual growth rate over 55%.
Yahoo Finance 2026-06-18
AbbVie Declares Quarterly Dividend — (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.
Yahoo Finance 2026-06-18
Amgen's Diversified Business, Emerging Pipeline Drives Positive View, RBC Says — Amgen's (AMGN) well diversified business with no specific product driving over 10% of the top-line,
Yahoo Finance 2026-06-18
FDA Accepts Roche's Filing for Lunsumio VELO-Polivy in LBCL
Yahoo Finance 2026-06-18
Merck (MRK) Stock Falls Amid Market Uptick: What Investors Need to Know — In the closing of the recent trading day, Merck (MRK) stood at $113.87, denoting a -1.36% move from the preceding trading day.
Yahoo Finance 2026-06-19
Under Dave Ricks, Lilly Is Minting Money on GLP-1 Drugs and Spending It Wisely — Ricks has led a $50 billion manufacturing Marshall Plan in pharma to safeguard Lilly’s lead in obesity and diabetes treatments.
Yahoo Finance 2026-06-19
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Novo Nordisk faces limited upside from ZEUS trial as patent cliff looms, Deutsche Bank warns 2026-06-19
Novo Nordisk faces limited upside from ZEUS trial as patent cliff looms, Deutsche Bank warns — The analyst has set a target of DKK290, just 3.6% above the last closing price of DKK280.10, and maintains a hold...
Yahoo Finance 2026-06-19
Novo Bets Bigger on Obesity Research
ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain 2026-06-19
ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain
Yahoo Finance 2026-06-19
Novo Nordisk Rises as Foundation Launches EUR 60 Million Incubator — Novo Nordisk Foundation commits up to EUR 60 million for drug discovery projects
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026? 2026-06-19
Amgen vs. NovoCure: Which Health Care Stock Is a Better Buy in 2026?
Cathie Wood dumps nearly $60 million in popular growth stocks 2026-06-19
Cathie Wood dumps nearly $60 million in popular growth stocks
Yahoo Finance 2026-06-20
Novo Nordisk (CPSE:NOVO B) Launches CardioMetabolic Bridge To Speed New Obesity And Diabetes Therapies
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With T 2026-06-20
Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock?
Yahoo Finance 2026-06-20
Eli Lilly (LLY) Stock After 45% Yearly Gain Is The Valuation Still Justified — The share price most recently closed at US$1,098.57, with returns of 5.5% over the past month and 45.1% over the past year, while also showing a decline of 3.0% over the last week and a modest 1.7% gain year to date.
AbbVie's biggest deal since 2019 could land soon 2026-06-21
AbbVie's biggest deal since 2019 could land soon — AbbVie (ABBV) is closing in on a deal to buy Apogee Therapeutics for $10.9 billion in cash, according to a Reuters report citing people familiar with the matter in the Financial Times. The price values Apogee at a roughly 60% premium to its closing share price on Thursday, June 18, a steep markup ...
Yahoo Finance 2026-06-21
Novo Nordisk Data Breach: Hackers Claim To Have Stolen Drug Research, Trial Data And AI Models — Novo Nordisk A/S is investigating claims by cyber extortion group FulcrumSec, which alleges it stole more than a terabyte of data from the pharmaceutical company and is considering selling portions of the information after an unsuccessful $25 million ransom demand.
Yahoo Finance 2026-06-22
AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm
Yahoo Finance 2026-06-22
Why Merck (MRK) Is Using KEYTRUDA and WELIREG to Deepen Its Kidney Cancer Franchise — The stock made up 2.91% of the ETF as of June 17, 2026.
Yahoo Finance 2026-06-22
CKGSB Hosts 10th Economic Symposium in Beijing, Spotlighting China-ASEAN and China-Europe Economic Ties
Yahoo Finance 2026-06-22
BioArctic and Lilly sign research and collaboration agreement combining Lilly compound with BioArctic's BrainTransporter™ technology — As part of the agreement, BioArctic will receive USD 30 million in upfront payment.
Yahoo Finance 2026-06-22
Prolium Bioscience Sclerosis, Lupus Treatment Studies Advancing
Yahoo Finance 2026-06-22
BioHeartland Indiana Debuts at BIO 2026, Showcasing Indiana's Global Bioscience Leadership
Yahoo Finance 2026-06-22
AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers — On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics.
Yahoo Finance 2026-06-22
Lilly declares third-quarter 2026 dividend — The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2026 of $1.73 per share on outstanding common stock.
Yahoo Finance 2026-06-22
Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
Yahoo Finance 2026-06-22
Sector Update: Healthcare Stocks Rise Late Afternoon — Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.9% and
Yahoo Finance 2026-06-22
AbbVie's $10.9 Billion Apogee Deal Joins a $200 Billion Pharma Spree — The $135.11 per share cash offer for Apogee carries a 49% premium
Yahoo Finance 2026-06-22
Update: Equities Mixed Intraday, Oil Falls as US-Iran Talks Advance
Yahoo Finance 2026-06-22
AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion — AbbVie (NYSE:ABBV) has agreed to acquire Apogee Therapeutics in a cash deal valued at US$10.9b.
Yahoo Finance 2026-06-22
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer 2026-06-22
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer
Yahoo Finance 2026-06-23
Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger
Yahoo Finance 2026-06-23
Eli Lilly (LLY) Taps BioArctic As Dealmaking Push Broadens Its Pipeline
Yahoo Finance 2026-06-23
Willful Patent Infringement Verdict Might Change The Case For Investing In Amgen (AMGN) — In June 2026, a Delaware jury ruled that Amgen and its subsidiary Teneobio willfully infringed Harbour BioMed’s Grosveld patent, awarding Harbour US$20,203,704 in damages with the option to seek a tripling of that amount.
Lilly and BioArctic sign deal to develop neurodegenerative therapy 2026-06-23
Lilly and BioArctic sign deal to develop neurodegenerative therapy
Yahoo Finance 2026-06-23
Enanta Pharmaceuticals’ Partner AbbVie Receives European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus
Yahoo Finance 2026-06-23
Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy
Yahoo Finance 2026-06-23
AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection
Yahoo Finance 2026-06-23
AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis
Yahoo Finance 2026-06-23
Wells Fargo Maintains Overweight on AbbVie (ABBV), Sees Value in Apogee Acquisition — With a 5-Year Average Dividend Growth Rate of 6.33%, AbbVie Inc. It also set a $260 price target on the shares.
Yahoo Finance 2026-06-23
NVO Gains as Foundation Unveils EUR 60M Cardiometabolic Research Push — Novo Nordisk stock rises 6% after the launch of a EUR 60.2M foundation-backed initiative to speed cardiometabolic drug discovery and support Europe-wide innovation.
Yahoo Finance 2026-06-23
ABBV Jumps on Deepening Immunology Portfolio With $10.9B APGE Buyout — AbbVie shares jump after its $10.9B Apogee deal adds late-stage eczema and respiratory candidates, deepening its immunology pipeline.
Yahoo Finance 2026-06-23
Daniel M. Skovronsky, MD, PhD, appointed to Illumina's Board of Directors
Yahoo Finance 2026-06-23
ŌURA and LillyDirect to Expand Support for People Using GLP-1 Therapies with New Tools and Savings Options
AbbVie Secures EU Approval for Skyrizi in Pediatric Plaque Psoriasis (ABBV) 2026-06-23
AbbVie Secures EU Approval for Skyrizi in Pediatric Plaque Psoriasis (ABBV)
Yahoo Finance 2026-06-23
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE) in Canada, the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adult patien
Yahoo Finance 2026-06-23
How New Immunology and Vaccine Milestones At Merck (MRK) Have Changed Its Investment Story
Yahoo Finance 2026-06-23
Eli Lilly and Company (LLY) CEO on How GLP-1s Will Reshape America
Yahoo Finance 2026-06-23
Novo Nordisk A/S (NVO) Primary Owner to Open Obesity Drug Incubators Across Europe
Yahoo Finance 2026-06-23
Sector Update: Healthcare Stocks Higher Late Afternoon — Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index adding 1.5% and the St
Yahoo Finance 2026-06-23
Redditors Think Tempus AI (TEM) Still Has 10X Potential — We just covered the 10 Stocks That Will 10X According to Social Media. Tempus AI (NASDAQ:TEM) ranks #7 (see 5 Stocks That Will 10X According to Social Media).
Yahoo Finance 2026-06-23
EXEL Down on Colorectal Cancer Study Data on Zanzalintinib
Yahoo Finance 2026-06-23
Sector Update: Healthcare Stocks Advance in Afternoon Trading — Healthcare stocks rose Tuesday afternoon, with the NYSE Healthcare Index adding 1.4% and the State S
Yahoo Finance 2026-06-23
How Eli Lilly's CEO Plans to Defeat Pharma's Boom-Bust Cycle
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation 2026-06-23
VKTX Stock Clocks Best Day In Nearly 3 Months On Obesity Pipeline Optimism, Buyout Speculation
Thinking Thin Pays Off: Lilly To Dominate Pharma World By 2032 2026-06-23
Thinking Thin Pays Off: Lilly To Dominate Pharma World By 2032 — Lilly's expected global sales of $137 billion in 2032 will be driven by its weight-loss drugs.
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? 2026-06-23
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-06-23
Merck's Anti-TL1A Antibody Meets Goal in Ulcerative Colitis Study
LLY Stock Rides Trump Spotlight: President Touts Eli Lilly’s $3.5B Factory As Weight-Loss Pill Plans 2026-06-24
LLY Stock Rides Trump Spotlight: President Touts Eli Lilly’s $3.5B Factory As Weight-Loss Pill Plans Go Global — Trump said the new “state-of-the-art” facility would create over 1,000 jobs.
Yahoo Finance 2026-06-24
Adding Eli Lilly’s R&D Chief to the Board Might Change The Case For Investing In Illumina (ILMN)
Yahoo Finance 2026-06-24
Abbisko Therapeutics Deepens R&D Collaboration with Lilly
Yahoo Finance 2026-06-24
Abridge CEO Dr. Shiv Rao Elaborates on New Partnerships with Eli Lilly + Nvidia
Yahoo Finance 2026-06-24
AbbVie Gets EU Nod for Skyrizi in Pediatric Plaque Psoriasis
Yahoo Finance 2026-06-24
Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays’ Target Increase? — TheFly reported on June 17 that Barclays maintained its Overweight rating on HIMS while increasing its price target to $39.00 from $29.00.
Yahoo Finance 2026-06-24
Is Novo Nordisk A/S (NVO) Strengthening Its Weight-Loss Leadership With Oral Wegovy Launch?
Yahoo Finance 2026-06-24
Is Merck & Co., Inc. (MRK) Strengthening Its Vaccine Portfolio With New Capvaxive Approval?
Yahoo Finance 2026-06-24
Enanta Pharmaceuticals (ENTA) Moves 5.2% Higher: Will This Strength Last?
Yahoo Finance 2026-06-24
Top Research Reports for Shell, Novo Nordisk & SAP
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise 2026-06-24
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise
Yahoo Finance 2026-06-24
Abu Dhabi Announces Partnership with MSD to Advance Operational Excellence and Expand Access across the Region
Yahoo Finance 2026-06-24
Why Illumina (ILMN) Stock Is Trading Up Today — Shares of genomics company Illumina (NASDAQ:ILMN) jumped 6.6% in the morning session after it appointed a high-profile Eli Lilly executive to its board and a price target increase from Barclays.
Yahoo Finance 2026-06-24
[Latest] Global Density Gradient Media Market Size/Share Worth USD 5.3 Billion by 2035 at a 11.5% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growt — [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Density Gradient Media Market size & share revenue was valued at approximately USD 1.8 Billion in 2025 and is expected to reach USD 2 Billion in 2…
Yahoo Finance 2026-06-24
Gilead Wins EC Approval to Expand Trodelvy's Label in Metastatic TNBC
Yahoo Finance 2026-06-24
Is Eli Lilly and Company (LLY) Strengthening Its Pain Management Strategy With New Biotech Acquisition?
Yahoo Finance 2026-06-24
NYSE Content Update: Abridge Partners with Eli Lilly, Nvidia to Improve Healthcare
Yahoo Finance 2026-06-24
Lilly completes acquisition of Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Yahoo Finance 2026-06-25
The Bull Case For Eli Lilly (LLY) Could Change Following New Multi‑Target R&D Alliances With Biotechs — In recent days, Abbisko Therapeutics and BioArctic each announced new research and license agreements with Eli Lilly, adding multi-target discovery work worth up to about US$1.90 billion in milestones for Abbisko and up to US$770 million for BioArctic, alongside royalties on any future product sales.
Yahoo Finance 2026-06-25
2 Healthcare Stocks to Consider Right Now and 1 We Brush Off — Players catalyzing medical advancements have benefited from elevated demand, which has supported the industry’s returns lately - over the past six months, healthcare stocks have gained 7.6%, nearly mirroring the S&P 500.
Yahoo Finance 2026-06-25
The Zacks Analyst Blog Highlights Shell, Novo, SAP, Rave and Vaso
Yahoo Finance 2026-06-25
Eli Lilly and Company (LLY) – Among the 10 Reliable Dividend Stocks to Buy for Long-Term Investors
Yahoo Finance 2026-06-25
Merck (MRK) Stock Gets New Outperform Rating from CICC — It also set a $138 price target on the stock.
Yahoo Finance 2026-06-25
Canaccord Says AbbVie’s (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook — (NYSE:ABBV) to $273 from $265.
Yahoo Finance 2026-06-25
Formula Wellness Earns Top 50 Status for 2026 from Allergan Aesthetics
Yahoo Finance 2026-06-25
Bio-Techne Is Today’s Top S&P 500 Stock. Germany’s Merck Is Paying a 24% Premium for the Company. — Shares of Bio-Techne surged Thursday after Germany’s Merck KGaA announced it agreed to purchase the company for $11.3 billion. Bio-Techne stock jumped 19% to $70.25 on Thursday, leading the for the trading session and set to log its best daily percentage gain since May 1, 2003, according to Dow Jones Market Data.
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion 2026-06-25
Merck KGaA to buy Bio-Techne for $11.3bn in life science footprint expansion — The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.
Yahoo Finance 2026-06-25
Gilead's Breast Cancer Drug Trodelvy Wins FDA Nod for Expanded Use
Yahoo Finance 2026-06-25
VKTX Stock Jumps on Phase I Study Initiation for New Obesity Drug
Yahoo Finance 2026-06-25
Lexaria's Human Study GLP-1-H26-7 Has Begun Dosing on Schedule
Yahoo Finance 2026-06-25
Bio-Techne to Be Acquired by Germany's Merck in $11.3 Billion Deal
Yahoo Finance 2026-06-25
Candel Therapeutics Designates Mark Sims as CCO
Yahoo Finance 2026-06-25
Sector Update: Healthcare Stocks Gain Late Afternoon — Healthcare stocks rose late Thursday afternoon with the NYSE Healthcare Index gaining 1.7% and the S
Yahoo Finance 2026-06-25
Novo Nordisk (CPSE:NOVO B) Wins UK Approval For Oral Wegovy With Wider Consumer Ripple Effects
Germany’s Merck to Acquire Bio-Techne in $11.3 Billion Deal 2026-06-25
Germany’s Merck to Acquire Bio-Techne in $11.3 Billion Deal
Yahoo Finance 2026-06-25
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), each with Trodelvy® (sacituzumab govitecan-hziy) as First-Line Treatment of PD-L1+ (CPS ≥10)
Yahoo Finance 2026-06-25
What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management
Yahoo Finance 2026-06-25
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement — (Nasdaq: PRQR) (“ProQR”), a clinical-stage biotechnology company dedicated to changing lives through transformative RNA therapies based on its proprietary Axiomer™ RNA editing technology platform, today announced the pricing of an underwritten registered direct offering of 27,624,310 ordinary shares (the “Offering”) at an offering price of $1.81 per share (the “Offering Pric…
WSJ 2026-06-25
Germany’s Merck to Buy Bio-Techne for $11 Billion — Merck KGaA offered $73 a share in cash for Bio-Techne, representing a 24% premium to the U.S. lab-tools supplier’s closing price Wednesday.
Yahoo Finance 2026-06-26
Bio-Techne (TECH) Soars 20% on Merck $11.3B Merger — Bio-Techne rallied for a third straight day on Thursday, surging 20.08 percent to close at $70.70 apiece, as investors gobbled up shares following news that it is merging with pharmaceutical giant Merck for $11.3 billion.
Yahoo Finance 2026-06-26
Nancy Pelosi Stock Tracker Flags Eli Lilly, Nokia After Trump Praise: ‘Keep An Eye On These Two’
Yahoo Finance 2026-06-26
Will AbbVie's (ABBV) Pediatric Expansions Reveal a Deeper Shift in Its Growth Mix?
Yahoo Finance 2026-06-26
Eli Lilly (LLY) Acquires Centessa Pharmaceuticals to Advance Orexin Receptor 2 Agonists
Yahoo Finance 2026-06-26
Why Moderna Stock Is Soaring and Leading the S&P 500 Today
Yahoo Finance 2026-06-26
Nike Stock Languishes, But Looming Earnings Report Fuels Turnaround Optimism
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca 2026-06-26
Eli Lilly shares rise after EU panel backs expanded use of Jaypirca — Eli Lilly and Co (NYSE:LLY) shares climbed nearly 6% on Friday after the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval of Jaypirca (pirtobrutinib) for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy.
Yahoo Finance 2026-06-26
Is Charles River (CRL) Quietly Redefining Its Moat Through Lilly’s AI-Driven TuneLab Collaboration?
Yahoo Finance 2026-06-26
Merck & Co., Inc. (MRK) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-06-26
Merck KGaA (MKKGY) Soars 5.3%: Is Further Upside Left in the Stock?
Yahoo Finance 2026-06-26
Amgen's Tavneos Faces EU Revocation After CHMP Review
Yahoo Finance 2026-06-26
SKYRIZI® (risankizumab-rzaa) Now FDA Approved for Pediatric Use in Psoriatic Disease
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services 2026-06-26
FDA accepts Replimune filing; Merck KGaA drops $11B on life sciences services — Elsewhere, Revolution Medicines outlined more RAS-blocking data and a Definium stock offering brought in $800 million.
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value? 2026-06-26
Fidelity (FHLC) vs. iShares (IXJ): Which Healthcare ETF Delivers Better Value?
Yahoo Finance 2026-06-26
Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
Yahoo Finance 2026-06-26
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences (GILD) Following Positive HIV Trial Results — Cantor Fitzgerald restated an Overweight rating and a $155 price target for Gilead Sciences Inc.
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy 2026-06-26
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy
Yahoo Finance 2026-06-26
Why Is Eli Lilly (LLY) Stock Soaring Today — Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 6.3% in the afternoon session after the European Medicines Agency's committee for human medicines backed its cancer drug, Jaypirca, and the company's popular weight-loss treatments were set for inclusion in a new Medicare program.
Yahoo Finance 2026-06-26
Merck (MRK) Gains As Market Dips: What You Should Know — Merck (MRK) closed the most recent trading day at $128.66, moving +2.56% from the previous trading session.
The $11 Billion Reason TECH Stock Is Up Today 2026-06-26
The $11 Billion Reason TECH Stock Is Up Today — Bio-Techne stock rallies as Merck announces an agreement to acquire it for $73 per share.
Yahoo Finance 2026-06-26
Piper Sandler and Morgan Stanley Highlight Amgen (AMGN) on Pipeline Strength and Obesity Drug Potential — On June 12, Piper Sandler reaffirmed its Overweight rating and $427 price target for Amgen Inc.
Yahoo Finance 2026-06-27
Eli Lilly (LLY) Wins EMA Backing For Jaypirca In Chronic Lymphocytic Leukemia
Yahoo Finance 2026-06-27
Eli Lilly Leads 5 Stocks Near Buy Points As The Market Rally Rotates
Yahoo Finance 2026-06-27
Eli Lilly (LLY) Announces Positive Phase 3 Results for Jaypirca Combination in Relapsed CLL/SLL
Yahoo Finance 2026-06-27
AbbVie (ABBV) to Acquire Apogee Therapeutics
Yahoo Finance 2026-06-27
Eli Lilly (LLY) and BioArctic AB Enter into Research and Collaboration Agreement
Yahoo Finance 2026-06-27
Is Novo Nordisk (NVO) One of the Best Low Volatility Stocks to Buy Under $50? — Novo Nordisk A/S (NYSE:NVO) is one of the best low volatility stocks to buy under $50.
Yahoo Finance 2026-06-27
Here’s What the Street Thinks About Eli Lilly and Company (LLY) — The firm lifted the price target on the stock to $1,232 from $1,119 and maintained an Outperform rating on the shares.
Yahoo Finance 2026-06-28
Gilead (GILD) Wins FDA Approval for Trodelvy in TNBC
Yahoo Finance 2026-06-28
AbbVie (ABBV) Wins Health Canada Approval for Boey
Yahoo Finance 2026-06-28
RBC Capital Maintains a Sector Perform Rating on Regeneron (REGN) – Here’s Why — (NASDAQ:REGN) on June 22, setting a $707 price target.
Yahoo Finance 2026-06-29
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
Yahoo Finance 2026-06-29
Eli Lilly and Company (LLY) Up More Than 6% Over the Past Month, Can it Move Higher? — Eli Lilly and Company (NYSE:LLY) has gained roughly 6% over the past 30 days, and the Street expects more than 13.6% upside from the current level.
Yahoo Finance 2026-06-29
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Yahoo Finance 2026-06-29
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults and Adolescents with Non-segmental Vitiligo
Yahoo Finance 2026-06-29
2 S&P 500 Stocks with Promising Prospects and 1 We Find Risky
Yahoo Finance 2026-06-29
Stock Market News for Jun 29, 2026
Yahoo Finance 2026-06-29
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-06-29
Gilead (GILD) Moves 3.3% Higher: Will This Strength Last?
Yahoo Finance 2026-06-29
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-06-29
Is AbbVie (ABBV) One of the 10 Best July Dividend Stocks to Buy?
Yahoo Finance 2026-06-29
AbbVie Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Yahoo Finance 2026-06-29
AbbVie (ABBV) Stock After 1-Year 41% Rally And Apogee Deal Valuation Check — AbbVie has recently traded at US$253.35, with returns of 10.1% over 7 days, 16.4% over 30 days, 10.5% year to date, 40.9% over 1 year, 109.0% over 3 years and 165.3% over 5 years, which has naturally focused attention on whether the current price fairly reflects the business.
Yahoo Finance 2026-06-29
MRNA Stock Jumps to 52-Week High on Expansion Plans Beyond Vaccines
Yahoo Finance 2026-06-29
AbbVie (ABBV) Wins Backing For Two RINVOQ Skin Disease Uses In Europe
Yahoo Finance 2026-06-29
ABBV Gets CHMP Nod for Rinvoq in Two Different Autoimmune Diseases
Yahoo Finance 2026-06-29
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?
Yahoo Finance 2026-06-29
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know — The latest trading day saw Eli Lilly (LLY) settling at $1, representing a +1.81% change from its previous close.
Yahoo Finance 2026-06-29
REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone — REGENXBIO will receive $100 million from AbbVie for this milestone.
Yahoo Finance 2026-06-29
Merck Announces New Agreement with ADAP Crisis Task Force to Improve Access and Care for People Living with HIV
Yahoo Finance 2026-06-29
Lilly (LLY) Moves 7.1% Higher: Will This Strength Last?
Yahoo Finance 2026-06-30
Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China
Yahoo Finance 2026-06-30
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases — This marks the fourth R&D milestone achieved under the collaboration, and the second in 2026, reflecting the steady progress of development under the collaborationUnder the terms of the agreement, Nxera is eligible to receive up to US$1.2 billion in potential option, development and commercial milestones, in addition to tiered royalties based on sales Tok…
Yahoo Finance 2026-06-30
Amgen (AMGN) Stock Weighs Strong Run Against Mixed Valuation Signals — Amgen shares last closed at US$360.55, with returns of 3.9% over the past week, 7.1% over the past month, 10.0% year to date, 27.8% over one year, 75.7% over three years, and 73.2% over five years.
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years 2026-06-30
Eli Lilly Is Dominating the GLP-1 Market: Here's What a $5,000 Investment Could Look Like in 5 Years
Yahoo Finance 2026-06-30
Merck's Lung Cancer Drug Seen Boosting Sales Potential, BofA Says
Yahoo Finance 2026-06-30
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters?
Yahoo Finance 2026-06-30
Shantha Biologics Announces Cartridge Fill-Finish Collaboration
Yahoo Finance 2026-06-30
AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance 2026-06-30
TRexBio Announces Pipeline Progress, Naming TRB-071 as a CD30 Agonist for Immune-Mediated Diseases and Advancement of Lilly-Partnered TRB-051
Yahoo Finance 2026-06-30
Amgen (AMGN) Faces EU Push To Revoke Tavneos Approval
Yahoo Finance 2026-06-30
Medicare GLP-1 Bridge Program Will Pay for Novo, Lilly Drugs
Yahoo Finance 2026-06-30
Sector Update: Healthcare Stocks Softer Late Afternoon — Healthcare stocks were lower late Tuesday afternoon, with the NYSE Healthcare Index decreasing 0.9%
Yahoo Finance 2026-06-30
Roche Gets FDA Priority Review for Enspryng in Thyroid Eye Disease
Yahoo Finance 2026-06-30
Merck (MRK) Faces U.S. Security Probe Over China Clinical Trials
Yahoo Finance 2026-06-30
Eli Lilly Hands China Sales Rights for Verzenio to Innovent
Yahoo Finance 2026-06-30
What Sparked the $43B Jump in AbbVie's Market Cap in the Past Week? — ABBV surged nearly 11% in a week as acquisitions, new approvals and pipeline expansion strengthen confidence in its long-term growth strategy.
Yahoo Finance 2026-06-30
Amgen Faces Fresh Pressure After NEJM Retracts Trial Behind $459 Million Drug
Yahoo Finance 2026-06-30
Pivotal Week Ahead: Warsh's Hawkish Turn, June Jobs Report on Deck
Yahoo Finance 2026-06-30
Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know
Merck, AbbVie investigated over China military hospital drug trials 2026-06-30
Merck, AbbVie investigated over China military hospital drug trials
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? 2026-06-30
Recursion Pharmaceuticals vs. Summit Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-06-30
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
Yahoo Finance 2026-07-01
Novo Nordisk (CPSE:NOVO B) Enlists Shantha Biologics For Cartridge Manufacturing In India — The stock is up 2.2% over...
Yahoo Finance 2026-07-01
AAHRPP Accredits Five More Research Entities
Beyond the GLP-1RA weight loss ceiling 2026-07-01
Beyond the GLP-1RA weight loss ceiling — Eli Lilly’s retatrutide has crossed the 30% weight loss benchmark in some patients.
Yahoo Finance 2026-07-01
Novo Nordisk (NVO) Upgraded to Buy at Nordea. Here is Why — With an annual dividend yield of 3.75%, Novo Nordisk A/S (NYSE:NVO) is included among the 12 Best NYSE Stocks to Buy for Dividends.
Yahoo Finance 2026-07-01
Eli Lilly (LLY) Faces China Trial Security Probe From U.S. Lawmakers
Yahoo Finance 2026-07-01
Amgen or Biogen: Which Biotech Stock Appears Better Poised?
Yahoo Finance 2026-07-01
Zacks Investment Ideas feature highlights: Eli Lilly and Altria
Yahoo Finance 2026-07-01
ARTAN Bio Closes $1 Million Seed Round to Advance its tRNA Platform Toward Human Studies — Petersburg, Florida, today announced the close of a $1 million seed round led by company co-founder Michael Torres, Ph.D., following his role as Co-Founder and Chief Executive Officer of CrossBridge Bio through its acquisition by Eli Lilly.
Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown 2026-07-01
Medical journal retracts Tavneos pivotal paper amid wider regulatory clampdown
Yahoo Finance 2026-07-01
Merck to Hold Second-Quarter 2026 Sales and Earnings Conference Call Aug. 4
Yahoo Finance 2026-07-01
AbbVie Inc. (ABBV) Hits New Milestone with Venetoclax on Chronic Lymphocytic Leukemia (CLL) Treatment
Yahoo Finance 2026-07-01
Eli Lilly Hits Highs on GLP-1 Medicare Inclusion, Huge Results — Eli Lilly and Company (LLY) shares up 18,585% since Big Money bought big in 1990.
Yahoo Finance 2026-07-01
Mizuho Highlights Amgen (AMGN) Pipeline Potential With MariTide and Olpasiran — (NASDAQ:AMGN) to $303 from $295 while keeping a Neutral rating on the company’s shares, with the firm highlighting MariTide and olpasiran as crucial focal points for the company.
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership 2026-07-01
MRK, NEUP Stocks Drop As Merck Scraps Another Alzheimer’s Drug Trial Under Neuphoria Partnership
Yahoo Finance 2026-07-01
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note — In the latest trading session, Novo Nordisk (NVO) closed at $48.77, marking a +1.73% move from the previous day.
Heavy, Unusual Put Option Volume Today in Novo Nordisk - Is NVO Overvalued? 2026-07-01
Heavy, Unusual Put Option Volume Today in Novo Nordisk - Is NVO Overvalued?
Yahoo Finance 2026-07-01
H.C. Wainwright Keeps Buy Rating on Oruka (ORKA) After Apogee Acquisition News — (NASDAQ:ORKA) with a price target of $120 on the stock.
Yahoo Finance 2026-07-02
Brenus Pharma Strengthens Its Governance With Designation of a New President and Appointment of Former Novo Nordisk EVP as Independent Member
Yahoo Finance 2026-07-02
Healthcare Stocks Rise To The Heart Of IBD's Elite List Of Growth Names
Yahoo Finance 2026-07-02
Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock?
Roche KRAS drug succeeds in head-to-head lung cancer study 2026-07-02
Roche KRAS drug succeeds in head-to-head lung cancer study
WSJ 2026-07-02
Roche Lung-Cancer Drug Candidate Beats Existing Therapies in Late-Stage Trial
Yahoo Finance 2026-07-02
European Stocks Surge, Oil Prices Drop; Defense, Luxury Shares Rally
Yahoo Finance 2026-07-03
Amgen (AMGN) Stock Is Up, What You Need To Know — Shares of biotech company Amgen (NASDAQ:AMGN) jumped 3.1% in the afternoon session after the company received a favorable court ruling that blocked a first-of-its-kind state price cap on its blockbuster drug, Enbrel.
Yahoo Finance 2026-07-03
[Latest] Global Antidiabetic Drugs Market Size/Share Worth USD 309.84 Billion by 2035 at a 11.62% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growt — [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Antidiabetic Drugs Market size & share revenue was valued at approximately USD 103.21 Billion in 2025 and is expected to reach USD 115.02 Billion…
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026? 2026-07-03
Moderna vs. Recursion: Which Cutting-Edge Pharma Stock Is a Better Buy in 2026?
Yahoo Finance 2026-07-03
Lexicon Pharmaceuticals (LXRX) Gains on Russell 3000 Inclusion — (NASDAQ:LXRX) has gained more than 15% over the past month, mainly driven by the stock’s inclusion in the Russell 3000 index and strong Q1 2026 earnings. Wall Street expects more than 21% upside over the next 12-months making Lexicon Pharmaceuticals, Inc.
Yahoo Finance 2026-07-03
Can Medicare Bridge Help Novo Nordisk Defend Its GLP-1 Leadership?
Yahoo Finance 2026-07-03
Novo Nordisk (NVO) Is At The Center Of A Fast Growing Diabetes Drug Market
Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It. 2026-07-03
Social Security Pays $2,081 a Month. Here’s How Much You Need Invested to Match It. — The average Social Security retirement check reached $2,081 per month as of April 2026, according to the Social Security Administration’s monthly statistical data. That figure carries the 2.8% cost-of-living adjustment that took effect in January 2026. Social Security Pays $2,081 a Month.
Yahoo Finance 2026-07-03
Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
Yahoo Finance 2026-07-03
WST Stock Up Nearly 33% YTD: Will the Uptrend Continue in the Rest of 2026? — WST has surged nearly 33% YTD as strong earnings, GLP-1 demand and biologics growth fuel momentum that could extend through 2026.
Yahoo Finance 2026-07-03
MRNA Stock on the Move: What Sparked the 33.5% Jump in the Past Week? — Moderna surges 33.5% after the company outlines plans to expand its mRNA platform beyond vaccines into oncology, autoimmune diseases and cell therapies.
Novo Nordisk (NVO) Stock May Be 48% Undervalued On Medicare GLP 1 Coverage 2026-07-03
NVO down 32.7% over three years but DCF suggests intrinsic value — potential mean reversion opportunity
Yahoo Finance 2026-07-03
AbbVie (ABBV) Faces Congressional Probe Over China Clinical Trials
Yahoo Finance 2026-07-03
Q1 Earnings Highlights: AbbVie (NYSE:ABBV) Vs The Rest Of The Therapeutics Stocks
Yahoo Finance 2026-07-04
Merck (MRK) Wins New KEYTRUDA Approvals As Tulisokibart Clears A Phase 3 Test
Yahoo Finance 2026-07-05
Trump’s FDA May Soon Throw Its Weight Behind Peptides. Should You Buy In?
Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year 2026-07-05
Six Dividend Aristocrats Keeping SCHD’s Income Stream Bulletproof This Year — The fund holds $71.6 billion in assets at an expense ratio of just 0.06%, and it tracks the Dow Jones U.S.
Lilly quietly hands Chinese partner its cancer drug 2026-07-06
Lilly quietly hands Chinese partner its cancer drug
Yahoo Finance 2026-07-06
The Cancer Therapy Strategy VERAXA Is Betting the Company On
Yahoo Finance 2026-07-06
Abivax Rebounds, but Obefazimod Unlikely to Replace JAK Inhibitors, Wedbush Says
Yahoo Finance 2026-07-06
Eli Lilly and Company (LLY) Fell on Regulatory And Pricing Policy Challenges
Yahoo Finance 2026-07-06
Investors Heavily Search Eli Lilly and Company (LLY): Here is What You Need to Know
Yahoo Finance 2026-07-06
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-07-06
Will the Label Expansion of Trodelvy Strengthen GILD's Oncology Portfolio?
Yahoo Finance 2026-07-06
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? 2026-07-06
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026? — Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Yahoo Finance 2026-07-06
Amgen (AMGN) Upgraded to Buy: What Does It Mean for the Stock?
Yahoo Finance 2026-07-06
Amgen (AMGN) Stock Dips While Market Gains: Key Facts — Amgen (AMGN) closed the most recent trading day at $366.44, moving 2.06% from the previous trading session.
A 2.86% Yield, 0.08% Fee, and 75 Stocks: Is HDV the Anti-Hype ETF? 2026-07-06
A 2.86% Yield, 0.08% Fee, and 75 Stocks: Is HDV the Anti-Hype ETF? — Dividend funds pulled in $24.1 billion in the first quarter of 2026, their strongest opening quarter in four years, and a lot of that cash went looking for a boring place to hide from AI-hype exhaustion. HDV holds 75 positions, charges 0.08%, and yields ...
Yahoo Finance 2026-07-06
Merck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade — Merck (MRK) concluded the recent trading session at $126.78, signifying a -2.15% move from its prior day's close.
Yahoo Finance 2026-07-07
Eli Lilly (LLY) Expands R And D Reach With Abbisko And China Drug Handover
Yahoo Finance 2026-07-07
3 Market-Beating Stocks Worth Investigating
Kailera says obesity pill succeeds in late-stage trial in China 2026-07-07
Kailera says obesity pill succeeds in late-stage trial in China — The drug spurred about 10% weight loss over 10 months, though that finding came alongside high rates of gastrointestinal side effects that “alarmed” one analyst.
Yahoo Finance 2026-07-07
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in t 2026-07-07
Eli Lilly and Novo Nordisk Are Fine -- but These 2 Stocks Could Be an Even Better Way to Invest in the GLP-1 Boom
Yahoo Finance 2026-07-07
Why Eli Lilly (LLY) Stock Is Trading Up Today — Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 2.8% in the afternoon session after JPMorgan's Chris Schott raised his price target to $1,400 from $1,300, reiterating an Overweight rating.
Yahoo Finance 2026-07-07
Eli Lilly (LLY) After The China Verzenios Shift And The Valuation Debate — The stock gave back some ground in the latest session as the share price fell 1.14% to US$1,200.06, yet it is still showing firm momentum with a 30 day share price...
Yahoo Finance 2026-07-07
Sector Update: Healthcare Stocks Gain Late Afternoon
Yahoo Finance 2026-07-07
Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant
Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They’re Dead Wrong 2026-07-07
Everyone Thinks the Eli Lilly Story Is Played Out. Cramer Thinks They’re Dead Wrong
Yahoo Finance 2026-07-07
Eli Lilly's Market Cap Balloons Again On This IPO's Setback
Yahoo Finance 2026-07-07
Amgen (AMGN) Recalls Sensipar And Corlanor In Broad US Quality Sweep
Yahoo Finance 2026-07-07
EU Approves Expanded Use of ABBV's Tepkinly in Follicular Lymphoma
Yahoo Finance 2026-07-07
The Zacks Analyst Blog Highlights Eli Lilly, HSBC, Palantir and CBL & Associates
Yahoo Finance 2026-07-08
Amgen (AMGN) Recalls Put Its Valuation Story Back In Focus — Against this recall backdrop, Amgen’s recent momentum has stayed intact, with a 30 day share price return of 5.30% and a year to date share price return of 12.35%. The 1 year total shareholder return of 27.66% and 3 year...
Yahoo Finance 2026-07-08
Is AbbVie (ABBV) Fully Valued After Its Tepkinly Approval? — Against this backdrop of oncology approvals and index inclusions, AbbVie’s recent momentum is clear, with a 30 day share price return of 12.07% and a 90 day share price return of 20.35%, while 1 year...
Yahoo Finance 2026-07-08
Eli Lilly Expected to Beat Q2 Revenue Forecasts on Weight-Loss Drugs, RBC Says
Yahoo Finance 2026-07-08
Eli Lilly Weight-Loss, Diabetes Franchise to Drive Second Quarter Sales Beat, RBC Says
Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown 2026-07-08
Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdown — Shares in Novo Nordisk (NYSE:NVO) fell 2.5% to DKK319.20 after Deutsche Bank pointed to a continued slowdown in the oral version of the company's Wegovy weight-loss drug in the US.
Yahoo Finance 2026-07-08
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now?
Yahoo Finance 2026-07-08
MRK Surpasses 50- & 200-Day SMAs: Buy, Hold or Sell at Current Levels?
Leading bank backs European pharma as the cleaner alternative to the AI trade 2026-07-08
Leading bank backs European pharma as the cleaner alternative to the AI trade
Yahoo Finance 2026-07-08
Stocks To Watch: 14 Names Test And Tease New Buy Zones
Yahoo Finance 2026-07-08
Will New KEYTRUDA Breast and Bladder Cancer Approvals Redefine Merck’s (MRK) Post-Exclusivity Narrative?
Yahoo Finance 2026-07-08
Sector Update: Healthcare Stocks Decline Late Afternoon — Healthcare stocks were lower late Wednesday afternoon, with the NYSE Healthcare Index down 0.9% and
Yahoo Finance 2026-07-08
Sector Update: Healthcare Stocks Lower Wednesday Afternoon
Yahoo Finance 2026-07-08
Former Merck and NASA Veterans Join SpaceMD as Space Pharma Momentum Builds
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant 2026-07-08
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
Yahoo Finance 2026-07-08
Former Merck and NASA Leaders Bring Strategic Expertise to SpaceMD Amid Rising Demand for its In-Space Pharmaceutical Development Capabilities
Yahoo Finance 2026-07-08
Merck (MRK) Gets New HIV Access Deal As Its Valuation Narrative Stays In Focus — Merck shares recently pulled back, with a 1-day share price return declining 2.23% to close at US$125.99. However, the 30-day share price return of 5.41% and 1-year total shareholder return of 55.54% point to momentum that remains broadly positive.
AbbVie Earnings Preview: What to Expect 2026-07-08
AbbVie Earnings Preview: What to Expect
GLP-1 weight-loss drug popularity reaches new heights with Americans 2026-07-09
GLP-1 weight-loss drug popularity reaches new heights with Americans
Yahoo Finance 2026-07-09
Innovent’s China Verzenios Deal and New Jaypirca Nod Might Change The Case For Investing In Eli Lilly (LLY)
Yahoo Finance 2026-07-09
1 Unpopular Stock That Should Get More Attention and 2 That Underwhelm
Yahoo Finance 2026-07-09
Southeast Asia Oncology Drug Access Market Now Available; Profiles Roche, AstraZeneca, Merck, and Other Key Peers
Yahoo Finance 2026-07-09
Cystic Fibrosis Market, Global & Regional Now Available; Profiles Vertex Pharmaceuticals, AbbVie, and Other Frontrunner Competitors in Orphan Drug Markets — Predominantly affecting Western populations, over 30,000 people in the U.S. live with this genetic disorder.
Yahoo Finance 2026-07-09
Buyout Buzz Around VKTX Is Back: What's Fueling the Speculation?
Yahoo Finance 2026-07-09
WST Completes SmartDose Sale to AbbVie to Focus on Core Growth
Yahoo Finance 2026-07-09
Eli Lilly Stock Gets a Lift After Canada Backs Eczema Drug
Yahoo Finance 2026-07-09
Novo Nordisk (NVO) In Focus After Wegovy Label Update As Undervalued Narrative Holds — The updated Wegovy data lands against a mixed backdrop for Novo Nordisk’s stock, with the share price up 19.19% over 30 days and 30.58% over 90 days, yet the 1 year total shareholder return is down 27.53% and the 3 year total...
Yahoo Finance 2026-07-09
EXEL Stock Soars 26.8% in Three Months: Is There More Room for Growth?
Yahoo Finance 2026-07-09
/C O R R E C T I O N -- Eli Lilly and Company/
Yahoo Finance 2026-07-09
Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With STEP UP Data — Novo Nordisk, trading at $48.89, sits at the center of renewed interest in obesity...
Yahoo Finance 2026-07-09
Stocks Look Shaky, But This Sector is Booming (Biotech)
Yahoo Finance 2026-07-09
Truist Raises its Price Target on Amgen (AMGN) — (NASDAQ:AMGN) to $340 from $327 as part of a broader Q2 earnings preview for biotech.
Yahoo Finance 2026-07-09
Novo Nordisk (CPSE:NOVO B) Could Be 13% Overvalued Following Its Vivani Deal — The Vivani agreement lands at a time when Novo Nordisk’s DKK323.15 share price has shown strong short term momentum, with a 30 day share price return of 18.81% and a 90 day share price return of 35.72%.
Yahoo Finance 2026-07-09
Lilly to present Alzheimer's disease diagnostic and therapeutic research at AAIC 2026, including new data on P-tau217 blood tests and amyloid-targeting treatment
Yahoo Finance 2026-07-10
Zacks Investment Ideas feature highlights: XLV, XBI, LLY, EXEL, PTCT, FTRE and ILMN
Yahoo Finance 2026-07-10
3 Psychedelic Stocks With Potential Clinical Trial Catalysts
Yahoo Finance 2026-07-10
AI Revolutionizes Cardiovascular Drug Development with $1.4+ Billion in Strategic Investments
Yahoo Finance 2026-07-10
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week 2026-07-10
Here's Why Shares in Novo Nordisk Rival, Agios Pharmaceutical, Soared This Week
Yahoo Finance 2026-07-10
West Pharmaceutical Services (WST) Sells SmartDose Rights To AbbVie To Refocus Its Business
Yahoo Finance 2026-07-10
FDA Approves KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each With Padcev® (enfortumab vedotin-ejfv), as Treatment Before and After Surgery for Adults
Yahoo Finance 2026-07-10
NVO Rallies 11% in a Month: How Should Investors Play the Stock? — Novo Nordisk stock gains 11% in a month as Wegovy access expands and U.K. approval boosts optimism, but rising competition and earnings pressure cloud the outlook.
Yahoo Finance 2026-07-10
Merck (MRK) Stock Sinks As Market Gains: Here's Why — In the closing of the recent trading day, Merck (MRK) stood at $123.54, denoting a -1.22% move from the preceding trading day.
Yahoo Finance 2026-07-11
Eli Lilly (LLY) To Share New Kisunla And Alzheimer’s Blood Test Data At AAIC
3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026 2026-07-11
3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026
Yahoo Finance 2026-07-13
Sofinnova Partners Appoints David Evans as Partner
Yahoo Finance 2026-07-13
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-07-13
Immutep Provides Clinical Update in 1st line NSCLC: Positive Mature Overall Survival Data from INSIGHT-003 and Update from TACTI-004 — INSIGHT-003 demonstrates mature mOS of 30.9 months in both the overall population (N=51) and patients with TPS <50% (N=47) in 1L non-squamous NSCLCOutcomes continue to compare favourably with historical benchmarksPreliminary immune monitoring data indicate that patients treated with efti in TACTI-004 exhibited a different immune activation pr…
Yahoo Finance 2026-07-13
Capital Square Fully Subscribes Richmond Active-Adult DST Offering
Own Regeneron For Biotech Growth? Incyte Is Making Its Case. 2026-07-13
Own Regeneron For Biotech Growth? Incyte Is Making Its Case.
Yahoo Finance 2026-07-13
Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece — Cosmos Health will supply DIABIT-IS X (sitagliptin), while Libytec handles distribution and promotion in GreeceFive-year agreement expected to contribute to revenue and cash-flow visibilityAs a prescription medicine, DIABIT-IS X is expected to be accessible to patients through Greece's national health insurance system, broadening its potential reachDIABI…
Yahoo Finance 2026-07-13
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
MDGL Stock In Focus — Retail Traders Buzz Over M&A Speculation And Fresh Patents For Liver Drug 2026-07-13
MDGL Stock In Focus — Retail Traders Buzz Over M&A Speculation And Fresh Patents For Liver Drug
Yahoo Finance 2026-07-14
Amgen (AMGN) Stock May Be 47% Undervalued After Enbrel Price Cap Ruling — Amgen stock has delivered a strong 73.5% return over the last three years, and the current checks suggest a mixed picture on value, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to upside while market based multiples look closer to fair.
Yahoo Finance 2026-07-14
Novo Nordisk (CPSE:NOVO B) Reports Fresh Hemophilia Trial Wins In Adults And Children
Yahoo Finance 2026-07-14
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It
Yahoo Finance 2026-07-14
SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development
Yahoo Finance 2026-07-14
Eli Lilly Wins Full FDA Approval for Selpercatinib in Solid Tumors
Yahoo Finance 2026-07-14
The Race to Commercialize the World’s Most Powerful Psychedelic
Yahoo Finance 2026-07-14
Biogen’s Alzheimer’s Drug Leaves Questions Unanswered, and That’s a Problem — Instead, Biogen stock is down 6%, to $197.
Yahoo Finance 2026-07-14
Biogen Wins FDA Approval for Subcutaneous Starter Dose of Leqembi
Yahoo Finance 2026-07-14
HRMY vs. AMGN: Which Stock Is the Better Value Option?
Earnings Preview: What To Expect From Merck & Co.'s Report 2026-07-14
Earnings Preview: What To Expect From Merck & Co.'s Report
Yahoo Finance 2026-07-14
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know — Amgen (AMGN) closed the most recent trading day at $355.25, moving 1.44% from the previous trading session.
Yahoo Finance 2026-07-15
Eli Lilly (LLY) Wins Full FDA Approval For Retevmo In Broader Cancers
Yahoo Finance 2026-07-15
Novo Nordisk receives European Commission approval of Wegovy® pill as first oral GLP-1 for weight management in the EU; single, ready-to-use pen for higher dose 7.2 mg also approved — First GLP-1 pill approved in the European Union for the treatment of obesity and overweightOnly Wegovy® pill demonstrates 17%* mean weight loss1 and cardiovascular benefitsWegovy® 7.2 mg injection in a single-dose pen, delivering 21%* weight loss, has now been approved in EU Bagsværd, Denmark,…
Yahoo Finance 2026-07-15
Can Dow Jones' Merck Nab $25 Billion With Its Smart Bomb For Cancer?
Yahoo Finance 2026-07-15
European Equities Traded in the US as American Depositary Receipts Advance Wednesday
UBS says market has turned too pessimistic on AI as themes climb back up rankings 2026-07-15
UBS says market has turned too pessimistic on AI as themes climb back up rankings
Yahoo Finance 2026-07-15
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Grow 2026-07-15
VivoSim Receives $5 Million Milestone Payment From Eli Lilly and Forecasts 500%+ FY2027 Revenue Growth — Key Investor TakeawaysVivoSim (NASDAQ:VIVS) received a $5 million milestone payment from Eli Lilly tied to the advancement of a previously sold drug candidate into Phase 2 studies.
Yahoo Finance 2026-07-15
AbbVie Inc. (ABBV) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-07-15
Cellular Intelligence Expands Leadership Team with Seasoned AI and Biotech Industry Executives
Yahoo Finance 2026-07-15
Novo Nordisk Stock Rises After Wegovy Pill Captured 89% of U.S. Prescriptions
Yahoo Finance 2026-07-15
Lilly's Obesity Pill Trails Wegovy — Wegovy captured about 89% of weekly prescriptions.
Yahoo Finance 2026-07-15
Sector Update: Healthcare Stocks Advance Late Afternoon — Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the
NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish 2026-07-15
NVO Stock Jumps 3% As EU Approves Oral Wegovy Pill — Retail Notes LLY Is ‘Clearly Behind’ Its Danish Counterpart
Yahoo Finance 2026-07-15
Novo Nordisk Gets EU Approval for Wegovy Pill for Weight Management
Yahoo Finance 2026-07-15
RHHBY's Gazyva Gets FDA Priority Review for Label Expansion
Yahoo Finance 2026-07-15
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Wednesday Amid Economic Reports — The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1%, and the actively tra
Yahoo Finance 2026-07-15
Merck (MRK) Wins FDA Nod For New Keytruda Bladder Cancer Use
Yahoo Finance 2026-07-15
Novo Nordisk (CPSE:NOVO B) Stock Fair Value Edges Higher As Analysts Rework Growth Assumptions
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal 2026-07-15
Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
Yahoo Finance 2026-07-15
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027 — (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAM) 3d human cellular models for preclinical safety, today announced revenue guidance for FY2027, and announced that it has received a $5 million payment from Eli Lilly.
Yahoo Finance 2026-07-15
Slate Medicines Strengthens Board of Directors with Appointment of Mark W. Hahn
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap 2026-07-15
AbbVie vs Baxter: One Golden Cross Is Real, One Is a Trap
Merck ADC, in China study, shows potential to replace chemo in lung cancer 2026-07-15
Merck ADC, in China study, shows potential to replace chemo in lung cancer
Yahoo Finance 2026-07-15
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates — Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +2.11% and +0.53%, respectively, for the quarter ended June 2026.
Yahoo Finance 2026-07-15
Merck to Present New Data on Daily, Weekly, and Monthly Options Across its HIV Treatment and Prevention Pipeline at AIDS 2026
Yahoo Finance 2026-07-15
KEYTRUDA® (pembrolizumab) as Monotherapy Significantly Improved Progression-Free Survival (PFS) in Certain Patients With Advanced or Recurrent Endometrial Cancer With Mismatch Repair Deficient (dMMR)
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly 2026-07-16
ATAI Stock Eyes Rocketing Back To 4-Year Highs: VC Sees Up to 105% Takeover Premium From Eli Lilly
Yahoo Finance 2026-07-16
Bear of the Day: General Mills (GIS)
Yahoo Finance 2026-07-16
Merck's HIV Pipeline Nears Key Inflection Point Ahead of ISLEND Data, RBC Says
Yahoo Finance 2026-07-16
Merck Snags A First-Of-Its-Kind Approval, And Shares Jump
Novo secures European approval for oral Wegovy to extend lead over Lilly 2026-07-16
Novo secures European approval for oral Wegovy to extend lead over Lilly
Yahoo Finance 2026-07-16
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover — Eli Lilly tripped into the psychedelics space Thursday with the up-to-$3.8 billion acquisition of AtaiBeckley.
Yahoo Finance 2026-07-16
Eli Lilly to Acquire AtaiBeckley for Up to $3.8 Billion to Expand Neuroscience Pipeline — AtaiBeckley (ATAI) shares surged more than 30% on Thursday after Eli Lilly (LLY) said it agreed to a
Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover 2026-07-16
Lilly enters psychedelic realm through $2.8bn AtaiBeckley takeover
Yahoo Finance 2026-07-16
ATAI Stock Soars on Reports of Potential Acquisition by Eli Lilly
Yahoo Finance 2026-07-16
AtaiBeckley Stock Is Soaring 31% as Eli Lilly Agrees to Buy Psychedelic Drugmaker — Psychedelic drugmaker AtaiBeckley was surging 31% early Thursday after pharma giant Eli Lilly agreed a deal to buy the company. AtaiBeckley shares were up 31.4% to $7.04 in early trading after the deal was confirmed.
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion 2026-07-16
Stock Market Today, July 16: AtaiBeckley Surges on Eli Lilly Acquisition Worth Up To $3.8 Billion — Today, July 16, 2026, the clinical-stage psychedelics developer jumped 33% after Lilly announced a cash deal plus milestone payments.
Yahoo Finance 2026-07-16
Eli Lilly Buys AtaiBeckley in $3.8 Billion Deal
Yahoo Finance 2026-07-16
Eli Lilly Buys AtaiBeckley for Up to $3.8 Billion
Yahoo Finance 2026-07-16
AtaiBeckley Soars as Eli Lilly Agrees to $2.8 Billion Buyout — Lilly will pay $6.75 a share in cash, plus up to $1 billion in milestones
Yahoo Finance 2026-07-16
Eli Lilly Likely to See More Momentum in GLP-1 Pipeline, UBS Says
Yahoo Finance 2026-07-16
Novo Nordisk (NYSE:NVO) Wins First EU Approval For Oral Wegovy In Weight Management
Yahoo Finance 2026-07-16
NVO Stock Up on EC Approval of Wegovy Pill to Treat Obesity
Why Is PSNL Stock Up 5% After-Hours? 2026-07-16
Why Is PSNL Stock Up 5% After-Hours?
UBS strongly resets Lilly stock target 2026-07-16
UBS strongly resets Lilly stock target
Yahoo Finance 2026-07-16
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to Note — Novo Nordisk (NVO) closed the most recent trading day at $51.48, moving +1.82% from the previous trading session.
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock 2026-07-16
Eli Lilly Is Buying AtaiBeckley in $2.8 Billion Deal. What It Means for LLY Stock — Eli Lilly stock rallies on a $2.8 billion acquisition of AtaiBeckley.
Yahoo Finance 2026-07-16
Merck (MRK) Stock Sees Modest Fair Value Lift As Analysts Raise Targets — Merck is back in focus as analysts refine their models, with bullish firms now setting price targets in a US$138 to US$155 range that sit above a refreshed fair value estimate of US$132.78 per share.
Yahoo Finance 2026-07-16
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
Yahoo Finance 2026-07-16
Eli Lilly to buy psychedelic drugmaker AtaiBeckley for up to $3.8 billion in bet on depression therapy
AtaiBeckley to be acquired by Eli Lilly in deal valued at up to $3.8 billion 2026-07-16
AtaiBeckley to be acquired by Eli Lilly in deal valued at up to $3.8 billion — (NASDAQ:ATAI, XETRA:9VC) has agreed to be acquired by Eli Lilly and Co (NYSE:LLY) in a transaction valued at up to approximately $3.8 billion, with the deal adding the clinical-stage biotechnology company's pipeline of investigational therapies for treatment-resistant depression...
Yahoo Finance 2026-07-16
Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe — Darmstadt, Germany, July 16, 2026 (GLOBE NEWSWIRE) -- New 2,000-square-meter facility expands Merck’s global testing network with commercial drug substance and drug product release testing and GMP-compliant stability studiesStrategic
Yahoo Finance 2026-07-16
Merck Stock Rises After U.S. Approval for Powerful Cholesterol-Cutting Pill
Yahoo Finance 2026-07-16
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?
Yahoo Finance 2026-07-16
Kalshi Will Offer Sports-Style Betting on Drug Trial Results — (Bloomberg) -- Kalshi Inc. is expanding in biotechnology by offering wagers on the outcomes of clinical trials and regulatory decisions, giving traders a more direct way to bet on key industry catalysts.Most Read from BloombergThailand Scraps Plan to End Visa-Free Entry for Indian TouristsOpenAI’s First Device Will Be Movable, Screenless Speaker Built as AI CompanionCIA Says AI Drones Give Russian Troops Only 30…
Yahoo Finance 2026-07-17
AtaiBeckley (ATAI) Soars to 4-Year High on $3.8B Merger with Eli Lilly — AtaiBeckley climbed to a new four-year high on Thursday, as investors bought into its shares following news that Eli Lilly agreed to acquire the company for up to $3.8 billion. In intra-day trading, the stock surged to a record high of $7.22 before trimming gains to end the session just up by 33.40 percent at […]
Eli Lilly's $3.8bn psychedelics bet is built on British science 2026-07-17
Eli Lilly's $3.8bn psychedelics bet is built on British science — Eli Lilly's first venture into psychedelic medicine, a takeover of AtaiBeckley worth up to $3.8 billion, is above all a vindication of two decades of British research once dismissed as fringe science.
Yahoo Finance 2026-07-17
Eli Lilly Long-Term GLP-1 Franchise Faces Limited Generic Threat, UBS Says
Yahoo Finance 2026-07-17
MRNA Advances Cancer Pipeline With New Immunotherapy Study
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics 2026-07-17
AtaiBeckley acquisition highlights growing Big Pharma interest in psychedelics — (NASDAQ:ATAI, XETRA:9VC)'s acquisition by Eli Lilly for up to $3.8 billion reinforces growing interest from large pharmaceutical companies in psychedelic-based therapies, according to analysts at Jefferies, who believe that the deal reflects increasing momentum driven by...
Yahoo Finance 2026-07-17
Yahoo Finance 2026-07-17
Zenas BioPharma Bear Case Overlooks Obexelimab's Commercial Potential, Wedbush Says
Yahoo Finance 2026-07-17
Allergan Aesthetics receives approval for Boey® (trenibotulinumtoxinE), for use in Europe: the first and only rapid-onset, short-duration neurotoxin for the temporary improvement of frown lines in adu
Yahoo Finance 2026-07-17
Company News for July 17, 2026
Yahoo Finance 2026-07-17
AbbVie (ABBV) Wins EU Approval For Boey Frown Line Treatment In Europe
Yahoo Finance 2026-07-17
IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three Months — Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base.
Yahoo Finance 2026-07-17
Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal — Sector leader Eli Lilly is in a buy zone above a pivot at 1,133.95 ahead of second-quarter results, due on Aug.
Yahoo Finance 2026-07-17
MRK Stock Jumps on FDA Nod for Cholesterol-Lowering Pill
Yahoo Finance 2026-07-17
Eli Lilly to Boost Neuroscience Pipeline With AtaiBeckley Buyout — LLY agrees to acquire AtaiBeckley for $2.8B upfront to expand its neuroscience pipeline with psychedelic therapies for mental health disorders.
Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win 2026-07-17
Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win
MSD wins FDA approval for cholesterol pill to help plug Keytruda void 2026-07-17
MSD wins FDA approval for cholesterol pill to help plug Keytruda void
The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Los 2026-07-18
The Most Overlooked Reason Eli Lilly Stock Keeps Surging -- and It Has Nothing to Do With Weight Loss
Yahoo Finance 2026-07-18
REGENXBIO Presents Positive Long-Term Data for Surabgene Lomparvovec in Wet AMD and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting
Yahoo Finance 2026-07-19
Eli Lilly (LLY) Stock Looks Undervalued On Fair Value Yet Full On Earnings — Eli Lilly stock has delivered a 406.3% return over the past five years, yet its latest valuation checks point to an unusual tension as the Discounted Cash Flow (DCF) intrinsic value suggests the shares trade at a discount while the broader scorecard still leans expensive.
Yahoo Finance 2026-07-19
Merck (MRK) Wins FDA Approval For First Oral PCSK9 Cholesterol Drug — Merck, trading around $127.5, is adding Lipfendra to its portfolio at a time when NYSE:MRK has posted a 64.8% return over the past year and 92.2% over five years.
Yahoo Finance 2026-07-19
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss Drug
Why Did ATAI, PANW, TRV Stocks Surge To 52-Week Highs Last Week? 2026-07-20
Why Did ATAI, PANW, TRV Stocks Surge To 52-Week Highs Last Week?
Yahoo Finance 2026-07-20
Fangzhou Launches Novo Nordisk’s Once-Weekly Basal Insulin/GLP-1 Therapy in China
Yahoo Finance 2026-07-20
Tempus AI Scoops Up Personalis For $1.5 Billion; But Shares Dive — Tempus AI pledged to buy cancer diagnostics outfit Personalis for $1.5 billion on Monday.
Yahoo Finance 2026-07-20
Novo Nordisk (CPSE:NOVO B) Launches Kyinsu In China Through Fangzhou Internet Hospital
Yahoo Finance 2026-07-20
Does EU Approval of Wegovy Pill Change NVO's Competitive Story?
Yahoo Finance 2026-07-20
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-07-20
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term 2026-07-20
ATAI Stock Downgraded Across Wall Street – Why Analysts Believe Buyout By Eli Lilly Capped Near-Term Upside
Yahoo Finance 2026-07-20
Claude AI Disagrees With President Trump on Eli Lilly (LLY) — President Donald Trump recently praised Eli Lily at a public event and called it “a great company” and highlighted its planned $3.5 billion investment for a manufacturing plant in Pennsylvania.
Yahoo Finance 2026-07-20
Scribe Therapeutics Files $107.2 Million IPO as Sanofi Backs Share Purchase — Gene-editing biotech targets up to $242.7 million valuation, with initial ASCVD trial data expected in 2027.
Yahoo Finance 2026-07-20
Sector Update: Healthcare Stocks Fall Late Afternoon — Healthcare stocks declined late Monday afternoon, with the NYSE Healthcare Index shedding 1.1% and t
Yahoo Finance 2026-07-20
Eli Lilly (LLY) Joins Illumina Atlas To Map Disease With AI — Eli Lilly enters this alliance with strong recent stock performance, with the share price at $1,146.9 and the stock up 51.5% over the...
Yahoo Finance 2026-07-20
Merck (MRK) Declines More Than Market: Some Information for Investors — Merck (MRK) concluded the recent trading session at $124.4, signifying a -2.43% move from its prior day's close.
Yahoo Finance 2026-07-20
Here's Why Eli Lilly (LLY) Fell More Than Broader Market — In the latest trading session, Eli Lilly (LLY) closed at $1, marking a -2.73% move from the previous day.
Yahoo Finance 2026-07-21
Phanes Therapeutics Announces Expansion of Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate Spevatamig in Combination with KEYTRUDA® (Pembrolizumab) and Chemotherapy for Treatm
Yahoo Finance 2026-07-21
Pharma heavyweights clash over anti-obesity drug ads
Yahoo Finance 2026-07-21
Why Agios Pharma, A Novo Rival, Just Pulled A Bearish Move
Yahoo Finance 2026-07-21
Novo Sues Lilly Over Weight-Loss Ad Claims
Novo Nordisk sues Eli Lilly over GLP-1 drug advertising claims 2026-07-21
Novo Nordisk sues Eli Lilly over GLP-1 drug advertising claims
Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads 2026-07-21
Novo accuses rival Eli Lilly of "deceptive" weight-loss drug ads
Yahoo Finance 2026-07-21
Sector Update: Healthcare Stocks Rise Late Afternoon — Healthcare stocks advanced late Tuesday afternoon with the NYSE Healthcare Index rising 0.6% and the
Yahoo Finance 2026-07-21
Novo sues Lilly, claiming misleading ads in weight-loss drug battle
Yahoo Finance 2026-07-21
Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Merck (NYSE:MRK)
Yahoo Finance 2026-07-21
Biotech IPOs Surge 55% as AI Listings Lose Momentum
Yahoo Finance 2026-07-21
Sector Update: Healthcare Stocks Advance Tuesday Afternoon — Healthcare stocks were higher Tuesday afternoon, with the NYSE Healthcare Index rising 0.4% and the
Yahoo Finance 2026-07-21
Novo Nordisk Sues Eli Lilly Over Alleged 'Misleading' Ad Campaigns
Novo sues Lilly after alleged misleading and false advertising campaign 2026-07-21
Novo sues Lilly after alleged misleading and false advertising campaign
Yahoo Finance 2026-07-21
Update: Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising
Yahoo Finance 2026-07-22
How Investors May Respond To AbbVie (ABBV) Securing EU Approval For Short-Acting Boey Aesthetic Toxin
Yahoo Finance 2026-07-22
Fishbone Advisors Survey: Institutional Investors See Healthcare's AI Story as Overblown — In every healthcare subsector, roughly half to two-thirds of investors (48% to 67%) agree that management overemphasizes AI relative to its actual financial contribution, the most consistent finding in "Hallucinating Value: Healthcare's AI Narrative."
Yahoo Finance 2026-07-22
Amgen (AMGN) Clears An Enbrel Overhang, Is The Stock Fully Priced? — A recent court decision blocking Colorado’s planned 70% price cap on Enbrel has removed a key regulatory overhang for Amgen (AMGN) and is refocusing attention on the stock’s earnings setup.
Yahoo Finance 2026-07-22
Gilead (GILD) Will Bring New HIV Data And A Merck Regimen To AIDS 2026 — The stock recently closed at $130.28, with a return of 7.1% year to date and 21.3% over the past year.
Yahoo Finance 2026-07-22
NVO Challenges LLY Ads in GLP-1 Battle: Why the Lawsuit Matters Now
Yahoo Finance 2026-07-22
Lilly confirms date and conference call for second-quarter 2026 financial results announcement
Yahoo Finance 2026-07-22
NKTR Up on Start of Phase III Program on Rezpeg for Atopic Dermatitis
Yahoo Finance 2026-07-22
Will Keytruda Remain the Driving Force Behind Merck's Q2 Performance?
Yahoo Finance 2026-07-22
Sector Update: Healthcare Stocks Softer Late Afternoon — Healthcare stocks declined late Wednesday afternoon, with the NYSE Healthcare Index down 0.4% and th
The Obesity Drug War Turns Ugly: Novo Nordisk Sues Eli Lilly and Wall Street Already Picked a Side 2026-07-22
The Obesity Drug War Turns Ugly: Novo Nordisk Sues Eli Lilly and Wall Street Already Picked a Side
What You Need to Know Ahead of Eli Lilly's Earnings Release 2026-07-22
What You Need to Know Ahead of Eli Lilly's Earnings Release
Novo Nordisk Takes Rival Eli Lilly to Court Over Weight-Loss Ad Claims 2026-07-22
Novo Nordisk Takes Rival Eli Lilly to Court Over Weight-Loss Ad Claims
Yahoo Finance 2026-07-22
Colorado Enbrel Price Cap Setback Might Change The Case For Investing In Amgen (AMGN) — Earlier in July, a federal judge blocked Colorado’s plan to impose a 70% price cap on Amgen’s blockbuster arthritis drug Enbrel, halting a significant state-level pricing move.
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never 2026-07-23
Missed AI, Memory Bull Run? Biotech May Be The Next Breakout Trade — But Retail Sentiment Has Never Been Lower — Drugmakers have announced 37 biotech acquisitions worth at least $1 billion this year, topping the previous annual record.
Yahoo Finance 2026-07-23
Lilly to file for next-gen obesity drug approval in early 2027
Yahoo Finance 2026-07-23
How Novo Nordisk’s GLP-1 Advertising Lawsuit Against Eli Lilly (LLY) Has Changed Its Investment Story
Organon & Co. Shareholders Clear Sun Pharma Merger Deal 2026-07-23
Organon & Co. Shareholders Clear Sun Pharma Merger Deal
Another win for Lilly’s triple-g agonist in two more Phase III trials 2026-07-23
Another win for Lilly’s triple-g agonist in two more Phase III trials
Yahoo Finance 2026-07-23
Cell Culture Market Analysis by Consumables, Vessels, Equipment, Application, and Competition - Global Forecast to 2031
Yahoo Finance 2026-07-23
How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q2 Results?
Yahoo Finance 2026-07-23
In Vitro Toxicology Testing Market to Exceed $20.97 Billion by 2031 as Non-Animal Testing & AI Adoption Accelerate - Analysis by Product, Toxicity Endpoints & Type, Technology, Method, Service, Region
Yahoo Finance 2026-07-23
Will GSK's Specialty Medicines Boost Q2 Revenue Growth?
Yahoo Finance 2026-07-23
Lilly Stock Is Rising on Plan to Seek Approval for Newest Weight-Loss Drug in 2027 — Among adults with general obesity, the weekly injectable lowered the weight of late-stage trial participants by an average of 28% over 80 weeks at the highest doses tested.
Yahoo Finance 2026-07-23
There's A Hidden Gem In Eli Lilly's Weight-Loss News — And It Could Slam Compounders
Yahoo Finance 2026-07-23
Genmab and AbbVie Provide Clarification on Phase 3 EPCORE® DLBCL-1 Trial Evaluating Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Yahoo Finance 2026-07-23
Roche H1 Sales Decline on Currency Headwinds, Key Drugs Keep Momentum — RHHBY posts 6% constant-currency sales growth in the first half of 2026 as strong demand for key drugs offsets legacy declines, while FDA pipeline progress supports momentum.
Yahoo Finance 2026-07-23
Can Gilead's Efforts to Develop New Treatments Solidify HIV Franchise?
Yahoo Finance 2026-07-23
Lilly Targets Early 2027 Filing for Next Obesity Drug — Two more Phase 3 trials showed weight loss above 20%
Yahoo Finance 2026-07-23
Eli Lilly's Retatrutide Clears Two More Trials Ahead of 2027 Filing
Yahoo Finance 2026-07-23
Merck (MRK) Could Be 4% Undervalued As LIPFENDRA Approval Tests Its Premium Valuation — Merck’s share price is $127.47, with a 30-day share price return of 10.38% and a year-to-date share price return of 19.75%. The 1-year total shareholder return of 56.86% reflects strong momentum alongside frequent product and trial updates.
Yahoo Finance 2026-07-23
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts — Amgen (AMGN) concluded the recent trading session at $371.47, signifying a +1.48% move from its prior day's close.
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know. 2026-07-23
Eli Lilly Is Acquiring a Psychedelic Medicine Biotech. Here's What You Need to Know.
Yahoo Finance 2026-07-23
Crux Collaborates with Novo Nordisk to Offer Access to Wegovy® and Other Obesity Management Medications
Yahoo Finance 2026-07-23
The 5th Annual Connected Worker Manufacturing Summit Returns Bigger Than Ever with Its Largest Speaker Faculty, Expo Hall and Industry Audience to Date
Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead 2026-07-23
Eli Lilly Moves Closer To Another Weight-Loss Drug: Retatrutide Clears Two More Phase 3 Trials Ahead Of FDA Filing
Lilly, with new data, to seek FDA approval of obesity drug retatrutide 2026-07-23
Lilly, with new data, to seek FDA approval of obesity drug retatrutide
WSJ 2026-07-23
Eli Lilly Preparing Retatrutide Applications After Positive Weight-Loss Data
Yahoo Finance 2026-07-23
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
Yahoo Finance 2026-07-24
Eli Lilly Stock In A Buy Zone, Set To Ride The Peptide Wave — Eli Lilly stock hit an all-time high of 1,249.50 before pulling back into a buy zone above a pivot of 1,133.95.
Yahoo Finance 2026-07-24
Update: Market Chatter: Novo Nordisk Seeks Immediate Court Order Against Lilly's Weight-Loss Drug Ads
Yahoo Finance 2026-07-24
Is Novo Nordisk (CPSE:NOVO B) Fully Valued On EU Approval For Its Wegovy Pill? — The Wegovy pill approval lands at a time when Novo Nordisk’s 90 day share price return of 23.22% suggests momentum is still building, even as the year to date share price return is down 3.01% and the 1 year total shareholder return...
Yahoo Finance 2026-07-24
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Yahoo Finance 2026-07-24
Incyte Gears Up to Report Q2 Earnings: Is a Beat Around the Corner?
Ozempic maker takes biggest rival to court over weight-loss drug ads 2026-07-24
Ozempic maker takes biggest rival to court over weight-loss drug ads
Yahoo Finance 2026-07-24
LLY's Retatrutide Nears 2027 Filing With Two More Phase III Wins
Yahoo Finance 2026-07-24
Sector Update: Healthcare Stocks Higher Late Afternoon — Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 0.6% and the State S
Yahoo Finance 2026-07-24
Scribe Therapeutics Soars 67% After $128.7 Million Upsized IPO — Gene-editing biotech debuts at $25, backed by Sanofi and Eli Lilly, with a roughly $440.3 million valuation.
Yahoo Finance 2026-07-24
Novo Nordisk (CPSE:NOVO B) Sues Eli Lilly Over GLP 1 Drug Advertising
Yahoo Finance 2026-07-24
European Stocks Close Higher Friday; Eurozone Private Sector Expands in July
Yahoo Finance 2026-07-24
Lilly-Backed Scribe Prices Upsized IPO — Strong demand helps the Lilly-backed biotech raise nearly $129 million
Yahoo Finance 2026-07-24
Novo Nordisk Seeks Injunction Against Eli Lilly Weight-Loss Ads
Yahoo Finance 2026-07-24
Par Health Launches First and Only Generic Version of Janumet® XR (sitagliptin and metformin HCl extended-release) Tablets in the United States
Novo Nordisk seeks injunction to block Eli Lilly weight loss drug ads 2026-07-24
Novo Nordisk seeks injunction to block Eli Lilly weight loss drug ads
Sanofi halts development of troubled immune drug in eczema 2026-07-24
Sanofi halts development of troubled immune drug in eczema
WSJ 2026-07-24
Novo Nordisk Seeks Injunction Against Eli Lilly in Dispute Over Weight-Loss Ads
Yahoo Finance 2026-07-24
Merck Announces Initial Access Plans for Alimatravir, an Investigational Once-Monthly Oral HIV Pre-Exposure Prophylaxis in Phase 3 Development
Novo Nordisk seeks court order to halt Eli Lilly weight-loss drug advertisements 2026-07-24
Novo Nordisk seeks court order to halt Eli Lilly weight-loss drug advertisements
Yahoo Finance 2026-07-25
Jim Cramer Wants Novo Nordisk A/S (NYSE:NVO) To Compete With Eli Lilly In The Market & Not The Courts
Yahoo Finance 2026-07-25
AbbVie (ABBV) Could Be 3% Undervalued Following Epcoritamab Trial Setback — Against this backdrop, AbbVie’s share price has had a strong run, with a 30-day share price return of 10.42% and a 90-day share price return of 30.52%. Its 1-year total shareholder return of 40.53% highlights momentum...
Yahoo Finance 2026-07-27
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance 2026-07-27
Sarepta Therapeutics Appoints Michael Severino, M.D., Chief Executive Officer
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It 2026-07-27
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It
Yahoo Finance 2026-07-27
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO 2026-07-27
Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO
Yahoo Finance 2026-07-27
Merck (MRK) Is Up 5.4% After Expanding HIV PrEP Access And Launching Oral Cholesterol Drug
Yahoo Finance 2026-07-27
3 Quality Compounders to Own for Decades
Yahoo Finance 2026-07-27
Scribe’s Genetic Editing Aims to Prevent Heart Attacks — Scribe Therapeutics shares are up 30% since it raised $125 million in its initial public offering Friday.
Yahoo Finance 2026-07-27
AZN Q2 Earnings and Sales Beat, Key Drugs Offset Generic Pressure
Yahoo Finance 2026-07-27
Merck (MRK) Says KEYTRUDA Beat Chemotherapy In Phase 3 Endometrial Cancer Trial
Yahoo Finance 2026-07-27
This Stock Of The Day Rides Big Pharma Royalties; It's Up 56% In 2026 — LGND stock has risen more than 56.5% so far in 2026.
Yahoo Finance 2026-07-27
Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead — IMCR's Kimmtrak sales climbed 29% in 2025 on wider adoption, with pivotal 2026 trial results set to test its next expansion opportunity.
Yahoo Finance 2026-07-28
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
Yahoo Finance 2026-07-28
Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline
Yahoo Finance 2026-07-28
AMGEN ANNOUNCES WEBCAST OF 2026 SECOND QUARTER FINANCIAL RESULTS
Yahoo Finance 2026-07-28
Botox Maker Tops Buy Point, But Here Comes The Earnings Report — AbbVie closed above the 230.47 buy point from a cup-with-handle base on June 23 and has climbed 15% from there. The previous day, the stock jumped more than 6% after AbbVie announced it agreed to acquire Apogee Therapeutics. The $10.9 billion deal would strengthen AbbVie's immunology pipeline.
Yahoo Finance 2026-07-28
INCY Q2 Earnings & Revenues Beat on Higher Sales, '26 View Raised
Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs 2026-07-28
Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs
Yahoo Finance 2026-07-28
Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline
Yahoo Finance 2026-07-28
Novo Nordisk (NVO) Surpasses Market Returns: Some Facts Worth Knowing — Novo Nordisk (NVO) reached $50.96 at the closing of the latest trading day, reflecting a +2.6% change compared to its last close.
Yahoo Finance 2026-07-28
Eli Lilly (LLY) Rises Higher Than Market: Key Facts — Eli Lilly (LLY) closed the most recent trading day at $1, moving +2.09% from the previous trading session.
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Sto 2026-07-29
Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even Better Bet.
Yahoo Finance 2026-07-29
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata
Yahoo Finance 2026-07-29
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
Yahoo Finance 2026-07-29
Merck Announces Fourth-Quarter 2026 Dividend
Yahoo Finance 2026-07-29
Gilead to Report Q2 Earnings: How Should You Play the Stock Now?
Yahoo Finance 2026-07-29
Graves Ophthalmopathy Market Expected to Witness Rapid Expansion at a CAGR of 9% During the Forecast Period (2026-2036), Driven by the Recent Approval of Viridian's LUMVOA and the Launch of Emerging T
Yahoo Finance 2026-07-29
Earnings Preview: EyePoint (EYPT) Q2 Earnings Expected to Decline
Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock 2026-07-29
Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock
Yahoo Finance 2026-07-29
Why This Drugmaker’s Earnings Guidance Cut Doesn’t Tell the Full Story
Yahoo Finance 2026-07-29
Novo Nordisk (CPSE:NOVO B) Teams Up With Crux To Expand Wegovy Access
Yahoo Finance 2026-07-29
How Will Ozempic and Wegovy Sales Aid NVO's Upcoming Q2 Results?
Yahoo Finance 2026-07-29
Novo Nordisk (CPSE:NOVO B) Is Up 5.9% After EU Wegovy Pill Approval And US Access Deal
Yahoo Finance 2026-07-29
Amgen (AMGN) Stock Moves -1.44%: What You Should Know — In the closing of the recent trading day, Amgen (AMGN) stood at $387.42, denoting a -1.44% move from the preceding trading day.
Yahoo Finance 2026-07-29
Merck (MRK) Stock Moves -1.11%: What You Should Know — In the most recent trading session, Merck (MRK) closed at $130.36, indicating a -1.11% shift from the previous trading day.
Yahoo Finance 2026-07-29
AbbVie (ABBV) Stock May Be Mispriced On Its 172% Run — AbbVie has returned 172.0% over five years, which puts extra focus on whether the current price still offers an attractive entry for new capital.
How Much Eli Lilly (LLY) Are You Really Betting On? 2026-07-29
How Much Eli Lilly (LLY) Are You Really Betting On?
Yahoo Finance 2026-07-30
Amgen (AMGN) Wins Backing In Europe For Broader Repatha Use
Yahoo Finance 2026-07-30
Inflammatory Bowel Disease Market to Experience Strong Uptake During the Forecast Period (2026-2036), Driven by Development of Next-generation Therapies Targeting IL-23, TL1A, and S1P Pathways | Delve
Yahoo Finance 2026-07-30
Eli Lilly (LLY) Joins Illumina’s Billion Cell Atlas For AI Drug Discovery — NYSE:LLY is trading at $1,210.02, with the share price up...
Yahoo Finance 2026-07-30
What To Expect From AbbVie’s (ABBV) Q2 Earnings
Yahoo Finance 2026-07-30
Exploring Analyst Estimates for Merck (MRK) Q2 Earnings, Beyond Revenue and EPS
Yahoo Finance 2026-07-30
What Analyst Projections for Key Metrics Reveal About Amgen (AMGN) Q2 Earnings
Yahoo Finance 2026-07-30
JUVÉDERM® Day Returns to U.S. on August 19
Yahoo Finance 2026-07-30
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Yahoo Finance 2026-07-30
Friday’s market movers: Oil earnings and consumer sentiment data
Yahoo Finance 2026-07-30
AMGEN ANNOUNCES 2026 THIRD QUARTER DIVIDEND — Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.52 per share dividend for the third quarter of 2026.
Yahoo Finance 2026-07-30
Lupin Announces U.S. FDA Approval and Launch of Sugammadex Injection
Yahoo Finance 2026-07-30
Lilly Boosts Diabetes and Obesity Capacity With $750 Million Deal — Expansion adds at least 400 jobs, taking Resilience's Ohio headcount above 1,400
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection? 2026-07-31
BIOA, GLUE Stocks Clock Worst Day In Years— What’s The NVO Connection?
Yahoo Finance 2026-07-31
AbbVie (ABBV) Wins EU Approval For RINVOQ In Vitiligo And Alopecia
Yahoo Finance 2026-07-31
AbbVie Inc (ABBV) (Q2 2026) Earnings Call Highlights: Robust Growth Driven by Skyrizi and ...
NVO Stock Plummets as Novo Nordisk Heart Drug Fails Late-Stage Trial 2026-07-31
NVO Stock Plummets as Novo Nordisk Heart Drug Fails Late-Stage Trial
Jim Cramer says one popular stock is meant to be owned, not traded 2026-07-31
Jim Cramer says one popular stock is meant to be owned, not traded
Yahoo Finance 2026-07-31
Novo Nordisk Shares Sink After Heart Disease Drug Candidate Fails Late-Stage Trial
Yahoo Finance 2026-07-31
MRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback
Yahoo Finance 2026-07-31
Novo Nordisk’s Heart Drug Suffers a Major Setback. What It Means for the Stock.
Yahoo Finance 2026-07-31
Weight Loss Drug Stocks Slump Below Key Levels. What Ozempic Maker Said.
Yahoo Finance 2026-07-31
Moderna Stock Has Doubled This Year. Can Earnings Keep the Rally Alive?
AbbVie Inc. Q2 2026 Earnings Call Summary 2026-07-31
AbbVie Inc. Q2 2026 Earnings Call Summary
Yahoo Finance 2026-07-31
European Equities Mixed in Friday Trading; Novo Nordisk Says Ziltivekimab Fails to Reduce Major Adverse Cardiovascular Events in Trial
Yahoo Finance 2026-07-31
Earnings Data Deluge
AbbVie Q2 Earnings Call Highlights 2026-07-31
AbbVie Q2 Earnings Call Highlights
Yahoo Finance 2026-07-31
AbbVie Beats but Cuts Guidance on $10.9 Billion Acquisition
Yahoo Finance 2026-07-31
Novo Nordisk Suffers Another Pipeline Setback
Yahoo Finance 2026-07-31
Novo Nordisk Stock Falls 7% as ZEUS Trial Fails
Yahoo Finance 2026-07-31
Pre-Market Trading Up in Final Session of the Week
NVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes T 2026-08-01
NVO Stock Ends Three-Month Winning Streak As Novo Nordisk’s Key Heart Drug Flops, Competition Goes To Court
Yahoo Finance 2026-08-01
Merck (MRK) Plans Early HIV Pill Licensing Across 129 Countries
Yahoo Finance 2026-08-01
Novo Nordisk (NVO) Stock Looks Below Fair Value Despite Recent Setbacks
Yahoo Finance 2026-08-02
Novo Nordisk (NVO) Trial Setback Hits Sentiment, Is The Stock Still Cheap?
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? 2026-08-02
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-08-02
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Novo Nordisk shares in hot water after disappointing trial 2026-08-02
Novo Nordisk shares in hot water after disappointing trial
Yahoo Finance 2026-08-03
Amgen (AMGN) To Report Earnings Tomorrow: Here Is What To Expect
Yahoo Finance 2026-08-03
Eli Lilly (LLY) Stock Looks Below Fair Value On Cash Flow
Yahoo Finance 2026-08-03
Kaléo Announces License Agreement with Amgen for Auto-Injector Technology
Yahoo Finance 2026-08-03
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer
Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy 2026-08-03
Ratio Therapeutics secures $70m Series C funding for cancer radiotherapy
Yahoo Finance 2026-08-03
Bear of the Day: Boston Beer (SAM)
Yahoo Finance 2026-08-03
What To Expect From Merck’s (MRK) Q2 Earnings
Yahoo Finance 2026-08-03
Bristol Myers Squibb Stock Falls on Report of $400 Billion Merger Talks With AstraZeneca
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity 2026-08-03
Merck Spotlights Weekly HIV Treatment, Monthly PrEP as $5B Growth Opportunity
Yahoo Finance 2026-08-03
Eli Lilly's Latest Cancer Win Comes With a Big Caveat
Amgen contends with data breach, exposing patient information 2026-08-03
Amgen contends with data breach, exposing patient information
Yahoo Finance 2026-08-03
Esophageal Cancer Market to Accelerate at a CAGR of 6% During the Forecast Period (2026–2036), Driven by the Advancements in Targeted and Immunotherapy Treatments | DelveInsight
Yahoo Finance 2026-08-03
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test
Yahoo Finance 2026-08-03
AbbVie Pipeline Draws Greater Investor Focus After 'Strong' Q2, RBC Says
Yahoo Finance 2026-08-03
Novo Nordisk Before Q2 Earnings: How Should Investors Play the Stock?
Yahoo Finance 2026-08-03
Agilent Technologies (A) Expands Its Oncology Diagnostics Reach—Can Growth Keep Up?
Yahoo Finance 2026-08-03
Eli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Backs $70 Million Raise
What Are Wall Street Analysts' Target Price for AbbVie Stock? 2026-08-03
What Are Wall Street Analysts' Target Price for AbbVie Stock?
Yahoo Finance 2026-08-03
Will Mounjaro & Zepbound Drive Lilly's Q2 Results: Buy, Sell or Hold?
Yahoo Finance 2026-08-03
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison
Yahoo Finance 2026-08-03
ABBV Q2 Earnings Call Balances Growth With Apogee Dilution
Eli Lilly’s Olomorasib Secures Second FDA Breakthrough Designation For Cancer Therapy – Retail Expec 2026-08-03
Eli Lilly’s Olomorasib Secures Second FDA Breakthrough Designation For Cancer Therapy – Retail Expects LLY Stock To Hit Record High Soon
Inspire Medical Systems Q2 Earnings Call Highlights 2026-08-04
Inspire Medical Systems Q2 Earnings Call Highlights
Yahoo Finance 2026-08-04
More Biotech M&A Is Coming, Whether an AstraZeneca-Bristol Myers Deal Happens or Not
Amplia Therapeutics partners with Lilly on lung cancer combination trial 2026-08-04
Amplia Therapeutics partners with Lilly on lung cancer combination trial
Yahoo Finance 2026-08-04
The Merck Product That Absolutely Demolished Wall Street's Forecasts
Yahoo Finance 2026-08-04
H1 Partners with Novo Nordisk to Scale AI-Driven Clinical Development
Yahoo Finance 2026-08-04
Adyen to Provide Payment Technology Services for LillyDirect
Yahoo Finance 2026-08-04
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
Merck Shares Advance After Strong Second-Quarter Earnings and Higher Revenue Outlook 2026-08-04
Merck Shares Advance After Strong Second-Quarter Earnings and Higher Revenue Outlook
Merck cuts 2026 profit forecast on Terns acquisition charges 2026-08-04
Merck cuts 2026 profit forecast on Terns acquisition charges
Yahoo Finance 2026-08-04
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
Yahoo Finance 2026-08-04
Merck Stock Rises as Wall Street Looks Past Earnings Guidance Cut
The $85 Billion Consolation Prize For JNJ Shareholders 2026-08-04
The $85 Billion Consolation Prize For JNJ Shareholders
Yahoo Finance 2026-08-04
Novo Nordisk (CPSE:NOVO B) Reports Mixed ZEUS Phase 3 Results For Ziltivekimab
Yahoo Finance 2026-08-04
Novo Nordisk Stock Stumbles On A Key Miss As Its Battle With Eli Lilly Heats Up
Yahoo Finance 2026-08-04
Novo Nordisk Raises Earnings Guidance. The Stock Sinks.
Yahoo Finance 2026-08-04
Lilly Opens Pre-Approval Access to Its Next Obesity Drug
Yahoo Finance 2026-08-04
Merck's Weekly HIV Treatment Pipeline 'Interesting,' UBS Says
Yahoo Finance 2026-08-04
MRK Q2 Earnings & Sales Beat Estimates, '26 Sales View Raised
Novo Nordisk Q2 2026 earnings beat, raises full-year outlook 2026-08-04
Novo Nordisk Q2 2026 earnings beat, raises full-year outlook
Yahoo Finance 2026-08-04
Amgen (AMGN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Yahoo Finance 2026-08-04
AbbVie (ABBV) Wins FDA Review For BOTOX Cosmetic In Jawline Treatment Push
Amgen Q2 Earnings Call Highlights 2026-08-04
Amgen Q2 Earnings Call Highlights
Yahoo Finance 2026-08-04
Amgen Hikes Sales Outlook By $1 Billion After Second-Quarter Smash
Yahoo Finance 2026-08-04
Amgen (AMGN) Q2 Earnings and Revenues Surpass Estimates
Yahoo Finance 2026-08-04
Gilead Posts a Loss on Acquisitions but Revenue Tells a Bigger Story
Yahoo Finance 2026-08-04
Merck & Co Inc (MRK) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and ...
Yahoo Finance 2026-08-04
Amgen (NASDAQ:AMGN) Delivers Strong Q2 CY2026 Numbers, Guides for Strong Full-Year Sales
Yahoo Finance 2026-08-05
3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations
Moby 2026-08-05
Charles River Laboratories International, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance 2026-08-05
Eli Lilly and Co (LLY) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% on Zepbound and ... — Eli Lilly and Co (LLY) raises full-year 2026 guidance after Q2 revenue jumps 48%, driven by blockbuster incretin sales and strong international expansion.
Yahoo Finance 2026-08-05
Amgen Stock Climbs as Drug Growth Outruns Obesity Setback
Yahoo Finance 2026-08-05
Eli Lilly Stock Jumps Over 5% as Mounjaro Sales Surge 91%
Yahoo Finance 2026-08-05
Healthcare Stocks Have Been Forgotten. Eli Lilly, McKesson, and 9 More to Buy.
Dow Makes More New Highs Despite AI Drag: Stock Market Today 2026-08-05
Dow Makes More New Highs Despite AI Drag: Stock Market Today
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs 2026-08-05
LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs
Yahoo Finance 2026-08-05
Sector Update: Healthcare Stocks Rise Late Afternoon
InvestorsHub 2026-08-05
Eli Lilly stock jumps as GLP-1 sales widen Novo lead — Key takeawaysEli Lilly’s second-quarter revenue surged 48 per cent to US$22. 97 billion, beating Wall Street expectations by more than US$2 billion.
Yahoo Finance 2026-08-05
Novo Nordisk Stock Falls 4% Despite Stronger GLP-1 Outlook
Yahoo Finance 2026-08-05
CVS, Eli Lilly Forge Partnership on Improved GLP-1 Access; Companies Top Second-Quarter Views
Yahoo Finance 2026-08-05
Sector Update: Healthcare Stocks Advance Wednesday Afternoon — Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 1.1% and th
Yahoo Finance 2026-08-05
INSP's 28.1% Past-Month Rally Raises a Key Question for Investors — Inspire Medical shares jumped 28.1% as an earnings beat, raised 2026 guidance and estimate revisions offset reimbursement pressure.
Proactive Investors 2026-08-05
Amgen gains after strong quarterly results and continued product momentum — Amgen Inc (NASDAQ:AMGN, XETRA:AMG) shares rose about 4% on Wednesday after the biotechnology company reported second quarter 2026 results that topped Wall Street expectations, supported by higher revenue and growth across its portfolio of medicines.
Yahoo Finance 2026-08-05
AMGN Beats on Q2 Earnings, Lifts Outlook Despite Legacy Drug Pressure
Yahoo Finance 2026-08-05
GILD Q2 Earnings Beat on HIV and Trodelvy Growth, Product Sales Outlook Raised
Stocks Supported by Stellar Earnings 2026-08-05
Stocks Supported by Stellar Earnings — The S&P 500 Index ($SPX ) (SPY ) today is up +0.31%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.05%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.03%. September E-mini S&P futures (ESU26 ) are up +0.33%, and September E-mini Nasdaq futures...
Yahoo Finance 2026-08-05
Eli Lilly is treating nearly 10% of US obesity population with GLP-1s: CFO
Yahoo Finance 2026-08-05
NVO Stock Down Despite Q2 Earnings and Sales Beat on GLP-1 Growth
Strong Earnings Push the S&P 500 to New Record High 2026-08-05
Strong Earnings Push the S&P 500 to New Record High — The S&P 500 Index ($SPX ) (SPY ) today is up +0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.51%. September E-mini S&P futures (ESU26 ) are up +0.50%, and September E-mini Nasdaq futures...
Yahoo Finance 2026-08-05
Novo Nordisk (CPSE:NOVO B) Stock Still Looks Like A Bargain As Shares Fell 48% — Over the past 3 years the share price is down 48.1%, which means long term holders are...
Yahoo Finance 2026-08-05
AMGN Q2 Earnings Call Centers on Raised Outlook and Pipeline
Yahoo Finance 2026-08-05
MRK Q2 Earnings Call Puts Pipeline Progress in Focus
Yahoo Finance 2026-08-05
Novo Nordisk wins Dutch court injunction protecting patients from unapproved, unlawful compounded semaglutide nasal spray
Stocktwits 2026-08-05
Eli Lilly CEO Bets On Weight-Loss Medicine Retatrutide As Next Growth Driver, Says Firm’s Future Has ‘Never Been Brighter’ — Lilly’s second-quarter revenue jumped 48% and comfortably beat Wall Street estimates, driven primarily by strong demand for its blockbuster weight loss drugs Mounjaro and Zepbound.
Quartz 2026-08-05
Amgen Q2 2026 earnings beat, raises full-year outlook, drops AMG 513 — The biotech raised its full-year revenue forecast to $38.2 billion–$39.4 billion after second-quarter revenue rose 10% to $10.1 billion
Yahoo Finance 2026-08-05
Eli Lilly's Diabetes And Obesity Drugs Blow Past Expectations; Shares Pop
Yahoo Finance 2026-08-05
Baron Capital Exits Apogee Therapeutics (APGE) Following AbbVie Buyout — The Fund gained 11.99% during the quarter, compared with the 10.48% gain for the Russell 3000 Health Care Index and the 15.44% gain for the Russell 3000 Index.
Yahoo Finance 2026-08-05
Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates — Lilly (LLY) delivered earnings and revenue surprises of +39.43% and +13.38%, respectively, for the quarter ended June 2026.
Yahoo Finance 2026-08-05
Eli Lilly and Novo Nordisk raise profit outlook as demand for weight-loss drugs soars
Yahoo Finance 2026-08-05
A New Biopharma Roadmap: Zifo's SiEE Basel Event Puts Data Before AI Hype
Yahoo Finance 2026-08-05
CVS Health Stock Climbs on Earnings Outlook Hike and Lilly Weight-Loss Drug Partnership — For the second quarter, CVS Health posted adjusted earnings of $2.58 a share. Analysts polled by FactSet were looking for $1.85 a share.
Yahoo Finance 2026-08-05
Lilly Stock Jumps on Earnings Beat as Mounjaro Revenue Nearly Doubles — The world’s biggest drugmaker by market value reported adjusted earnings of $8.38 a share in the period, better than the $6.01 consensus estimate among analysts polled by FactSet. Revenue surged 48% to nearly $23 billion—Wall Street was looking for $20.7 billion.
Yahoo Finance 2026-08-05
Eli Lilly shares pop as weight-loss drug demand fuels guidance hike — Investing.com -- Eli Lilly shares jumped more than 5% in premarket trading Wednesday after the U.S. pharma giant raised its annual revenue guidance amid strong demand for its popular weight-loss and diabetes drugs.
Quartz 2026-08-05
Eli Lilly Q2 2026 earnings beat, raises full-year revenue forecast — Mounjaro revenue jumped 91% to $9.9 billion and Zepbound brought in $4.9 billion as the drugmaker beat Wall Street estimates
WSJ 2026-08-05
Eli Lilly Posts Higher Revenue on Continued GLP-1 Demand
Quartz 2026-08-05
CVS Health Q2 2026 earnings beat, Eli Lilly weight loss drug deal — CVS beat Wall Street expectations by a wide margin in the second quarter and raised its full-year profit forecast to as much as $8.10 per share
Yahoo Finance 2026-08-05
CVS shares jump on earnings beat, raised full-year guidance — Investing.com -- CVS Health shares jumped about 5% in premarket trading Wednesday after the company raised its full-year profit guidance following better-than-expected second-quarter results.
Yahoo Finance 2026-08-05
Onsera Health Strengthens Cardiometabolic Care Delivery with Eli Lilly's(R) Oral GLP-1 Foundayo(R)
InvestorsHub 2026-08-05
Novo Nordisk shares fall despite improved outlook as Wegovy sales disappoint — The company’s shares dropped 6% during US trading on Tuesday, while its Copenhagen-listed stock declined 4.
Merck & Co., Inc. Q2 Earnings Call Highlights 2026-08-05
Merck & Co., Inc. Q2 Earnings Call Highlights — (NYSE:MRK) reported second-quarter revenue of $16.6 billion, up 5% from a year earlier, driven by oncology, animal health and contributions from newer product launches. Revenue increased 4% excluding foreign exchange, according to Chief Financial Officer Caroline Litchfield.
Yahoo Finance 2026-08-05
Novo Nordisk falls as Wegovy sales miss, trial setback overshadow raised outlook
Yahoo Finance 2026-08-05
Eli Lilly (LLY) Wins FDA Breakthrough Tag For Olomorasib, Is The Stock Still Cheap? — Eli Lilly’s share price has eased recently, with a 7 day share price return down 8.60% and a 30 day share price return down 8.09%. This is even though the 1 year total shareholder return sits at 46.69% and the 5 year total...
Yahoo Finance 2026-08-05
Amgen Inc (AMGN) (Q2 2026) Earnings Call Highlights: Revenue Surges Past $10 Billion, Guidance ... — Amgen Inc (AMGN) delivers 10% revenue growth driven by key products like Repatha and UPLIZNA, while raising full-year 2026 guidance.
Yahoo Finance 2026-08-05
Amgen (AMGN) Faces Patient Data Breach And Tavneos Review Risk
Yahoo Finance 2026-08-06
Lexicon Pharmaceuticals Inc (LXRX) (Q2 2026) Earnings Call Highlights: Zynquista NDA ...
Yahoo Finance 2026-08-06
Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ... — Regenxbio advances RGX-202 and RGX-121 programs while securing $208 million in new funding to support operations through late 2027.
Novo Nordisk faces a rough patch 2026-08-06
Novo Nordisk faces a rough patch — Novo’s shares have fallen 15% this year, tumbling further this week after guidance missed analysts’ targets.
Yahoo Finance 2026-08-06
RVMD Posts Wider-Than-Anticipated Loss in Q2, Lifts '26 Expense View
Yahoo Finance 2026-08-06
The Bull Case For Eli Lilly (LLY) Could Change Following Raised 2026 Guidance On GLP-1 Demand — Eli Lilly recently reported that second-quarter 2026 sales rose to about US$23.0 billion with net income of roughly US$7.10 billion, and the company raised its full-year 2026 revenue guidance to US$85.0 billion–US$87.0 billion from US$82.0 billion–US$85.0 billion.
Yahoo Finance 2026-08-06
EXEL Tops Q2 Earnings Estimates, Misses on Sales, Lowers '26 View
Yahoo Finance 2026-08-06
The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to Watch | DelveInsight
Merck & Co’s Stock: Analyst Estimates & Ratings 2026-08-06
Merck & Co’s Stock: Analyst Estimates & Ratings
Merck KGaA Q2 Earnings Call Highlights 2026-08-06
Merck KGaA Q2 Earnings Call Highlights — Group net sales rose 3.4% year over year to €5.434 billion.
Yahoo Finance 2026-08-06
NVO Q2 Earnings Call Centers on Wegovy Pill and Outlook Lift
Yahoo Finance 2026-08-06
LLY Q2 Earnings Call Raises Outlook as Foundayo Gains Traction
Moby 2026-08-06
Arcus Biosciences, Inc. Q2 2026 Earnings Call Summary
Yahoo Finance 2026-08-06
VivoSim Provides Financial and Listing Compliance Update
Yahoo Finance 2026-08-06
Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates
Eli Lilly raises 2026 outlook again as Q2 soars past estimates 2026-08-06
Eli Lilly raises 2026 outlook again as Q2 soars past estimates — Reporting 91% growth for Mounjaro, Lilly widened the gap to cardiometabolic rival Novo Nordisk.
Yahoo Finance 2026-08-06
REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights
MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data 2026-08-06
MSD and Gilead scrap Phase III Trodelvy-Keytruda study on lacklustre interim data
Yahoo Finance 2026-08-06
Scholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Yahoo Finance 2026-08-06
U.S. FDA Accepts sBLA for ENFLONSIA™ (clesrovimab-cfor) to Update its Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease Indication to Include Children Under Two Years at Increased Risk
Eli Lilly Stock: Analyst Estimates & Ratings 2026-08-06
Eli Lilly Stock: Analyst Estimates & Ratings
Yahoo Finance 2026-08-06
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Yahoo Finance 2026-08-06
Merck KGaA Q2 adjusted profit rises 9%, hikes FY outlook
Yahoo Finance 2026-08-06
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings — Analysts expect the company to report quarterly earnings of $6.58 per share, up from $6.31 per share in the year-ago period.
Moby 2026-08-06
Eli Lilly and Company Q2 2026 Earnings Call Summary
The Motley Fool 2026-08-07
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-08-07
Scholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by Se
Yahoo Finance 2026-08-07
AbbVie (ABBV) Is Down 5.3% After Raising 2026 Revenue Outlook and Issuing New Debt - What's Changed — In late July and early August 2026, AbbVie reported stronger second‑quarter results, raised full‑year revenue guidance to about US$67.6 billion, advanced RINVOQ and BOTOX regulatory milestones, and completed a multi‑billion‑dollar mix of new fixed‑ and floating‑rate bond issuances.
Yahoo Finance 2026-08-07
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
Yahoo Finance 2026-08-07
Ironwood Q2 Earnings Beat Estimates, Revenues Lag, 2026 View Raised
Yahoo Finance 2026-08-07
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.
Yahoo Finance 2026-08-07
Lilly and Novo Win a Key GLP-1 Antitrust Fight
Yahoo Finance 2026-08-07
IOVA Q2 Earnings Beat, Stock Jumps 43% on Strong Amtagvi Uptake — Iovance rises 43% after Q2 results top estimates as Amtagvi sales beat forecasts, boosting revenues and prompting a review of full-year guidance.
Yahoo Finance 2026-08-07
Merck (MRK) Could Be 3% Undervalued On Raised Outlook And Key Drug Approvals — Merck’s share price has moved to US$128.37 after a strong run, with a 90 day share price return of 15.25% and a 1 year total shareholder return of 65.06%, suggesting momentum has been building as approvals, trial readouts and raised...
Yahoo Finance 2026-08-07
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance 2026-08-07
CVS Health (CVS) Is Down 8.6% After Raising 2026 Guidance And Expanding GLP-1 Tie-Up With Lilly – Has The Bull Case Changed? — In early August 2026, CVS Health reported second-quarter results showing higher sales of US$35,117 million and revenue of US$106.10 billion, alongside net income of US$2,979 million and materially higher earnings per share versus a year earlier.
Yahoo Finance 2026-08-07
These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks
For Moderna’s Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off 2026-08-07
For Moderna’s Greenlit mRNA Flu Vaccine, Payoff Is a Ways Off
Yahoo Finance 2026-08-08
Novo Nordisk (CPSE:NOVO B) Wins Dutch Injunction Over Compounded Semaglutide Spray
Novo Nordisk A/S Q2 Earnings Call Highlights 2026-08-08
Novo Nordisk A/S Q2 Earnings Call Highlights — Novo Nordisk A/S (NYSE:NVO) reported second-quarter adjusted sales growth of 7% at constant exchange rates, supported by GLP-1 volume growth across its obesity and diabetes franchises, while lower realized prices and manufacturing-related costs weighed on margins.
Yahoo Finance 2026-08-08
LLY Q2 Deep Dive: Key Products and Pipeline Expansion — Global pharmaceutical company Eli Lilly (NYSE:LLY) reported Q2 CY2026 results topping the market’s revenue expectations, with sales up 47.7% year on year to $22.97 billion. The company’s full-year revenue guidance of $86 billion at the midpoint came in 0.6% above analysts’ estimates. Its non-GAAP profit of $8.38 per share was 27.3% above analysts’ consensus estimates.
Yahoo Finance 2026-08-08
Eli Lilly (LLY) Gains FDA Breakthrough Nod As Olomorasib Cancer Trial Broadens
Yahoo Finance 2026-08-08
Amgen (AMGN) Stock Sees Fair Value Lift After Q2 Beat And Analyst Target Hikes — Amgen is back in focus after updated valuation work lifted its modeled fair value from US$352.23 to US$371.93 per share, signaling a higher price target in the latest analyst run.
Eli Lilly and Company Q2 Earnings Call Highlights 2026-08-08
Eli Lilly and Company Q2 Earnings Call Highlights — Eli Lilly and Company (NYSE:LLY) reported 48% revenue growth in the second quarter of 2026, driven primarily by continued demand for its cardiometabolic medicines MOUNJARO and ZEPBOUND, while raising its full-year revenue and earnings guidance.
Yahoo Finance 2026-08-09
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call — CEO Robert Michael emphasized that “each [portfolio] delivered growth above 20%,” with SKYRIZI achieving market leadership in multiple countries.
Yahoo Finance 2026-08-09
Eli Lilly (LLY) Posts Blowout Growth And Raises Its Outlook — On August 5, the company reported second-quarter revenue of $23.0 billion, up 48% from a year earlier, and used the momentum to raise its full-year sales and profit targets.
Yahoo Finance 2026-08-10
Eli Lilly (LLY) Stock Gets Fair Value Bump After GLP 1 Driven Analyst Revisions — Eli Lilly’s updated fair value price target has shifted from US$1,270.37 to US$1,297.31, giving investors a fresh reference point for how analysts are framing the stock today.
Yahoo Finance 2026-08-10
Eli Lilly vs. Novo Nordisk: Which Company Is Better Positioned for America’s New Drug Manufacturing Policies?
Yahoo Finance 2026-08-10
Eli Lilly vs. Novo Nordisk: Has GLP-1 Manufacturing Become the New Competitive Moat?
Yahoo Finance 2026-08-10
Sector Update: Healthcare Stocks Gain Late Afternoon — Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 1% and th
Yahoo Finance 2026-08-10
Eli Lilly Stock Rises 2.1% as UK Clears Obesity Pill
Yahoo Finance 2026-08-10
Sector Update: Healthcare Stocks Rise in Afternoon Trading — Healthcare stocks were higher Monday afternoon, with the NYSE Healthcare Index up 0.9% and the State
Stocktwits 2026-08-10
Eli Lilly’s GLP-1 Pill Secures First European Milestone – Here’s Everything To Know About UK MHRA’s Foundayo Approval
Yahoo Finance 2026-08-10
AbbVie’s (ABBV) Botox Just Got A Step Closer To A Fifth Use
Yahoo Finance 2026-08-10
This Biotech’s Drug Could Treat Hot Flashes. The Stock Is Up 34% on Good News.
Yahoo Finance 2026-08-10
IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum
Yahoo Finance 2026-08-10
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Yahoo Finance 2026-08-10
Lifespan Vision Ventures Leads Remedium Bio's Series A Financing — Lifespan Vision Ventures today announced that it is leading Remedium Bio, Inc.'s ("Remedium") $10 million Series A financing and has completed the round's initial closing, with participation from Eli Lilly and Company ("Lilly") and HKX Capital.
24/7 Wall St. 2026-08-10
We Said These 4 Dividend Aristocrats Could Soar. Here’s How They Did, Plus 3 New Picks.
Yahoo Finance 2026-08-10
Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Did Novo’s phase 3 flop kill the inflammation hypothesis in heart disease? 2026-08-10
Did Novo’s phase 3 flop kill the inflammation hypothesis in heart disease?
Yahoo Finance 2026-08-10
Update: Scholar Rock Holding Says Apitegromab BLA Review Stays on Track for September 30 PDUFA Date
The Motley Fool 2026-08-11
Amgen (AMGN) Q2 2026 Earnings Call Transcript — Revenue surged 10% as six growth drivers now fuel 70% of product sales.
Mineralys Therapeutics Q2 Earnings Call Highlights 2026-08-11
Mineralys Therapeutics Q2 Earnings Call Highlights — Mineralys Therapeutics (NASDAQ:MLYS) said it is continuing commercial-launch preparations for lorundrostat ahead of its December 22 Prescription Drug User Fee Act target date, while reporting a wider second-quarter loss driven largely by a $200 million upfront payment related to its amended agreemen
Yahoo Finance 2026-08-11
AbbVie (ABBV) Wins Canada Reimbursement Backing For Adult Migraine Treatment
Absci Q2 Earnings Call Highlights 2026-08-11
Absci Q2 Earnings Call Highlights
Yahoo Finance 2026-08-11
AbbVie (ABBV) Gains On Botox Filing, Is The 9% Discount Still There? — Alongside Allergan Aesthetics' Botox update and several recent approvals and guidance changes, AbbVie’s share price has moved to $247.97, with a 90 day share price return of 19.3% and a 1 year total...
The Motley Fool 2026-08-11
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026? — AbbVie commands a premium valuation for its specialty drug pipeline, while CVS Health trades at a discount despite managing 37 million medical members.
Yahoo Finance 2026-08-11
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results — Announced positive interim Phase 1 data from the HEADLINE™ trial of ABS-201 Completed $100 million underwritten offering, including $40 million strategic investment from Eli Lilly & Company Cash, cash equivalents, and marketable securities now sufficient to fund operations into the second half of 2028 VANCOUVER, Wash. and NEW YORK, Aug.
Yahoo Finance 2026-08-11
Eli Lilly Scores Major Win in Weight-Loss Drug Race
Yahoo Finance 2026-08-11
Merck (MRK) Wins FDA And EMA Review For Broader RSV Use In Children
The Motley Fool 2026-08-11
Merck (MRK) Q2 2026 Earnings Call Transcript — Oncology and animal health drove $16.6B revenue growth amid upcoming patent expirations.
Yahoo Finance 2026-08-11
European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Yahoo Finance 2026-08-11
MRK Stock Up 5.6% in a Month as Estimates Fall: Buy, Hold or Sell?
Yahoo Finance 2026-08-11
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Product," and "Best Product for Rare/Orphan Diseases"
Yahoo Finance 2026-08-11
Eli Lilly and Company (LLY) vs. Novo Nordisk A/S (NVO): Is Lilly Pulling Ahead in the $100 Billion Obesity Market?
Yahoo Finance 2026-08-11
ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer
Quartz 2026-08-11
Eli Lilly's Foundayo weight-loss pill approved in the U.K.
Yahoo Finance 2026-08-11
Allergan Aesthetics Refreshes Allergan Partner Privileges® to Better Support Today's Modern Aesthetics Practices
UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition 2026-08-11
UK regulators greenlight Lilly’s Foundayo, intensifying Novo competition
Yahoo Finance 2026-08-12
5 Insightful Analyst Questions From Merck’s Q2 Earnings Call
Yahoo Finance 2026-08-12
Sector Update: Healthcare Stocks Advance Late Afternoon — Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and t
Yahoo Finance 2026-08-12
Eli Lilly Stock Falls While Retatrutide Lawsuits Expand
Yahoo Finance 2026-08-12
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation — Absci (ABSI) is back in focus after releasing early Phase 1 data for its lead antibody ABS-201 and securing a US$40 million investment and development support from Eli Lilly tied to the program.
Yahoo Finance 2026-08-12
Lilly Targets Black-Market Retatrutide Sellers
Yahoo Finance 2026-08-12
Novo Nordisk Dips 4% in a Month: How Should Investors Play the Stock?
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide 2026-08-12
Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide
Yahoo Finance 2026-08-12
Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market
Yahoo Finance 2026-08-12
AMGEN TO OPEN NEW SCIENCE & INNOVATION CENTER IN GENOME VALLEY, HYDERABAD
Yahoo Finance 2026-08-12
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? — Absci Corporation recently reported second-quarter 2026 results showing a net loss of US$33.21 million, wider than a year ago, while basic and diluted loss per share from continuing operations narrowed to US$0.21.
Moby 2026-08-12
Absci Corporation Q2 2026 Earnings Call Summary
Yahoo Finance 2026-08-13
Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab?
Yahoo Finance 2026-08-13
Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Yahoo Finance 2026-08-13
Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth? — (NYSE:ABBV) reported its first-quarter 2026 financial results, delivering worldwide net revenues of $15.002 billion, an increase of 12.4% on a reported basis (10.3% operationally). The company posted GAAP diluted EPS of $0.39 and adjusted diluted EPS of $2.65, which exceeded internal expectations despite including a $0.41 per share unfavorable impact from acquired IPR&D […]
Yahoo Finance 2026-08-13
Merck (MRK) Stock Fair Value Edges Higher After Analysts Back Pipeline Progress — Price target commentary for Merck has shifted toward a US$140 to US$155 range, anchored by a modest uplift in fair value from US$132.78 to US$136.85.
Yahoo Finance 2026-08-13
Should Investors Buy WST as HVP Growth Meets a Premium Valuation?
Yahoo Finance 2026-08-13
WST Q2 Beat and Raised 2026 Outlook Reinforce the HVP Growth Story
TheStreet 2026-08-13
Lilly gains access to market that could add millions of customers
Yahoo Finance 2026-08-13
European Equities Traded in the US Rise in Thursday Trading
Yahoo Finance 2026-08-13
Novo Nordisk (CPSE:NOVO B) Sees New Pressure In Weight Loss Drugs — In the US, Amazon Pharmacy launches a new Medicare weight loss drug program priced at $50 per month that will include Novo Nordisk and Eli Lilly medications.
Yahoo Finance 2026-08-13
Can Novo Nordisk's GLP-1 Pill Momentum Offset LLY's Growing Edge?
Yahoo Finance 2026-08-13
2 S&P 500 Stocks with Exciting Potential and 1 We Ignore
Yahoo Finance 2026-08-13
Can Keytruda Sustain Merck's Growth in the Second Half of 2026?
Yahoo Finance 2026-08-13
Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
Yahoo Finance 2026-08-13
LLY's Foundayo Posts $98M in Q2 Sales: What's Next for the Oral GLP-1? — Lilly's Foundayo records $98M in Q2 sales, while rising prescriptions, broader access and global expansion set the stage for H2 growth
Yahoo Finance 2026-08-13
OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests — (NASDAQ: OPK) today announced the expansion of its financing relationship with HealthCare Royalty, a business of KKR (HCRx), through the issuance of an additional $125 million aggregate principal amount of senior secured notes.
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits 2026-08-13
Eli Lilly cracks down on illicit weight loss drug trade with US lawsuits
Yahoo Finance 2026-08-13
Amgen’s Q2 Earnings Call: Our Top 5 Analyst Questions — CEO Robert Bradway highlighted that 22 products achieved double-digit sales growth, and 17 products annualized over $1 billion in sales, noting, “Our strong results were driven by the breadth and depth of our portfolio and once again demonstrate our ability to grow
The Motley Fool 2026-08-13
Eli Lilly (LLY) Q2 2026 Earnings Call Transcript — Revenue surged 48% on Mounjaro and Zepbound demand, with full-year guidance raised.
Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps 2026-08-13
Novo Nordisk CEO Concedes Eli Lilly’s Market-Share Gains as Stock Slumps
Yahoo Finance 2026-08-13
BeOne Medicines Ltd (ONC) (Q2 2026) Earnings Call Highlights: Revenue Surges 30% to $1. ...
Yahoo Finance 2026-08-14
Jim Cramer Reevaluates Novo Nordisk (NVO) as Wegovy Pill Adoption Accelerates
Yahoo Finance 2026-08-14
Eli Lilly (LLY) Steps Up Legal Fight Over Illegal Retatrutide Sales
The Motley Fool 2026-08-14
Eli Lilly Just Scored Europe's First Weight Loss Pill Approval -- and the Growth Story Keeps Getting Bigger
Yahoo Finance 2026-08-14
Eli Lilly Stock Nears Buy Point After Earnings-Fueled Gains
Yahoo Finance 2026-08-14
Amgen (AMGN) Opens New Science And Innovation Center In Hyderabad
Yahoo Finance 2026-08-14
5 Revealing Analyst Questions From Eli Lilly’s Q2 Earnings Call
24/7 Wall St. 2026-08-15
5 Safe High-Yield Stocks Boomers Should Own in August
Yahoo Finance 2026-08-15
Eli Lilly’s Weight-Loss Pill Just Got Its First Foothold in Europe — Shares of LLY increased more than 2% in response to the announcement, a modest but insightful reaction for a company whose […]
Yahoo Finance 2026-08-16
Eli Lilly’s (LLY) Growth Story Keeps Adding Chapters — On August 5, Eli Lilly (NYSE:LLY) told investors its second quarter delivered 48% revenue growth, and the days since have brought even more good news.
Yahoo Finance 2026-08-17
OmniAb Jumps 18% as Lilly Deal Lifts Cash Outlook
24/7 Wall St. 2026-08-17
Jim Cramer Says One Group of Stocks is ‘So Hated’ Right Now. Is it Time to Buy?
The Motley Fool 2026-08-17
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years
Yahoo Finance 2026-08-17
Can Eli Lilly (LLY) Stay Undervalued If Growth Keeps Delivering? — Eli Lilly stock trades around US$1,180 per share after a very strong five year run. Eli Lilly has delivered a 361.1% total return over the past five years, which sets a high bar for any further upside from here.
Yahoo Finance 2026-08-17
LLY Up Around 6% Post Robust Q2 Results: Buy, Sell or Hold the Stock?
Yahoo Finance 2026-08-17
Eli Lilly and Company (LLY)’s Weight-Loss Pill Just Won Its First Race in Europe. Novo Nordisk A/S (NVO) Still Has a Head Start
Yahoo Finance 2026-08-17
Leal Therapeutics Announces $30 Million Series A Extension and Initiation of Phase 1b/2a Clinical Trial of LTX-001 in Schizophrenia — (Leal), a clinical-stage biopharmaceutical company developing first-in-class neuro-metabolic therapeutics, today announced a second close of $30 million of its Series A financing.
Yahoo Finance 2026-08-17
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-08-17
Novo Nordisk AS's Dividend Analysis — Novo Nordisk AS (NYSE:NVO) recently announced a total dividend of $0.58 per share, with the ex-dividend date set for 2026-08-17. This payment includes a $0.58 per share cash dividend payable on 2026-08-25.
Yahoo Finance 2026-08-17
OmniAb Announces Global Collaboration and License Agreement for Ion Channel Program with Eli Lilly & Company
Yahoo Finance 2026-08-18
Why Eli Lilly (LLY) Stock Is Up Today — Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3% in the afternoon session after the company announced two deals, acquiring rights to a preclinical Alzheimer's drug and entering a collaboration for an ion channel program.
Yahoo Finance 2026-08-18
Eli Lilly (LLY) Adds Neuroscience And Lung Cancer Research Deals
Yahoo Finance 2026-08-18
Eli Lilly Stock Jumps 2.6% as Investors Flee Expensive Tech
Yahoo Finance 2026-08-18
OPKO Health Secures $125 Million Financing Against Mazdutide Royalties — OPK raises $125 million against mazdutide royalties, gaining non-dilutive capital while retaining longer-term royalty upside.
Yahoo Finance 2026-08-18
Eli Lilly, Stock Of The Day, Is Erasing Novo's Early Lead In Weight-Loss Pills
Yahoo Finance 2026-08-18
AZN Ends NSCLC Study for Bispecific Antibody Over Unlikely Success
Yahoo Finance 2026-08-18
Hims & Hers CEO pushes back against FTC suit, says "we are active disruptors"
Yahoo Finance 2026-08-18
Michael Burry is Bullish on This Beaten-Down Healthcare Stock. Time to Buy? — The stock is down about 40% so far this year. Zoetis has dropped more than 70% from its 2021 […]
Yahoo Finance 2026-08-18
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support
Yahoo Finance 2026-08-18
Valeris Welcomes Patient Services Veteran Lauren Cole to Lead Commercial Strategy
Leal Therapeutics raises $30m to fund schizophrenia and ALS trials 2026-08-18
Leal Therapeutics raises $30m to fund schizophrenia and ALS trials
Yahoo Finance 2026-08-18
AlzeCure Receives a USD 10 Million Upfront Payment and Completes Initial Transaction with Lilly
Yahoo Finance 2026-08-18
Coultreon Biopharma Appoints Prista Charuworn, MD as Chief Medical Officer
Stocktwits 2026-08-18
Why Did ROKU, MRK, SCHW Stocks Jump To 52-Week Highs?
Yahoo Finance 2026-08-19
Why this mRNA cancer vaccine is raising new treatment hope
Yahoo Finance 2026-08-19
Can Eli Lilly Catch Novo Nordisk in the Oral GLP-1 Race?
Stocktwits 2026-08-19
IOVA Stock Hits New 52-Week High As Shares Jump 14% — What Drove The Rally?
Yahoo Finance 2026-08-19
Merck (MRK) Stock Trades Up, Here Is Why — Shares of global pharmaceutical company Merck (NYSE:MRK) jumped 11.3% in the afternoon session after the company and its partner Moderna announced that their personalized mRNA cancer vaccine succeeded in a late-stage trial.
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough? 2026-08-19
Eli Lilly Price Forecast: The Next Big Stock After Weight-Loss Drug Breakthrough?
Yahoo Finance 2026-08-19
Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?
Yahoo Finance 2026-08-19
Amplitude Therapeutics and Lilly Enter Strategic Collaboration to Develop Trans-Amplifying RNA Vaccines for Infectious Diseases
Yahoo Finance 2026-08-19
Top Midday Gainers — ZeroStack (ZSTK) said Wednesday it entered a $1 billion crypto contribution agreement that will add
Stocktwits 2026-08-19
These Two Biotech Stocks Recorded Fresh Milestones Today – What’s Driving Today’s Gains?
Yahoo Finance 2026-08-19
Merck Surges 7.5% After First Phase 3 mRNA Cancer-Vaccine Win
Stocktwits 2026-08-19
TEM, BNTX, MRVI, RGEN, NVAX Stock Rallies As Moderna-Merck Cancer Vaccine Clears Late-stage Trial — TEM stock rose as investors connected the upbeat clinical results to Tempus’s planned $1.5 billion acquisition of Personalis, announced last month.
Yahoo Finance 2026-08-19
Moderna, Merck Report Positive Phase 3 Trial Results of Melanoma Drug; Moderna Shares Jump Over 100%
Yahoo Finance 2026-08-19
Amgen Stock Surges 3.5% as Healthcare Hits Record High
Yahoo Finance 2026-08-19
Sector Update: Healthcare Stocks Gain Wednesday Afternoon — Healthcare stocks were higher Wednesday afternoon, with the NYSE Healthcare Index rising 2.2% and th
Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means 2026-08-19
Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means — A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
Moderna stock surges as melanoma vaccine trial shows "landmark moment" 2026-08-19
Moderna stock surges as melanoma vaccine trial shows "landmark moment"
Yahoo Finance 2026-08-19
Real Parkinson’s Disease Hope from Jupiter Neurosciences — The market isn’t recognizing the story yet with its paltry market cap of $5.0M, and that disconnect has created a sizable opportunity for investors for a future rerating.
Yahoo Finance 2026-08-19
How Does LLY's Q2 GLP-1 Portfolio Performance Stack Up Against NVO's?
Yahoo Finance 2026-08-19
Altimmune's Phase III MASH Study Puts 2029 Data in Investor Focus
24/7 Wall St. 2026-08-19
Stock Forecast: The Market is Sleeping on Eli Lilly’s Next $1 Trillion Opportunity — Eli Lilly just became the first pharmaceutical company ever valued above $1 trillion, yet analysts who dig into its pipeline are arguing the market still has not grasped what the next two years could look like for shareholders.
Yahoo Finance 2026-08-19
Moderna Skyrockets 90%, Merck Jumps On Late-Stage Cancer Vaccine Trial Win
Yahoo Finance 2026-08-19
Moderna’s Cancer Breakthrough Just Sent the Stock Soaring 93%
Stocktwits 2026-08-19
MRNA Stock Heads For Its Best Ever Day After Melanoma Therapy Meets Primary Goal
24/7 Wall St. 2026-08-19
Why Novartis, Lilly, and Bristol Myers Are Eyeing This Clinical-Stage Cancer Play
Yahoo Finance 2026-08-19
Eli Lilly, Novo Nordisk Battle It Out In Weight-Loss Pills Market — The weight-loss pills battle between Eli Lilly and Novo Nordisk could add to the projected $200 billion market for obesity drugs.
Yahoo Finance 2026-08-19
The Precision Peptide Company Inc. Announces Development of Needle-Free Tirzepatide Transdermal Patch — Vancouver, British Columbia--(Newsfile Corp. - August 19, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), a publicly traded wellness company focused on advanced peptide formulations and delivery systems, today announces that the Company is developing a tirzepatide-based transdermal patch delivery system in the United States as an a…
Yahoo Finance 2026-08-19
Merck and Moderna Announce Phase 3 INTerpath-001 Trial of Intismeran Autogene Plus KEYTRUDA® Met Endpoints of Recurrence-Free Survival (RFS) and Distant Metastasis-Free Survival (DMFS) in Patients Wit
Yahoo Finance 2026-08-19
UnitedHealth Group (UNH) vs. Eli Lilly and Company (LLY): Which Healthcare Stock Offers the Better Dividend? — Its quarterly dividend now stands at $2.32 per […]
Yahoo Finance 2026-08-20
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery? — (NYSE:MRK) disclosed holding 1,214,126 shares of micro-cap AI immunology firm Evaxion A/S (NASDAQ:EVAX). Evaxion shares bumped up 2% to $3.17 in early trading on the news.
Yahoo Finance 2026-08-20
Why Moderna (MRNA) Stock Is Trading Lower Today — Shares of biotechnology company Moderna (NASDAQ:MRNA) fell 20% in the morning session after investors took profits as the stock surged over 175% in the previous session on positive clinical trial news.
Yahoo Finance 2026-08-20
Morgan Stanley Revamps Merck Stock Target After Cancer Breakthrough
Yahoo Finance 2026-08-20
Sector Update: Healthcare Stocks Fall Late Afternoon — Healthcare stocks declined late Thursday afternoon, with the NYSE Healthcare Index decreasing 0.9% a
Yahoo Finance 2026-08-20
Merck Slips After 12.6% Cancer-Vaccine Surge
Yahoo Finance 2026-08-20
Eli Lilly Slips After Crossing $1.1 Trillion
Yahoo Finance 2026-08-20
Is Eli Lilly (LLY) Undervalued On UK Foundayo Approval? — The Foundayo approval arrives during a strong run for Eli Lilly’s stock, with a 30 day share price return of 11.63% and a year to date share price return of 18.51%. Over the longer term, total shareholder returns of 82.64% over one year and 136.19% over three years...
Yahoo Finance 2026-08-20
Moderna Is Up 350% Since Our Recommendation. Here’s What to Do Next.
Stocktwits 2026-08-20
ARCT Defies mRNA Selloff And Extends Rally As Moderna, BioNTech Shares Pull Back
Yahoo Finance 2026-08-20
Why Merck Stock Got Downgraded After a Massive Cancer-Vaccine Win — RBC Capital Markets analyst Trung Huynh downgrades shares of the Keytruda maker following a nearly 13% rally.
Yahoo Finance 2026-08-20
Sector Update: Healthcare Stocks Fall Thursday Afternoon — Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.7% and th
Stocktwits 2026-08-20
TEM Stock On Track For Best Week In 4 Months Following Personalis Deal Spotlight — BTIG analyst Mark Massaro raised the firm’s price target on Tempus AI to $80 from $70 and kept a Buy rating.
TheStreet 2026-08-20
135-year-old healthcare giant surges on cancer vaccine breakthrough
Proactive Investors 2026-08-20
Moderna oncology platform draws Street value after melanoma trial win
Yahoo Finance 2026-08-20
Moderna And Merck's Cancer Vaccine: Are Investors Putting The Cart Before The Horse?
Yahoo Finance 2026-08-20
GKOS Stock Surges 67% Year to Date: What's Driving the Rally?
Yahoo Finance 2026-08-20
Merck's Momentum Remains Strong But Valuation Limits Further Upside, RBC Says
Yahoo Finance 2026-08-20
Can Awiqli Help Novo Nordisk Build a New Growth Engine Beyond GLP-1s?
Yahoo Finance 2026-08-20
Moderna (MRNA) Is Up 173.9% After First Successful Phase 3 Individualized mRNA Cancer Therapy Trial - What's Changed
Yahoo Finance 2026-08-20
Moderna stock pulls back after massive one-day rally: analysts weigh in — Investing.com -- Moderna shares pulled back sharply on Thursday, giving up a small chunk of Wednesday’s record-breaking rally after the stock rocketed as much as 177% on data showing its personalized cancer vaccine, developed with Merck, slowed the spread and recurrence of melanoma. Merck shares had jumped 12.6% on Wednesday alongside Moderna’s surge.
InvestorsHub 2026-08-20
Moderna shares slide as investors lock in gains after historic cancer vaccine rally
Yahoo Finance 2026-08-20
2 Momentum Stocks Worth Investigating and 1 We Avoid
Stocktwits 2026-08-20
Why Did MRNA, MRK, TGT Stocks Jump To 52-Week Highs Today?
Yahoo Finance 2026-08-20
Elon Musk Says mRNA Has 'Tremendous Promise,' Turning Disease Into a 'Software Problem,' as Moderna Stock Rockets 177% on Cancer Vaccine Breakthrough
Stocktwits 2026-08-20
Moderna Is Now S&P 500’s No. 2 Stock This Year — Wall Street, Jim Cramer And Elon Musk Cheer Cancer Vaccine Breakthrough
Yahoo Finance 2026-08-21
Moderna, Merck Cancer Vax Gives Hope
Stocktwits 2026-08-21
SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing
Yahoo Finance 2026-08-21
Eli Lilly Jumps as Weight-Loss Leadership Drives Another Breakout
Yahoo Finance 2026-08-21
Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK — On August 10, the company said it will spend about $2.3 billion on a new plant in Houston, part of a larger $40 billion U.S. investment pledge.
Yahoo Finance 2026-08-21
Merck (MRK) Gains A New Cancer Growth Story As Valuation Debate Heats Up — Merck’s recent mRNA melanoma result has arrived alongside powerful price momentum, with a 30 day share price return of 18.0% and a year to date share price return of 40.0%.
Yahoo Finance 2026-08-21
Thank Moderna for the Healthcare Sector’s Standout Week — Moderna stock saw its best weekly performance ever, rising over 140%.
Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet. 2026-08-21
Moderna Just Doubled on a Massive Cancer Breakthrough. Here’s Why MRNA Stock Isn’t a Buy Yet.
Yahoo Finance 2026-08-21
AbbVie (ABBV) Presented New Lung Cancer Clinical Data At WCLC 2026
The Motley Fool 2026-08-21
Stock Split Watch: Is Eli Lilly (LLY) Stock Next? — Shares recently traded at $1,280 each, so a split wouldn't be surprising.
Yahoo Finance 2026-08-21
Merck's Near-Term Catalysts Create Bull-Bear Debate, RBC Capital Markets Says
Yahoo Finance 2026-08-21
Why the Dow Is Beating the Nasdaq Again — The S&P 500 was still up 0.3%.
Yahoo Finance 2026-08-21
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Yahoo Finance 2026-08-21
Scholar Rock Removes Catalent Indiana From Apitegromab BLA as Fill-Finish Facility
Yahoo Finance 2026-08-21
Apple paid $17bn in taxes to Ireland after court ruling on back levies — Apple paid Ireland $17bn in taxes last year, representing 40 per cent of its worldwide total, according to filings that offer new insight into...
Yahoo Finance 2026-08-21
Amgen (AMGN) Gets A Fresh Target, Is It Fully Priced? — Analyst reaction to Amgen’s latest quarter Amgen (AMGN) is back in focus after Argus raised its price target to $460 from $375 while maintaining a Buy rating, following second quarter results and reported progress across the company’s drug portfolio.
Yahoo Finance 2026-08-21
Eli Lilly Is In A Race with Novo Nordisk But Its Stock Is The Clear Winner — Its Mounjaro drug sales surged 91% in the second quarter.
Yahoo Finance 2026-08-21
AbbVie to Present New Data at WCLC 2026 Showcasing Innovation Across Lung Cancer Pipeline
Stocktwits 2026-08-21
SLS, IBRX Stocks In Focus: Analyst Says Moderna-Merck Cancer Vaccine Success ‘Bodes Well’ For Oncology — Moderna soared 177% Wednesday, while Merck gained 13% and the rally spread to BioNTech, Arcturus, Tempus AI and Novavax.
Yahoo Finance 2026-08-21
Hims & Hers Health (HIMS) & Novo Nordisk A/S (NVO): Two Weight-Loss Pill Players Just Got Punished for Growing Fast — (NYSE:HIMS) shares fell over 2% on Tuesday even after the telehealth company posted second-quarter revenue of $753.2 million, up 38% and above the $699 million analysts expected. Novo Nordisk A/S (NYSE:NVO) suffered a similar fate a week earlier, with shares dropping about 6% […]
2 Biotech Stocks Shaping Up for Major Breakouts 2026-08-22
2 Biotech Stocks Shaping Up for Major Breakouts
Yahoo Finance 2026-08-22
Will Eli Lilly’s Global Vault CRM Deal and Leadership Shift Change Veeva Systems’ (VEEV) Narrative?
Yahoo Finance 2026-08-22
Eli Lilly (LLY) Is Up 6.4% After UK Clears Foundayo and GLP‑1 Portfolio Advances - What's Changed
Stocktwits 2026-08-22
ARCT Surges Over 60% Toward Best Week In Year As Moderna Cancer Win Lifts Sector — Retail Says Arcturus Getting ‘Harder To Dismiss’
The Motley Fool 2026-08-23
Eli Lilly and Novo Nordisk Can't Treat This Form of Obesity. Billionaire Stanley Druckenmiller Is Betting Rhythm Pharmaceuticals Can
Yahoo Finance 2026-08-23
Merck (MRK) Takes An AI Vaccine Stake And Expands Its Discovery Playbook
24/7 Wall St. 2026-08-23
Prediction: Eli Lilly Could Be One of the Biggest Winners of the Next Decade. Here’s Why.
Yahoo Finance 2026-08-24
Novo Resources Releases Updated Corporate Presentation
Yahoo Finance 2026-08-24
Myriad Genetics and Moderna Shares Plummet, What You Need To Know
Stocktwits 2026-08-24
GILD Stock Garners Retail Attention On Trodelvy EU Approval Ahead Of August 27 HIV FDA Verdict
Yahoo Finance 2026-08-24
Sector Update: Healthcare Stocks Softer Late Afternoon
Yahoo Finance 2026-08-24
Moderna and Merck Cancer Vaccine Success Is Good News for CancerVax
Yahoo Finance 2026-08-24
Eli Lilly Slips as Its $1.1 Trillion Valuation Cools
Yahoo Finance 2026-08-24
Eli Lilly (LLY) Is Suing Six Companies Over an Unapproved Drug—Leaving Novo Nordisk (NVO) Clear in the GLP-1 Wars
Yahoo Finance 2026-08-24
Is the Weight-Loss Drug Market Really a Winner-Take-All Fight Between Novo Nordisk (NVO) and Eli Lilly (LLY)?
Yahoo Finance 2026-08-24
Sector Update: Healthcare Stocks Decline in Afternoon Trading
Yahoo Finance 2026-08-24
Novo Nordisk (CPSE:NOVO B) Reaches LX9851 Obesity Drug Milestone
24/7 Wall St. 2026-08-24
Eli Lilly Has a $100 Billion Revenue Story in the Making, 18% Upside Ahead — Eli Lilly just crossed a $1 trillion market cap for the first time, and management is already pointing toward a milestone that would rewrite the drugmaker's history.
24/7 Wall St. 2026-08-24
Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips — Moderna just handed back 7% of its staggering year-to-date run in a single session, and the question rattling traders is whether this is a routine exhale or the beginning of a painful unwind for latecomers.
Trefis 2026-08-24
Can Eli Lilly Keep The Margin You Are Now Paying For?
Yahoo Finance 2026-08-24
Amgen Touches 52-Week High: Buy, Sell or Hold the Stock?
The Motley Fool 2026-08-24
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
Yahoo Finance 2026-08-24
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
TheStreet 2026-08-24
A cancer vaccine years in the making just proved itself
Yahoo Finance 2026-08-24
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
InvestorsHub 2026-08-24
Roche and Eli Lilly Win FDA Clearance for Alzheimer’s Blood Test
24/7 Wall St. 2026-08-24
Top Biopharma Analyst Sees Biotech M&A Market Reopening After a Long Freeze
Proactive Investors 2026-08-24
Lilly's GLP-1 pill hits UK pharmacies as US battle with Novo intensifies
Yahoo Finance 2026-08-24
GeoVax Applauds Clinical Validation of Combination Immunotherapy Strategies
Yahoo Finance 2026-08-24
Lexicon Pharmaceuticals Earns Third $10 Million Milestone Payment from Novo Nordisk Following Achievement of Key Phase 1 Development Milestone for LX9851 — LX9851 is a first-in-class, oral non-incretin candidate being developed by Novo Nordisk for the treatment of obesity and associated metabolic disorders Lexicon is eligible to receive up to $1 billion in total upfront and milestone payments from the collaboration, plus royalties on net sales THE WOODLANDS, Texas, Aug.
Yahoo Finance 2026-08-24
Beat the Market Like Zacks: Amgen, FirstCash, Delek in Focus
InvestorsHub 2026-08-24
Eli Lilly Launches Foundayo Weight-Loss Pill in UK
Roche commits to lean-mass preservation with Hanmi obesity deal 2026-08-24
Roche commits to lean-mass preservation with Hanmi obesity deal — For $190 million up front and as much as $2.3 billion overall, the Swiss drugmaker is building its portfolio with a shot that aims to spur weight loss but spare muscle tissue.
Proactive Investors 2026-08-24
Eli Lilly launches oral weight-loss pill in UK pharmacies
Yahoo Finance 2026-08-24
3 Market-Beating Stocks with Exciting Potential
Stocktwits 2026-08-24
Why Did TGT, MRK, SCHW Stocks Surge To 52-Week Highs Last Week?
Yahoo Finance 2026-08-24
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
Yahoo Finance 2026-08-24
AbbVie’s Humira Replacement Strategy Is Working, But Could Growth Be Too Concentrated? — Its worldwide revenue increased 10.2% to $16.99 billion, supported by strong growth in immunology […]
Yahoo Finance 2026-08-24
Analysts See Drastic Change For This Particular Part Of Healthcare — While Moderna shares have remained volatile since then — down 23.5% Thursday after rising 177% Wednesday — the biotech ETF is doing its job as a diversified fund, keeping its one-day price moves to within 6%.
Related: Defensive Rotation into Large-Cap Value and Consumer Staples 2026-08-25
Spillover from a related thesis (semantic)
Related: Healthcare pharma pipeline catalysts 2026-08-25
Spillover from a related thesis (semantic)
Related: mRNA platform expansion beyond vaccines 2026-08-25
Spillover from a related thesis (semantic)
Related: AbbVie large-cap pharma M&A pipeline build 2026-08-25
Spillover from a related thesis (semantic)
Related: GLP-1 and obesity drug coverage expansion 2026-08-25
Spillover from a related thesis (shares holding)
Related: Healthcare managed care and aging demographics 2026-08-25
Spillover from a related thesis (shares holding)
Related: Pfizer and large-cap pharma value recovery 2026-08-25
Spillover from a related thesis (shares holding)
Related: AbbVie large-cap pharma M&A pipeline build 2026-08-25
Spillover from a related thesis (shares holding)
Related: mRNA platform expansion beyond vaccines 2026-08-25
Spillover from a related thesis (shares holding)
Related: GLP-1 and weight-loss drug supercycle 2026-08-25
Spillover from a related thesis (shares holding)
Related: Healthcare pharma pipeline catalysts 2026-08-25
Spillover from a related thesis (shares holding)
Yahoo Finance 2026-08-25
Is AbbVie (ABBV) Quietly Rebalancing Its Growth Story Around Oncology Innovation?
Yahoo Finance 2026-08-25
2 Profitable Stocks with Solid Fundamentals and 1 We Turn Down
Proactive Investors 2026-08-25
Novo Resources maps a discovery-led path through strong gold and copper markets — The London Metal Exchange’s official copper cash price stood at about US$14,168 a tonne on 24 August, after the International Energy Agency said prices reached record highs earlier in...
Yahoo Finance 2026-08-25
RGNX Stock Slumps 25% on FDA Clinical Hold for RGX-121 Gene Therapy — REGENXBIO stock plunges 25% after the FDA places a clinical hold on RGX-121 for MPS II, following asymptomatic spine MRI findings in five participants.
Yahoo Finance 2026-08-25
What Happens if Moderna’s Cancer Vaccine Works?
24/7 Wall St. 2026-08-25
Eli Lilly vs Novo Nordisk: One Winner in The Weight-Loss Drug Gold Rush
Yahoo Finance 2026-08-25
Merck (MRK) Surges on a Melanoma Win. Can Intismeran Extend Keytruda’s Growth Runway? — (NYSE:MRK) jumped 12.6% to a record $152.20 on August 19 after a pivotal melanoma trial validated intismeran autogene, the individualized mRNA cancer therapy developed with Moderna.
24/7 Wall St. 2026-08-25
Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here’s Who’s Best Positioned.
InvestorsHub 2026-08-25
Moderna Shares Rebound After Pullback Following Cancer Vaccine Rally — Moderna (NASDAQ:MRNA) shares rose 2. 9% in pre-market trading, recovering some ground after several sessions of declines that followed a dramatic rally triggered by positive Phase 3 results for its personalised mRNA cancer vaccine, intismeran autogene.
Yahoo Finance 2026-08-25
Lilly Gains as Foundayo Crosses the Atlantic Without a Needle
Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease? 2026-08-25
Measles Kills 2 in Pennsylvania: What Do Prediction Markets Say About the Disease?
Stocktwits 2026-08-25
MRK, RPRX Stocks Hit 52-Week Highs – What Drove Today’s Gains?
TheStreet 2026-08-25
Schwab SCHD draws $679M as dividend ETF climbs 2.39%
Stocktwits 2026-08-25
MRNA Stock Jumps 14% Past $150 As Wolfe Sees $9.2B Cancer-Vaccine Opportunity
Yahoo Finance 2026-08-25
NBIX vs. TEVA: Which Drugmaker Is the Better Investment?
Yahoo Finance 2026-08-25
Moderna Stock Soars on Cancer Vaccine Breakthrough
Stocktwits 2026-08-26
Why Did RUM, MRK, NEM Stocks Jump To 52-Week Highs Today?
Yahoo Finance 2026-08-26
BioArctic: Interim Report for the period April - June 2026
24/7 Wall St. 2026-08-26
Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips — Moderna stock shed 7% on Wednesday with no company news to blame, reopening a brutal question that its 439% year-to-date rally had been drowning out: what exactly does a $59 billion valuation buy on a revenue base this thin?
The Motley Fool 2026-08-26
Is It Too Late to Buy Eli Lilly? Billionaire Ken Griffin Doesn't Think So. He Nearly Quadrupled His Stake in the Pharma Stock in Q2.
Yahoo Finance 2026-08-26
Merck Stock Hits New 52-Week High: What's Driving the Rally?
Stocktwits 2026-08-26
LLY Stock In Spotlight After Study Shows Zepbound Use Linked To Up To 38% Lower Healthcare Costs In Adults Above 55 Years
Yahoo Finance 2026-08-26
Eli Lilly (LLY) Adds Alzheimer’s Research Deal As Obesity Cost Data Builds
Yahoo Finance 2026-08-26
NVO vs. GPCR: Which Obesity Stock Is the Better Buy Right Now?
Yahoo Finance 2026-08-26
Stuart Therapeutics, Inc. Appoints Dave LeCause as Senior Commercial Advisor
Yahoo Finance 2026-08-26
Revolution Medicines Wins FDA Approval for Pancreatic Cancer Pill. What It Means for the Stock.
Yahoo Finance 2026-08-26
Eli Lilly Clears Big Hurdle in Alzheimer's Fight
Yahoo Finance 2026-08-26
Sector Update: Healthcare Stocks Decline Late Afternoon — Healthcare stocks fell late Wednesday afternoon, with the NYSE Healthcare Index shedding 1% and the
Yahoo Finance 2026-08-26
Why Is Amgen (AMGN) Ending Its Crohn's Disease Research Partnership?
Yahoo Finance 2026-08-26
Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study
Veeva Systems Q2 Earnings Call Highlights 2026-08-26
Veeva Systems Q2 Earnings Call Highlights — Veeva Systems (NYSE:VEEV) reported fiscal 2027 second-quarter revenue of $928 million and non-GAAP operating income of $416 million, with Chief Executive Officer Peter Gassner saying results exceeded the company’s guidance.
The Motley Fool 2026-08-26
Billionaire Ken Griffin Increased His Stake in This Dividend King by 547% in Q2. Wall Street Thinks It's Still a Buy.
Stocktwits 2026-08-27
SLS, IBRX Eye Fresh Oncology Tailwind As Cathie Wood’s ARK Backs Personalized Cancer-Vaccine Future — ARK sees a path toward custom cancer treatments for every patient, though current costs of $200,000-$300,000 remain a major hurdle.
Yahoo Finance 2026-08-27
TEZSPIRE® DEMONSTRATES POSITIVE PHASE 3 RESULTS IN EOSINOPHILIC ESOPHAGITIS ACROSS BOTH CO-PRIMARY AND ALL KEY SECONDARY ENDPOINTS
Yahoo Finance 2026-08-27
AbbVie Submits Regulatory Application to EMA for SKYRIZI® (risankizumab) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
24/7 Wall St. 2026-08-27
3 Dividend Stocks, 12 Paychecks a Year: How to Get Paid Every Month
Yahoo Finance 2026-08-27
European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
Yahoo Finance 2026-08-27
AZN/AMGN's Tezspire Hits Primary Goal in Eosinophilic Esophagitis Study
Yahoo Finance 2026-08-27
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
Yahoo Finance 2026-08-27
Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? — Amgen and AstraZeneca's drug, Tezspire, scored Thursday in an esophageal disease that affects an estimated 470,000 patients in the U.S.
Stocktwits 2026-08-27
Moderna’s $2B Convertible-Note Deal To Focus On Oncology Growth, Debt Repayment – But Retail Calls It A ‘Bull Trap’ — The biotech firm announced plans to raise $2 billion through convertible notes, which could be increased to $2.3 billion.
Yahoo Finance 2026-08-27
Deutsche Bank cuts Novo Nordisk to Sell after earnings, shares dip — Investing.com -- Deutsche Bank downgraded Novo Nordisk (NYSE:NVO) (CSE:NOVOb) to Sell from Hold and cut its price target by 9% to 265 Danish crowns from 290 crowns, flagging persisting concerns over the company’s growth trajectory. The stock fell more than 3% in Copenhagen trading Thursday.
Yahoo Finance 2026-08-27
1 Unpopular Stock That Should Get More Attention and 2 We Find Risky
Yahoo Finance 2026-08-27
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?
Yahoo Finance 2026-08-27
BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?
Yahoo Finance 2026-08-27
AstraZeneca Stock Remains 14% Lower Despite Tezspire Phase 3 Success — Tezspire met both primary endpoints in an esophagitis trial, but AstraZeneca shares slipped roughly 0.6% Thursday.
Yahoo Finance 2026-08-27
Novo Nordisk Could Be 54% Undervalued On Obesity Drug Setbacks — At a share price of US$47.19, Novo Nordisk has seen short term pressure build, with the share price return down 3.0% over the last day and about 5.0% over the past month. The year to date share price return is down 9.9% and the 1 year total shareholder return is down 13.5%, indicating...
Yahoo Finance 2026-08-27
Novo Nordisk Stock Is Downgraded to Sell, and GLP-1s Aren’t the Reason
Yahoo Finance 2026-08-27
SMMT Rises on Akeso's Win in Phase III Biliary Tract Cancer Study
24/7 Wall St. 2026-08-27
When Inflation Is Sticky, 5 Dividend Aristocrats Are the Stocks to Own Now and Forever
Proactive Investors 2026-08-27
GLP-1 maker hit with 'sell' rating as 2027 revenue cliff fears mount — The shares dropped 2.52% to DKK 297.25 as the broker adjusted its rating to 'sell', moving down from a previous 'hold' view...
Quartz 2026-08-27
Moderna raises $2 billion in convertible notes for cancer vaccine — The biotech company will sell notes due 2032, with an option to raise an additional $300 million, days after its stock hit a multi-year high
New data could widen use of AstraZeneca, Amgen immune disease drug 2026-08-27
New data could widen use of AstraZeneca, Amgen immune disease drug
Amgen-AstraZeneca’s Tezspire nets another Phase III inflammatory disease win 2026-08-27
Amgen-AstraZeneca’s Tezspire nets another Phase III inflammatory disease win
Pharma’s new CEOs to watch 2026-08-27
Pharma’s new CEOs to watch
Yahoo Finance 2026-08-27
AbbVie (ABBV) Filed For EU Crohn's Disease Label Expansion
Stocktwits 2026-08-27
Novo’s 2027 Growth Rebound Faces Fresh Doubts From Deutsche Bank – Even As China Wegovy Milestone Offers Retail Hope
Yahoo Finance 2026-08-27
Novo Sends Oral Wegovy Into China's GLP-1 Race Behind Lilly
Yahoo Finance 2026-08-28
Merck (MRK) Stock Looks Fully Priced After A 127% Run — Over 5 years, Merck has returned 126.6%, which sets expectations high for what investors are willing to pay for the next leg of the...
Yahoo Finance 2026-08-28
AstraZeneca (LSE:AZN) Reports Positive TEZSPIRE Phase 3 Results, Is The Discount Too Wide? — Even with a steady stream of late stage trial updates around TEZSPIRE, Tagrisso combinations and Enhertu, AstraZeneca’s share price has drifted, with a year to date share price return down 10.87% at £121.14.
Yahoo Finance 2026-08-28
Accenture Stock And 2 Dividend Compounders for Passive Income — This article looks at three stocks from the Dividend Powerhouses screener that currently offer 5%+ yields with covered, growing, and stable payouts.
Yahoo Finance 2026-08-28
BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna’s Big Win
Yahoo Finance 2026-08-28
Mounjaro Just Opened a Much Bigger Door
Yahoo Finance 2026-08-28
BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast — Investing.com -- BioNTech SE (NASDAQ: BNTX) shares tumbled 10% in Friday, rapidly unwinding the gains the stock had accumulated during a sector-wide mRNA rally just days prior.
Stocktwits 2026-08-28
Mounjaro Vs Trulicity: Eli Lilly’s New FDA Win Puts Its Blockbuster Weight-Loss Drug In Focus — Mounjaro produced an 8% lower rate of cardiovascular death, heart attack or stroke than Lilly’s diabetes drug Trulicity.
Yahoo Finance 2026-08-28
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
Yahoo Finance 2026-08-28
Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial — On the August 26 episode of Mad Money, a caller mentioned that they had purchased 1,000 shares of Moderna, Inc. (NASDAQ:MRNA) at $54 a couple of weeks prior, watched the price go up to $150, and asked what they should do.
Yahoo Finance 2026-08-28
Sector Update: Healthcare Stocks Decline Late Afternoon
Yahoo Finance 2026-08-28
Is OmniAb (OABI)’s Eli Lilly (LLY) Partnership a Game Changer for OABI? — Leveraging OmniAb’s specialized antibody discovery platform, the deal grants Lilly exclusive global rights to commercialize resulting candidates in exchange for an upfront payment, up to $370 million in […]
24/7 Wall St. 2026-08-28
GLP-1 Coverage Fell From 72% to 60%. Is Eli Lilly’s Weight-Loss Boom Hitting an Insurance Wall? — Employer insurance coverage for GLP-1 weight-loss drugs is shrinking, yet Eli Lilly just posted a 47% revenue surge.
Yahoo Finance 2026-08-28
Novo's Wegovy Pill Enters China Behind Lilly
Eli Lilly's diabetes drug Mounjaro gets approval for a new use 2026-08-28
Eli Lilly's diabetes drug Mounjaro gets approval for a new use
Yahoo Finance 2026-08-28
Sector Update: Healthcare Stocks Decline Friday Afternoon
Stocktwits 2026-08-28
BNTX Stock On Track For Worst Day Since March After Cancer Vaccine Trial Halt — BMO Capital Terms It ‘Clear Setback’
Yahoo Finance 2026-08-28
Eli Lilly Stock Gets a Fresh Catalyst as FDA Clears Mounjaro for Heart Risk
Yahoo Finance 2026-08-28
Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks? — The news sent Moderna shares up as much as 177%, adding $44 billion to its market value, while Merck […]
Yahoo Finance 2026-08-28
Lilly's $9.94 Billion Mounjaro Franchise Wins a Heart-Risk Label
Yahoo Finance 2026-08-28
3 Big Reasons to Love Eli Lilly (LLY) — Eli Lilly trades at $1,175 per share and has stayed right on track with the overall market, gaining 15.4% over the last six months. At the same time, the S&P 500 has returned 11.6%.
Yahoo Finance 2026-08-28
Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial — (NYSE:MRK) said their personalized melanoma vaccine, intismeran, combined with Merck’s Keytruda, met its goals in a Phase 3 trial of 1,137 patients.
Yahoo Finance 2026-08-28
Eli Lilly Scores Major FDA Win for Weight Loss Drug
Yahoo Finance 2026-08-28
2 Mega-Cap Stocks Worth Investigating and 1 Facing Headwinds
Is Eli Lilly Stock Outperforming the Dow? 2026-08-28
Is Eli Lilly Stock Outperforming the Dow?
The Motley Fool 2026-08-29
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? — Amgen generated $8.1 billion in free cash flow in 2025, with a 21% net margin, while Axsome is scaling rapidly but still unprofitable.
The Motley Fool 2026-08-29
AbbVie vs. Eli Lilly and: Which Healthcare Stock Is a Better Buy in 2026? — Eli Lilly's metabolic therapies drove 45% revenue growth, but its valuation premium demands scrutiny against AbbVie's defensive dividend appeal.
Yahoo Finance 2026-08-30
Is AbbVie (ABBV) Undervalued As It Expands Skyrizi In Crohns Disease?
The Motley Fool 2026-08-30
3 Things That Matter Most for Eli Lilly Now
Yahoo Finance 2026-08-30
Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer Trial — The health-care sector was on track for its strongest week since June 26, with the Health Care index rising more than 4% in the five trading days leading up to August 21, compared to a 7.9% increase in late June.
Yahoo Finance 2026-08-30
Why Is Eli Lilly (LLY) Getting A Bigger Role For Mounjaro?
Yahoo Finance 2026-08-30
Merck (MRK) Posts First Positive Phase 3 Result For Personalized mRNA Melanoma Therapy
Is Merck Stock Outperforming the Nasdaq? 2026-08-30
Is Merck Stock Outperforming the Nasdaq?
Yahoo Finance 2026-08-31
Non-Melanoma Skin Cancer Market: Focus on Disease Indication, Treatment Type, Country and Region, 2025-2035
Yahoo Finance 2026-08-31
AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
Yahoo Finance 2026-08-31
One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20% — Amgen said Monday its cholesterol buster, Repatha, reduced the risk of death by 20% in a study of more than 12,000 high-risk patients.
Yahoo Finance 2026-08-31
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging — The former’s stock closed 12.6% higher and the latter’s stock closed 176% higher on August 19th.
Yahoo Finance 2026-08-31
Aging Population Drives Healthcare Growth: Stocks to Watch
Proactive Investors 2026-08-31
Eli Lilly to buy Merida Biosciences for up to $2.88B, expanding immunology pipeline — Eli Lilly and Co (NYSE:LLY) said on Monday it will acquire privately held Merida Biosciences for up to $2.88 billion in cash, part of a deal-making push to broaden its treatments for immune-related and allergic diseases.
Yahoo Finance 2026-08-31
Eli Lilly Strikes $2.88 Billion Deal to Buy Merida Biosciences — Eli Lilly (LLY) has agreed to acquire Merida Biosciences for up to $2.875 billion in cash, as it see
Yahoo Finance 2026-08-31
LLY's Mounjaro Gets FDA Nod to Cut Cardiovascular Risk in Diabetes
Yahoo Finance 2026-08-31
Lilly Is Bigger Than Ever. Why Its Latest $2.9 Billion Immunology Deal Makes Sense.
Stocktwits 2026-08-31
Eli Lilly Strikes $2.9B Deal For Its 13th Acquisition This Year – As Fresh Zepbound Data Impresses
Yahoo Finance 2026-08-31
Sector Update: Healthcare Stocks Decline Late Afternoon — Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index decreasing 0.5% a
Stocktwits 2026-08-31
Eli Lilly CEO Says $25B Deal Spree Is About Building Growth Beyond Obesity Into 2030s — ‘Not All These Bets Will Pay Off’
Yahoo Finance 2026-08-31
There Was No Beating Moderna in August. These Are the Best and Worst S&P 500 Stocks for the Month. — Moderna stock surged 158% in August to lead the S&P 500, while Edison International plunged 27% to rank last in the index.
Yahoo Finance 2026-08-31
Eli Lilly (LLY) Stock May Be 30% Undervalued Despite Fresh FDA Approval — Eli Lilly has returned 373.6% over five years, which puts a lot of optimism into the share price and raises the bar for what counts as good value today.
Yahoo Finance 2026-08-31
Eli Lilly Stock Falls After Pharma Giant Unveils $2.9 Billion Acquisition — Eli Lilly Stock Slides as Pharma Giant Strikes $2.9 Billion Merida Deal
Yahoo Finance 2026-08-31
Can CagriSema Help Novo Nordisk Close the Gap With LLY in Obesity?
Yahoo Finance 2026-08-31
Eli Lilly (LLY) Makes a $2.88 Billion Autoimmune Bet. What Could Go Right or Wrong? — Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held Merida Biosciences for up to $2.875 billion in cash, including an upfront payment and milestone-based payments.
A $2.88 Billion Reason Why Eli Lilly Stock Is in Focus Today 2026-08-31
A $2.88 Billion Reason Why Eli Lilly Stock Is in Focus Today — Eli Lilly announced a $2.88 billion acquisition of Merida Biosciences.
Quartz 2026-08-31
Eli Lilly buying Merida Biosciences for up to $2.875 billion
How Is Amgen’s Stock Performance Compared to Other General Drug Manufacturers 2026-08-31
How Is Amgen’s Stock Performance Compared to Other General Drug Manufacturers
WSJ 2026-08-31
Eli Lilly to Buy Merida Biosciences for Up to $2.875 Billion — Eli Lilly has agreed to pay up to $2.875 billion in cash for biotechnology company Merida Biosciences in a deal that bolsters the drugmaker’s immunology portfolio.
Lilly adds to immune drug pipeline with $2.9B Merida buyout 2026-08-31
Lilly adds to immune drug pipeline with $2.9B Merida buyout
Yahoo Finance 2026-08-31
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-08-31
New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity
Yahoo Finance 2026-09-01
Lilly's $2.88 Billion Immunology Deal Starts in Phase 1
Yahoo Finance 2026-09-01
Moderna (MRNA) Soars 156% in August — Here’s What Propelled The Rally
Yahoo Finance 2026-09-01
Lilly to participate in Morgan Stanley 24th Annual Global Healthcare Conference
Yahoo Finance 2026-09-01
GSK Stock Down 14% in Six Months: Time to Buy, Hold or Exit? — GSK's shares are down 14% in six months, but strong Specialty Medicines growth and a robust pipeline may support long-term gains.
24/7 Wall St. 2026-09-01
Jim Cramer: This Little-Talked-About Drug Could Target the “Biggest Market of All Time” Aside From Eli Lilly’s GLP-1 Drugs
Yahoo Finance 2026-09-01
Novo Nordisk (CPSE:NOVO B), What Is Behind The Fresh Attention? — The stock has been under pressure despite Novo Nordisk’s obesity pipeline progress, with a 30 day share price return of 4.16%, a year to date share price return decline of 11.05%, and a 1 year total shareholder return down 14.14%.
Yahoo Finance 2026-09-01
Can Bixlenvo Unlock New Growth for Gilead's HIV Business?
24/7 Wall St. 2026-09-01
Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
Yahoo Finance 2026-09-01
Novo Nordisk Trades Nearly 58% Below GF Value as Wegovy Pill Launches in Germany
Yahoo Finance 2026-09-01
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture — Multiple market-research firms size it at roughly US$22 billion to US$23 billion in 2026, with projections reaching approximately US$40 billion by 2031 at a compound annual growth rate near 12 percent, and other forecasts running higher still over longer horizons.
24/7 Wall St. 2026-09-01
Insurers Are Pulling Back From GLP-1 Drugs. The FDA Just Handed Eli Lilly Its Best Weapon Yet
Yahoo Finance 2026-09-01
The Oral PCSK9 Inhibitor Market Enters High-Growth Phase Owing to the Approval of Merck's LIPFENDRA and the Emergence of Oral PCSK9 Inhibitor Drugs, Including, AstraZeneca's AZD0780, Aqur's AQR-008, a
Yahoo Finance 2026-09-01
Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Yahoo Finance 2026-09-01
Novartis Reports 3 Patient Deaths. Why the Stock Is Heading for Its Best Day Since 2023.
Yahoo Finance 2026-09-01
SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal 2026-09-01
Eli Lilly continues near-monthly M&A presence with $2.9bn Merida deal
Yahoo Finance 2026-09-01
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
Yahoo Finance 2026-09-01
A leadership gap looms in Nordic and Benelux boardrooms
Stocktwits 2026-09-02
HIMS Stock Kicks Off September In The Red: FDA’s GLP-1 Alert Steals The Spotlight From Australia Expansion — The FDA reported more than 1,700 adverse events involving compounded Semaglutide and Tirzepatide
Yahoo Finance 2026-09-02
Amgen Faces Major Blow to Rare-Disease Drug
24/7 Wall St. 2026-09-02
No ETFs Required: How a 64-Year-Old Built a $5,700 Monthly Paycheck From Five Dividend Stocks — Most retirees assume hitting a $68,400 annual income floor demands either a massive nest egg or risky high-yield instruments, but five ordinary dividend stocks across five sectors challenge both assumptions in ways the math makes hard to ignore.
Yahoo Finance 2026-09-02
Can LLY's Merida Deal Boost Its M&A Push to Diversify Beyond GLP-1s?
Yahoo Finance 2026-09-02
Global Health Leader Jeffrey L. Sturchio, PhD, Joins FINN Partners' Health Policy and Impact Group as Senior Advisor
Peptide innovator says the drug class is due for a rethink 2026-09-02
Peptide innovator says the drug class is due for a rethink
Yahoo Finance 2026-09-02
Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care — Allergan Aesthetics, an AbbVie company, today unveiled the Layered Beauty: The New Aesthetic Mindset report, informed by research among more than 12,000 beauty-involved consumers across nine global markets, complemented by practitioner expertise and regional perspectives.
Yahoo Finance 2026-09-02
2026 Complement Inhibitors Market Analysis Report (2nd Edition) Featuring Amgen, CSL Behring, Innovent Biologics, Novartis, Regeneron, Roche, Sanofi, Takeda, UCB
Yahoo Finance 2026-09-02
TEZSPIRE’s Positive EoE Phase 3 Results Could Be A Game Changer For Amgen (AMGN)
Yahoo Finance 2026-09-02
HIMS Raises 2026 Revenue Outlook as Q2 Sales Rise 38.2% Despite Loss — HIMS raised its 2026 revenue outlook after Q2 sales jumped 38.2%, but margin contraction and an $86.3 million net loss highlighted growth costs.
24/7 Wall St. 2026-09-02
Lilly’s Record Stock Price Is Hiding an Even Bigger Opportunity
Yahoo Finance 2026-09-02
Merck to Participate in the Wells Fargo 21st Annual Healthcare Conference
Yahoo Finance 2026-09-02
Trump Expands Drug Pricing Deals With 9 Pharma Companies, Bringing Total to 26 — RFK Jr. Details 'Very, Very Emotional' Conversations With President
The Motley Fool 2026-09-02
Eli Lilly Just Announced a Major Acquisition. Here's What It Means.
Yahoo Finance 2026-09-03
Wegovy’s German Debut Opens a New Front for Novo Nordisk (NVO)
Yahoo Finance 2026-09-03
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress — This milestone triggers a payment of US$8.6 million to Nxera pursuant to its research collaboration with Centessa.
Yahoo Finance 2026-09-03
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multi
Yahoo Finance 2026-09-03
AbbVie Completes Acquisition of Apogee Therapeutics — Under the terms of the agreement, Apogee shareholders received $135.11 per share in cash, for a total equity value of approximately $10.9 billion.
Yahoo Finance 2026-09-03
Why Is Merck (MRK) Up 18.2% Since Last Earnings Report?
Yahoo Finance 2026-09-03
Why Is Amgen (AMGN) Up 8.6% Since Last Earnings Report?
Yahoo Finance 2026-09-03
Moderna’s Cancer Vaccine Rally Sparks Rare Sell Rating and Projected 45% Stock Drop
Yahoo Finance 2026-09-03
Merck's $8.4 Billion Keytruda Fortress Gets a 2028 Warning
Yahoo Finance 2026-09-03
The "Untouchable" List: Stocks That Short Sellers Won't Dare Bet Against
Yahoo Finance 2026-09-03
Fresenius Kabi Launches Generic Sugammadex in Simplist® Ready‑to‑Administer Prefilled Syringe in the U.S.
Yahoo Finance 2026-09-03
Summit Packs A Punch For Merck's Keytruda — But Not Everyone Is Sold
Yahoo Finance 2026-09-03
Sector Update: Healthcare Stocks Edge Higher Late Afternoon
The Motley Fool 2026-09-03
Great News for Eli Lilly Stock Investors
Yahoo Finance 2026-09-03
AbbVie Touts Positive Data For Multiple Myeloma Drug
Yahoo Finance 2026-09-03
Healthcare Stocks Pick Up Steam as Investors Play Offense and Defense
Yahoo Finance 2026-09-03
What Does Eli Lilly (LLY) Gain From Its $2.88 Billion Immunology Deal? — Eli Lilly (NYSE: LLY) agreed to acquire Merida Biosciences in a deal valued at up to US$2.88b to expand its immunology pipeline.
Yahoo Finance 2026-09-04
AbbVie (ABBV)’s Blood Cancer Success Adds Weight to its Pipeline Story — The drug produced an objective response rate of 74%, compared with 45.7% for standard treatments selected by investigators.
Yahoo Finance 2026-09-04
12 Top Press Releases from August
Yahoo Finance 2026-09-04
AbbVie (ABBV) Reports Positive Phase 3 Results For Etentamig In Multiple Myeloma
Yahoo Finance 2026-09-04
Amgen (AMGN) Says Repatha Reduced Mortality Before a First Heart Attack or Stroke. Can Earlier Use Expand the Market? — (NASDAQ:AMGN) reported that Repatha reduced the risk of all-cause mortality by 20% in a prespecified secondary analysis of the Phase 3 VESALIUS-CV trial. The study enrolled more than 12,000 high-risk adults without a previous heart attack or stroke and followed them for a median of 4.6 years.
Yahoo Finance 2026-09-04
Lilly (LLY) Down 2.7% Since Last Earnings Report: Can It Rebound?
Yahoo Finance 2026-09-04
ABBV's Etentamig Meets Goals in Phase III Multiple Myeloma Study
Yahoo Finance 2026-09-04
SMMT Stock Soars on NSCLC Drug Survival Data Beating Keytruda in China — Summit Therapeutics stock jumps 17% after ivonescimab showed a significant overall survival benefit over Keytruda in a China phase III lung cancer study.
24/7 Wall St. 2026-09-04
AbbVie’s Humira Cash Cow Is Shrinking—Can Its Dividend Keep Growing?
24/7 Wall St. 2026-09-04
Here Are 5 ETFs That Retirees Use to Skip Stock Picking Entirely
This week in charts: China deals, stock flatlines and Lilly’s M&A spree 2026-09-04
This week in charts: China deals, stock flatlines and Lilly’s M&A spree
Yahoo Finance 2026-09-04
Merck (MRK) Sees a More Significant Dip Than Broader Market: Some Facts to Know — Merck (MRK) concluded the recent trading session at $150.32, signifying a -1.33% move from its prior day's close.
Yahoo Finance 2026-09-04
Sector Update: Healthcare Stocks Decline Late Afternoon — Healthcare stocks were lower late Friday afternoon, with the NYSE Healthcare Index falling 1.2% and
Yahoo Finance 2026-09-04
Sector Update: Healthcare Stocks Decline Friday Afternoon
Yahoo Finance 2026-09-04
Novo Nordisk Falls 2% as Wegovy Opens a German Front
Yahoo Finance 2026-09-04
Could Merck (MRK) Change Cholesterol Treatment With The First Oral PCSK9 Pill?
TheStreet 2026-09-04
Lilly looks beyond obesity with $2.88B autoimmune buyout
Stocktwits 2026-09-04
NVS, IONS, AMGN Stocks Drop After-Hours — What’s Driving The Selloff?
Superluminal Medicines secures $60m to advance rare obesity therapy 2026-09-04
Superluminal Medicines secures $60m to advance rare obesity therapy
Yahoo Finance 2026-09-05
Lilly Launches Foundayo in the UK as NICE Review Continues
Yahoo Finance 2026-09-05
Could Roche and Lilly’s Blood Test Make Alzheimer’s Assessment More Accessible?
The Motley Fool 2026-09-05
Prediction: Here's What a $5,000 Investment in Eli Lilly Could Look Like in 5 Years — Eli Lilly's total return topped 367% over the past five years, largely thanks to enthusiasm for its GLP-1 offerings.
Yahoo Finance 2026-09-05
A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?
Yahoo Finance 2026-09-06
Eli Lilly’s $100B incretin opportunity: Is more upside coming?
Yahoo Finance 2026-09-07
Novo Nordisk STEP Young phase 3 data: 40.4% of children living with obesity achieved a BMI below the obesity threshold with semaglutide and lifestyle modification — Data highlights The STEP Young phase 3 trial met its primary endpoint, demonstrating greater body mass index (BMI) reduction in children aged 6 to under 12 treated with once-weekly subcutaneous semaglutide compared with placeboBoth groups received lifestyle modification throughout the trial, including reduced-cal…
Yahoo Finance 2026-09-07
Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down
Yahoo Finance 2026-09-07
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Yahoo Finance 2026-09-07
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-09-07
Amgen's 7,297-Patient Heart Bet Just Inherited a Higher Bar
The Motley Fool 2026-09-07
Eli Lilly Has Been on an Acquisition Spree. How Much Could Its Latest Deals Boost the Stock?
Yahoo Finance 2026-09-07
Wegovy’s Latest Trial Gives Novo Nordisk (NVO) Another Potential Growth Catalyst — Novo Nordisk A/S (NYSE:NVO) has delivered encouraging late-stage data for Wegovy in younger children, with its STEP Young trial showing that 40.4% of children aged 6 to under 12 were no longer classified as having obesity after 68 weeks of semaglutide treatment, compared with none in the placebo group.
Yahoo Finance 2026-09-07
Novo is Down Nearly 2% as a 40.4% Childhood Win Meets Two Trial Cancellations
Yahoo Finance 2026-09-07
Ulcerative Colitis Market Outlook: 5 Late-Stage Drug Candidates to Watch | DelveInsight
24/7 Wall St. 2026-09-07
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party?
Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other. 2026-09-07
Eli Lilly vs. Novo Nordisk: One Has 39% Upside. I'm Picking the Other. — Eli Lilly is worth 5.5x Novo Nordisk but earns nowhere near 5.5x more. Here's how the obesity pill war, a 13x vs. 32x valuation gap, and the dividend stack up, and which one I'd buy.
Yahoo Finance 2026-09-08
Could Mounjaro’s New Heart Benefit Unlock the Next Growth Phase for Lilly?
Yahoo Finance 2026-09-08
Why CEO of Wegovy maker Novo Nordisk isn't sold yet on the peptide craze
Yahoo Finance 2026-09-08
Dow Futures Slump as Middle East Fears Grip Markets — Dow Jones Industrial Average futures slumped 479 points, or 0.9%. S&P 500 futures dropped 0.4%.
Yahoo Finance 2026-09-08
AlzeCure Pharma to Present at Aktiedagen in Stockholm on September 15
Yahoo Finance 2026-09-08
Assessment of the Rheumatoid Arthritis Market 2026-2036 Featuring Rise Therapeutics, Taiho Pharmaceutical, Abbvie, Eli Lilly/Incyte, and AstraZeneca
Yahoo Finance 2026-09-08
The Hashgraph Group and Merck with support from PwC Germany develop solution for cocoa traceability and digital product passports
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI 2026-09-08
The Cure for Cancer is Becoming an Investable Opportunity: Analyst Sees $600 Million for Tempus AI
Disappointing Clinical Trial Results Are Dragging Novartis, Amgen and the Dow Lower Tuesday 2026-09-08
Disappointing Clinical Trial Results Are Dragging Novartis, Amgen and the Dow Lower Tuesday
Yahoo Finance 2026-09-08
One Stock Is Weighing Heavily on the Dow
Yahoo Finance 2026-09-08
Why Novartis’ Drug Trial Results Are Blowing Up Amgen Stock
Yahoo Finance 2026-09-08
How Novartis And Ionis' High-Profile Failure Reverberated Through Biopharma
Yahoo Finance 2026-09-08
Novo Nordisk's Semaglutide Meets Goal in Pediatric Obesity Study — NVO's semaglutide cuts BMI in children with obesity in phase III study, with 40.4% no longer classified as having obesity after 68 weeks.
Yahoo Finance 2026-09-08
IMDELLTRA® IN COMBINATION WITH IMFINZI® DEMONSTRATED LANDMARK IMPROVEMENT IN OVERALL SURVIVAL IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER
Yahoo Finance 2026-09-08
IMFINZI® (durvalumab) plus tarlatamab demonstrated a statistically significant and highly clinically meaningful improvement in overall survival and progression-free survival in 1st-line extensive-stag
Yahoo Finance 2026-09-08
Novartis Stock Tanks Following Third Major Pipeline Setback
Yahoo Finance 2026-09-08
Sector Update: Healthcare Stocks Fall Late Afternoon — Healthcare stocks declined late Tuesday afternoon with the NYSE Healthcare Index falling 2.5% and th
Yahoo Finance 2026-09-08
Sector Update: Healthcare Stocks Fall Tuesday Afternoon — Healthcare stocks declined Tuesday afternoon, with the NYSE Healthcare Index falling 2.4% and the St
Yahoo Finance 2026-09-08
GLP1 Drugs Work for Kids, Says Novo Nordisk. They Could Be Another Huge Market.
Yahoo Finance 2026-09-08
Amgen's Olpasiran May Still Show Heart-Risk Reduction Despite Novartis Miss, UBS Says
Why the CNS boom owes its success to breakthroughs in neurological pathologies 2026-09-08
Why the CNS boom owes its success to breakthroughs in neurological pathologies
24/7 Wall St. 2026-09-08
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
Yahoo Finance 2026-09-08
AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival Test
Yahoo Finance 2026-09-08
Novartis Trial Failure Sparks Biopharma Options Frenzy
Quartz 2026-09-08
Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, Lilly — Pelacarsen lowered Lp(a) levels in more than 8,000 patients but did not reduce the risk of heart attacks, strokes, or cardiovascular death
Yahoo Finance 2026-09-08
Merck Trading Near 52-Week High: Is the Stock a Buy, Hold or Sell?
Yahoo Finance 2026-09-09
Influenza A Market Insight, Epidemiology, and Market Forecast - 2036 Now Available — See Why a 70% Vaccine Failure Rate Is Fueling the Race for Next-Gen Flu Therapies
Kura spins diabetes work into a Lilly-backed biotech startup 2026-09-09
Kura spins diabetes work into a Lilly-backed biotech startup
Yahoo Finance 2026-09-09
Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes — – $50 million financing led by BVF Partners with participation from the T1D Fund, Invus, Montanova, Eli Lilly and Company, Kura Oncology, members of the Kura leadership team, and multiple, successful biotech entrepreneurs – – Preclinical studies with KO-7246 demonstrate selective expansion of pancreatic β cells, increased…
InvestorsHub 2026-09-09
Amgen, AstraZeneca combination improves survival measures in late-stage lung cancer study
The Motley Fool 2026-09-09
Prediction: This Is What a $5,000 Investment in Eli Lilly Will Be Worth in 2031
Yahoo Finance 2026-09-09
Could AstraZeneca (AZN)’s Stronger Growth Make it a Better Bet than Amgen (AMGN)?
Yahoo Finance 2026-09-09
Is AbbVie (ABBV)’s $10.9 Billion Apogee Therapeutics (APGE) Deal the Next Catalyst for Growth? — (NASDAQ:APGE) for $135.11 per share in cash. The $10.9 billion buyouts immediately fold Apogee’s promising inflammatory and immunology (I&I) pipeline into AbbVie’s commercial engine.
Yahoo Finance 2026-09-09
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Yahoo Finance 2026-09-09
Amgen's Imdelltra Sales Surge 115% as Lung-Cancer Combination Meets Major Goals
The Motley Fool 2026-09-09
Billionaire Israel Englander Is Doubling Down on These 2 Outstanding Dividend Stocks. Should You?
Yahoo Finance 2026-09-09
Can Oral Wegovy Help Novo Nordisk Capture China’s $4.46 Billion GLP-1 Opportunity?
Yahoo Finance 2026-09-10
HSBC lifts Novartis, downgrades Amgen in biopharma catalyst review
Merck Targets $70B Pipeline as It Prepares for KEYTRUDA Exclusivity Loss 2026-09-10
Merck Targets $70B Pipeline as It Prepares for KEYTRUDA Exclusivity Loss
Yahoo Finance 2026-09-10
AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study
Yahoo Finance 2026-09-10
Can Papzimeos Drive Precigen's Growth Through the Rest of 2026?
Yahoo Finance 2026-09-10
Medicare’s $2,000 Drug Cap Is Getting Expensive — More Than 1 in 5 Seniors Hit It as Drug Spending Heads Toward $346 Billion — Health policy analysts are raising concerns about the rising cost of Medicare’s prescription drug program after more than 1 in 5 Medicare Part D enrollees hit the program’s $2,000 out-of-pocket drug cap in 2025.
Yahoo Finance 2026-09-10
Obesity Market Set for Explosive 27% CAGR Growth by 2036, Fueled by 7 Promising Emerging Therapies | DelveInsight — Novo Nordisk's oral WEGOVY surpassed 5 million cumulative US prescriptions within 30 weeks, while Eli Lilly's FOUNDAYO gained notable momentum among patients initiating ora
Yahoo Finance 2026-09-10
AbbVie Extends Migraine Leadership with Positive Phase 3 Atogepant Results in Menstrual Migraine
Yahoo Finance 2026-09-10
Ritedose Appoints Carolyn Berg as New Vice President of Strategic Growth
Yahoo Finance 2026-09-10
Amgen (AMGN) Dips More Than Broader Market: What You Should Know — The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.
Yahoo Finance 2026-09-10
Novo Nordisk (NVO) Suffers a Larger Drop Than the General Market: Key Insights — Novo Nordisk (NVO) closed the most recent trading day at $44.01, moving 1.23% from the previous trading session.
Yahoo Finance 2026-09-10
AbbVie Declares Quarterly Dividend — (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share.
Yahoo Finance 2026-09-10
AbbVie Gains as Qulipta Opens a New Migraine Market
Yahoo Finance 2026-09-10
Novo Stays Flat as Wegovy Wins China's First GLP-1 MASH Label
24/7 Wall St. 2026-09-10
Got $10,000? Eli Lilly vs. Nvidia: The Better Buy For 2026 — Eli Lilly and Nvidia both just posted stunning quarters riding two of the biggest secular waves in markets today, but a $10,000 bet can only tilt one way.
24/7 Wall St. 2026-09-10
Eli Lilly Stock Has Become a Trillion-Dollar Giant. Is It Too Late to Buy? — Eli Lilly just crossed the trillion-dollar threshold on the back of a GLP-1 empire growing at nearly 50% annually, but a recent pullback and rising risks are forcing investors to decide whether this pharmaceutical giant still has meaningful upside left.
The Motley Fool 2026-09-10
Amgen vs. Moderna: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-09-11
Advanced Bioreactor Systems Market Size, Share & Trends Analysis - Global Opportunity Analysis & Industry Forecast (2026-2036) — The global Advanced Bioreactor Systems Market is projected to grow from USD 4.2 billion in 2026 to USD 11.8 billion by 2036, at a CAGR of 10.9%.
24/7 Wall St. 2026-09-11
Moderna Rallies 8% on 2026 Melt-Up Momentum Even While BioNTech and Merck Stay Flat — Moderna just surged 8% on a morning when its closest cancer-vaccine peer barely budged and its own pipeline partner slipped into the red, and no announcement, trial readout, or analyst call explains why.
The Motley Fool 2026-09-11
Amgen vs. Revolution Medicines: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-09-11
Novo Nordisk Stock Plunges on Morgan Stanley Downgrade Warns of Semaglutide Patent Cliff
The Motley Fool 2026-09-11
Amgen vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-09-11
Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
Yahoo Finance 2026-09-11
MRK Banks on Growing Pipeline & New Drugs to Offset Keytruda LOE
Yahoo Finance 2026-09-11
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
Yahoo Finance 2026-09-11
AbbVie's Atogepant Meets Goal in Late-Stage Menstrual Migraine Study
Yahoo Finance 2026-09-11
Morgan Stanley Downgrades Novo Nordisk to Sell on Lilly Competition
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential 2026-09-11
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential
Yahoo Finance 2026-09-11
Lilly completes acquisition of AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win 2026-09-11
AbbVie eyes extended Qulipta use case on Phase III menstrual migraine win
24/7 Wall St. 2026-09-11
Here Are Friday’s Top Wall Street Analyst Research Calls: Atmos Energy, Celanese, Check Point Software, Chewy, Dell Technologies, Fortinet, Global Payments, HP, Shopify, and More
24/7 Wall St. 2026-09-11
How Much Dividend Income Can You Buy With $250,000? — A $250,000 rollover sounds like a clean starting point until you realize yield alone is not the whole story, and only one name on this roster actually clears the current Treasury rate.
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months 2026-09-11
OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months
Stocktwits 2026-09-11
MLTX Stock On Track For Worst Week Since Last Fall As FDA Filing Date For Skin Disease Drug Draws Near — MLTX has faded since a mid-June rally on year-long hidradenitis suppurativa data and an August psoriatic arthritis readout, leaving the stock more than 75% below its 52-week high.
The Motley Fool 2026-09-12
Why Did Billionaire Israel "Izzy" Englander More Than Double His Stake in AbbVie Stock and Start a Position in SpaceX Stock?
Yahoo Finance 2026-09-12
Eli Lilly’s (LLY) GLP-1 Growth Made It a Core “Running Back” Stock for Jim Cramer
Yahoo Finance 2026-09-12
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
Yahoo Finance 2026-09-12
Novo Nordisk (NVO)’s Pediatric Obesity Opportunity Faces a Bigger Test — In the trial, 40.4% of children treated with semaglutide were no longer classified as having […]
Yahoo Finance 2026-09-12
Jim Cramer Explains Why Merck (MRK) Is His Fantasy Defense Stock
24/7 Wall St. 2026-09-12
How Much Does a 61-Year-Old Need Invested to Collect $8,600 a Month for Life?
Yahoo Finance 2026-09-13
Amgen (AMGN) Fell 5% on a Drug That Isn’t Even Its Own. Here’s the Lp(a) Bet Now in Question. — (NASDAQ:AMGN) shed roughly $12 billion in market value after hours on September 4, 2026. The stock declined by about 5% to $415.
The Motley Fool 2026-09-13
Novo Nordisk May Be Poised to Outpace Eli Lilly With This Key Catalyst
Yahoo Finance 2026-09-14
OPKO Health (OPK) Cashes In A Future Royalty Stream Early — On August 13, OPKO Health (NASDAQ:OPK) expanded its financing relationship with HealthCare Royalty, a business of KKR, issuing an additional $125 million in senior secured notes secured by the royalty stream tied to mazdutide, the GLP-1 drug OPKO licensed to Eli Lilly and now collects royalties on in China.
Yahoo Finance 2026-09-14
Ozempic-maker Novo Nordisk slims down to 'Novo'
Yahoo Finance 2026-09-14
Novo ditches Nordisk from name as drugmaker attempts revival
Yahoo Finance 2026-09-14
Novo Nordisk enters next chapter to bring better health to more people, supported by ‘Novo’ rebrand and updated corporate culture
No more Nordisk: Novo’s latest trim is in its name 2026-09-14
No more Nordisk: Novo’s latest trim is in its name
Moderna’s Cancer Vaccine Win Fuels Broad Push Across Tumor Types 2026-09-14
Moderna’s Cancer Vaccine Win Fuels Broad Push Across Tumor Types
Yahoo Finance 2026-09-14
AbbVie’s Latest Migraine Success Strengthens its Growth Story
Yahoo Finance 2026-09-14
Novo Nordisk Expands Wegovy’s Reach with China MASH Approval
Yahoo Finance 2026-09-14
Precigen Gains 43% in 3 Months: Is It an Indication to Buy the Stock?
Yahoo Finance 2026-09-14
Novo Nordisk A/S - share repurchase programme — This programme is part of the overall share repurchase programme of up to DKK 15 billion to be executed during a 12-month period beginning 4 February 2026.
Yahoo Finance 2026-09-14
BioMarin Announces Appointment of Robert Plenge, M.D., Ph.D., Chief Research Officer of Bristol Myers Squibb, to Board of Directors
Yahoo Finance 2026-09-14
AbbVie (ABBV) Advances While Market Declines: Some Information for Investors — The latest trading day saw AbbVie (ABBV) settling at $261.7, representing a +1.78% change from its previous close.
Yahoo Finance 2026-09-14
Why the Market Dipped But Eli Lilly (LLY) Gained Today — Eli Lilly (LLY) concluded the recent trading session at $1, signifying a +1.99% move from its prior day's close.
24/7 Wall St. 2026-09-14
SCHD’s 0.06% Fee Hides the Real Cost: March’s 31% Reshuffle Sold Two Top-10 Holdings Out From Under Holders — SCHD's 0.06% expense ratio gets all the attention, but something that happened quietly in March may have cost dividend investors far more than a decade of fees combined.
Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive Transformation 2026-09-14
Merck CEO Sees Pipeline Upside as Launches, Animal Health Drive Transformation
Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets 2026-09-14
Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets
Yahoo Finance 2026-09-14
Novo Nordisk Is Dropping Some Weight. Can a Rebrand Save the Stock?
NVO Stock Alert: What to Know as Novo Nordisk Rebrands to 'Novo' 2026-09-14
NVO Stock Alert: What to Know as Novo Nordisk Rebrands to 'Novo'
Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results 2026-09-14
Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results
Yahoo Finance 2026-09-14
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-09-14
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Yahoo Finance 2026-09-14
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
Novo Nordisk Rebrands as ‘Novo': Stock Falls as Company Aims GLP-1s at Consumers 2026-09-15
Novo Nordisk Rebrands as ‘Novo': Stock Falls as Company Aims GLP-1s at Consumers
Yahoo Finance 2026-09-15
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases
Yahoo Finance 2026-09-15
Novo Nordisk (CPSE:NOVO B) Rebrands As Novo In Consumer Health Push
Yahoo Finance 2026-09-15
Novo Nordisk (NVO) Unveils Global Rebrand As Novo
Yahoo Finance 2026-09-15
Why One of the Last Eli Lilly Holdouts Just Upgraded the Stock to Buy
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline 2026-09-15
AbbVie Maps Post-HUMIRA Growth With Apogee Deal, Immunology Pipeline
Yahoo Finance 2026-09-15
Novo Nordisk Stock Falls After Major Rebrand
Yahoo Finance 2026-09-15
Berenberg Lifts Lilly to Buy With a $1,400 Target
Yahoo Finance 2026-09-15
Lilly’s Foundayo Quickly Gains Ground in the Oral Weight-Loss Market — Eli Lilly and Company (NYSE:LLY) says its newly launched oral obesity drug Foundayo has captured more than 30% of new U.S. patients starting oral weight-loss medicines, a notable early gain against Novo Nordisk’s Wegovy pill. Reuters reports that Wegovy initially held roughly 90% of the oral market, making Lilly’s rapid share capture an important sign […]
Yahoo Finance 2026-09-15
From Novo Nordisk to ‘Novo’: A Strategic Reset Amid Rising Lilly Pressure
Yahoo Finance 2026-09-15
Can Redwire's Microgravity Platform Expand Commercial Opportunities?
Yahoo Finance 2026-09-15
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside? — (NYSE:ABBV)’s ratings from Peer Perform, with Wolfe assigning them similar $300 price targets.
The Motley Fool 2026-09-15
3 Absurdly Cheap Growth Stocks to Buy Before the End of 2026
Yahoo Finance 2026-09-15
Thatch Raises $108M at $1B Valuation as Employers Shift Away From Traditional Health Plans — Thatch, the health benefits platform helping employers move from traditional group health plans to a consumer-directed model, today announced that it has raised $108 million in new funding at a $1 billion valuation from The General Partnership, Index Ventures, General Catalyst, and Andreessen Horowitz, with participation from ADP Ventures, Paychex, Eli Lilly and Company, Scale Ventur…
24/7 Wall St. 2026-09-15
Novo Nordisk Expands Obesity Drug to Children, But Market Hesitates on Adoption
Yahoo Finance 2026-09-15
Ulta Beauty, Etsy upgraded: Wall Street's top analyst calls
InvestorsHub 2026-09-15
Eli Lilly Shares Rise 1.6% as Berenberg Upgrades Stock to Buy — Eli Lilly (NYSE:LLY) shares rose 1. 6% to $1,155.
Yahoo Finance 2026-09-15
Berenberg bullish on Eli Lilly, sees nearly 25% upside — Investing.com -- Berenberg analyst Kerry Holford upgraded Eli Lilly to buy, raising its price target to $1,400 in a note Tuesday, representing almost 25% upside, as it backs the drugmaker to extend its lead in the fast-growing obesity market.
Yahoo Finance 2026-09-15
Sector Update: Healthcare Stocks Fall Pre-Bell Tuesday
24/7 Wall St. 2026-09-15
There Are Plenty of Eli Lilly Bulls: Here’s What They Aren’t Telling You — Eli Lilly's bulls are pointing at a 47% revenue surge and a pipeline loaded with blockbuster candidates, but there are a few uncomfortable details quietly buried in the earnings report that change how the story reads.
Yahoo Finance 2026-09-16
Oncology Tie-Up and Blockchain Pilot Might Change The Case For Investing In Merck (MRK)
Eli Lilly and QurCan sign genetic medicine deal 2026-09-16
Eli Lilly and QurCan sign genetic medicine deal
Yahoo Finance 2026-09-16
Novo to share real-world and clinical data including Wegovy® pill, and cardiometabolic pipeline progress with next-generation amylin treatments at EASD 2026
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities 2026-09-16
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities
Yahoo Finance 2026-09-16
Ascendis Has Capacity To Execute Alone After Termination of Novo Nordisk Collaboration, Wedbush Says
Yahoo Finance 2026-09-16
Billionaire Ray Dalio’s Bridgewater’s and Cathie Wood’s ARK Portfolios: 2 Stocks They Both Own
Yahoo Finance 2026-09-16
Novo Nordisk Scores Major AI Deal With World's Most Valuable AI Company
Yahoo Finance 2026-09-16
Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
Yahoo Finance 2026-09-16
Sector Update: Healthcare Stocks Edge Higher Pre-Bell Wednesday
Stocktwits 2026-09-16
Novo Nordisk Taps Anthropic’s Claude Science To Speed Up Drug Discovery — Here’s Everything Investors Need To Know
Yahoo Finance 2026-09-16
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Yahoo Finance 2026-09-16
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note — Novo Nordisk (NVO) closed the most recent trading day at $41.67, moving 2.02% from the previous trading session.
Yahoo Finance 2026-09-16
Novo Drops as Claude Enters Drug Development
Yahoo Finance 2026-09-16
Avalyn Appoints Robert J. Meyer, MD, to its Board of Directors
The Motley Fool 2026-09-16
Worried About a Market Crash? This Dividend Stock Outperformed as the S&P 500 Sank in Both 2008 and 2022
Yahoo Finance 2026-09-16
Sector Update: Healthcare Stocks Edge Lower Late Afternoon
NVO Stock Alert: What to Know as Novo Partners With Anthropic on Drug Discovery 2026-09-16
NVO Stock Alert: What to Know as Novo Partners With Anthropic on Drug Discovery
Yahoo Finance 2026-09-16
Critics Warn of AI-Driven Disaster. Anthropic and Novo Are Betting on the Opposite.
This Dividend Stock Is Beating the Market in 2026 and Yields 2.36% 2026-09-16
This Dividend Stock Is Beating the Market in 2026 and Yields 2.36% — Merck is beating the market year-to-date after a jump on positive Phase 3 data, while paying an annualized dividend of about $3.40 for a yield above 2.3%.
Yahoo Finance 2026-09-16
Novo Nordisk partners with Anthropic to turbocharge drug discovery
InvestorsHub 2026-09-16
Novo Nordisk Partners With Anthropic to Apply AI to Drug Discovery and Research
Yahoo Finance 2026-09-16
Eli Lilly (LLY) Stock Could Be A Bargain At This Price — Eli Lilly has turned into one of the market’s biggest healthcare stories, with the share price at US$1,136.11 and a very large 5 year gain, so the obvious question for you is whether that move is backed up by the cash the business can generate. The stock is up about 416.5% over 5 years, which puts a lot...
Yahoo Finance 2026-09-16
Novo and Anthropic will collaborate to advance drug discovery with Claude
Yahoo Finance 2026-09-16
Twist Bioscience Joins Lilly TuneLab to Advance Antibody Drug Discovery
Yahoo Finance 2026-09-17
Why Novo Nordisk (NVO) Is Getting Attention Today — At a share price of US$41.71, Novo Nordisk has seen momentum fade, with the 7 day share price return down 6.4% and the year to date share price return down 20.39%. The 1 year total shareholder return has declined 25.89%, pointing to a reassessment of both its growth potential and perceived risk.
Yahoo Finance 2026-09-17
Eli Lilly (LLY) Gets a Big Price Target Boost, Analysts See 20% Upside — On September 15, Berenberg upgraded its rating on Eli Lilly and Company (NYSE:LLY) from Hold to Buy and lifted its price target from $1,220 to $1,400.
Yahoo Finance 2026-09-17
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds — Patients on Eli Lilly and Company (NYSE:LLY)’s low-dose tirzepatide lost an average of 5.5% of their […]
Yahoo Finance 2026-09-17
LLY Stock Down Around 7% in a Month: Buy the Dip or Stay Cautious?
24/7 Wall St. 2026-09-17
How Large Does Your Portfolio Need to Be to Generate $10,600 a Month? — The capital required to replace a professional salary with investment income swings by more than $2 million depending on one decision, and most investors default to the wrong tier without realizing it.
Yahoo Finance 2026-09-17
Novo Expands AI Push With Anthropic Deal to Accelerate Drug Discovery
Yahoo Finance 2026-09-17
Novo Falls 5% in a Week: How Should Investors Approach the Stock Now? — NVO's 5% drop in a week reflects intensifying GLP-1 competition and semaglutide risks, but its broad pipeline offers potential long-term growth.
Yahoo Finance 2026-09-17
Novo Nordisk Signs Up To $1.4 Billion Licensing Deal With Orbis Medicines — Danish drugmaker Novo Nordisk (NVO) and Orbis Medicines struck an up to $1.4 billion licensing deal
Stocktwits 2026-09-17
TWST Stock Hits Multi-Year High, But ‘Pharma Bro’ Martin Shkreli Calls Twist A Short — Twist traded as high as $163.70 on Thursday and finished the session about 9% higher near $156.
Yahoo Finance 2026-09-17
Ascendis Pharma (ASND) Will Regain Metabolic Drug Rights. Is Greater Ownership Worth the Cost?
Yahoo Finance 2026-09-17
Merck Gains as Keytruda's Space Research Seeks a New Home
Yahoo Finance 2026-09-17
Novo Nordisk's hemophilia drug clears a key hurdle in Europe
Stocktwits 2026-09-17
NVO Stock Jumps 4% As European Committee Backs Novo’s Haemophilia Pen
Yahoo Finance 2026-09-17
Sector Update: Healthcare Stocks Rise Thursday Afternoon — Healthcare stocks rose Thursday afternoon, with the NYSE Healthcare Index adding 0.5% and the State
Yahoo Finance 2026-09-17
A Failed Cholesterol Drug Raises the Stakes for Amgen (AMGN) and Eli Lilly (LLY) Too
Yahoo Finance 2026-09-17
Novo Nordisk (NVO) Pulls the Plug on Two More Heart Drug Trials
Yahoo Finance 2026-09-17
Is Novo Nordisk (CPSE:NOVO B) A Bargain Following The FREHEMGO CHMP Green Light? — Novo Nordisk has packed several catalysts into September, yet the share price tells a different story, with a 30 day share price return of down 5.7% and a year to date share price return of down 15.4% despite today’s 2.5% one day gain to DKK279.35.
Yahoo Finance 2026-09-17
Merck (MRK) Outperforms Broader Market: What You Need to Know — Merck (MRK) closed at $147.17 in the latest trading session, marking a +1.56% move from the prior day.
Amgen Stock Fell 10% in a Day on a Drug It Doesn’t Own. Is It Time to Buy AMGN? 2026-09-17
Amgen Stock Fell 10% in a Day on a Drug It Doesn’t Own. Is It Time to Buy AMGN? — Key Stats for Amgen StockCurrent Price: $375. 65Target Price (Mid): ~$495Street Target: ~$388Potential Total Return: ~32%Annualized IRR: ~6.
24/7 Wall St. 2026-09-17
Moderna Climbs 6% as Cancer Vaccine Trade Extends a 137% Month; BioNTech and Novavax Edge Higher
Yahoo Finance 2026-09-17
Is CRBP a Good Cannabis Investment After Positive Obesity Study Data?
InvestorsHub 2026-09-17
Novo Nordisk Publishes Phase 3b Denecimig Results in Haemophilia A
Yahoo Finance 2026-09-18
Novo's Denecimig Gets CHMP Nod for Hemophilia A in the European Union
Yahoo Finance 2026-09-18
Lilly’s Newest Bull Says Near 300% Rally Is Only the Beginning — Eli Lilly & Co. has surged about 300% since its first GLP-1 was approved over four years ago, propelling it past $1 trillion in market value and making it the world’s most valuable pharmaceutical company.
Yahoo Finance 2026-09-18
AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
Yahoo Finance 2026-09-18
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Yahoo Finance 2026-09-18
AlzeCure Pharma Publishes Updated Company Presentation Following the Eli Lilly and QuantumCell Agreements
Yahoo Finance 2026-09-18
Merck Launches Your Hive of Whole Health to Support Whole Person Care for People Living With HIV
Yahoo Finance 2026-09-18
Novo’s once-weekly Sogroya® (somapacitan) receives positive CHMP opinion in Europe for children with idiopathic short stature (unexplained shortness)
Yahoo Finance 2026-09-18
Amgen (AMGN) Surpasses Market Returns: Some Facts Worth Knowing — In the most recent trading session, Amgen (AMGN) closed at $385.65, indicating a +1.55% shift from the previous trading day.
24/7 Wall St. 2026-09-18
Can Eli Lilly’s Two-Drug Obesity Treatment Justify Its $1 Trillion Valuation?
Yahoo Finance 2026-09-18
Media Advisory - Novo Nordisk confirms stable Ozempic® supply across Canada
Yahoo Finance 2026-09-18
U.S. FDA approves Inluriyo (imlunestrant) in combination with Verzenio (abemaciclib) for adults with ER+, HER2-, ESR1-mutated advanced or metastatic breast cancer
Yahoo Finance 2026-09-18
Novo CEO Says Drugmaker Needs to “Rethink” its Obesity Strategy
Yahoo Finance 2026-09-18
AbbVie’s Dividend Growth Remains Solid Despite a Moderate Yield — (NYSE:ABBV) has declared another quarterly dividend of $1.73 per share. There is no new increase this time, since AbbVie has kept its quarterly dividend at $1.73 throughout 2026.
Yahoo Finance 2026-09-18
4 Biotech Stocks to Watch as Potential Takeover Targets
Yahoo Finance 2026-09-18
What Does Merck (MRK) Mean For EU Bladder Cancer Treatment After CHMP Support?
Yahoo Finance 2026-09-18
Can Sotyktu's Long-Term PsA Data Boost Bristol Myers' Prospects?
Novo is Building a Strong Base to Address Unmet Needs in Diabetes and Obesity Drugs 2026-09-18
Novo is Building a Strong Base to Address Unmet Needs in Diabetes and Obesity Drugs
The Motley Fool 2026-09-18
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
Yahoo Finance 2026-09-19
Amgen (AMGN) Stock Sees Modest Fair Value Lift As Analysts Weigh Pipeline Risks — Amgen’s updated analyst model now points to a fair value price target of US$388.03, compared with the prior US$371.93.
24/7 Wall St. 2026-09-19
Amgen or Merck: Which Drugmaker Has the Stronger Dividend Growth Story?
Yahoo Finance 2026-09-19
Ascendis Pharma (ASND) Regains Exclusive Rights To Key TransCon Metabolic Programs
Yahoo Finance 2026-09-19
AbbVie (ABBV) Unveiled New VRAYLAR Data In Real World And Pediatric Care
Yahoo Finance 2026-09-20
What does the EU have that the U.S. does not?
Yahoo Finance 2026-09-20
Eli Lilly (LLY) Stock Fair Value Edges Higher As Analysts Back GLP 1 Growth — Eli Lilly’s updated fair value estimate has shifted from US$1,297.31 to US$1,325.39, adding a fresh data point to an already closely watched price target range. This move sits alongside analyst price targets that often sit above US$900, with a cluster between US$1,300 and US$1,600, as research teams debate how much of the GLP-1 and obesity story is already reflected in the stock.
Yahoo Finance 2026-09-21
Novo Plunges as Investors Seek More Robust Sales Targets — Novo Nordisk shares plunged in early trading as the company pledged to launch more than five blockbuster drugs and deliver more than $23 billion in new sales in coming years.
Yahoo Finance 2026-09-21
Novo Nordisk stock gets drilled on pipeline concerns— its CEO sees this as the main problem
Yahoo Finance 2026-09-21
ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy
Yahoo Finance 2026-09-21
Highlights to be presented at Novo’s Capital Markets Day 2026
Stocktwits 2026-09-21
Biotech Week Ahead: XLV Beats The Market — Here Are The Stocks, Readouts And Events To Watch Next
Yahoo Finance 2026-09-21
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Yahoo Finance 2026-09-21
European Stocks Close Higher Monday as Oil Prices Tumble
24/7 Wall St. 2026-09-21
Moderna Surges 9% as Phase 3 Melanoma Data Wins Presidential Symposium Slot; Merck and BioNTech Edge Higher — A coveted Presidential Symposium slot at Europe's top oncology congress just sent Moderna shares flying 9%, but the actual Phase 3 melanoma data remains unseen.
Yahoo Finance 2026-09-21
European Equities Traded in the US as American depositary Receipts Rise in Monday Trading
WSJ 2026-09-21
Wegovy Maker Novo Promises New Drugs to Boost Sales, but Investors Are Wary — Shares in the company fell roughly 8% as its CEO laid out plans for new blockbuster drugs in the next few years.
Yahoo Finance 2026-09-21
Accenture Up on Partnership with Anthropic; Novo Nordisk Falls on Turnaround | Stock Movers — The company pledged to launch more than five blockbusters and deliver more than $23 billion in new sales in coming years, but investors are selling shares due to lack of concrete news. - Arhaus (ARHS) is moving after Jefferies upgraded the furniture company
Yahoo Finance 2026-09-21
Lilly breaks ground in Houston, one of ten U.S. manufacturing sites announced since 2020 — As part of the company's $50 billion push to reshore medicine production to meet growing demand at home and export American-made medicines to people around the world, the $6.5 billion Houston site will manufacture Foundayo (orforglipron), Lilly's first synthetic oral GLP-1 medicine, alo
Yahoo Finance 2026-09-21
Novo Nordisk (CPSE:NOVO B) Unveiled A 2030 Blockbuster Drug Plan
Eli Lilly Starts Building Record $6.5B Houston Manufacturing Facility 2026-09-21
Eli Lilly Starts Building Record $6.5B Houston Manufacturing Facility
Stocktwits 2026-09-21
LLY Stock Gains As CEO Says Foundayo Wins One-Third of New GLP-1 Pill Starts, Breaks Ground On $6.5B Houston Plant
The $15.6B Smart Ring Bet: Oura Takes On Wall Street With IPO 2026-09-21
The $15.6B Smart Ring Bet: Oura Takes On Wall Street With IPO — Oura Inc. is pitching its U.S. initial public offering to investors, aiming for a fully diluted value of about $15.62 billion as it sizes up demand for consumer tech deals.
Yahoo Finance 2026-09-21
Sector Update: Healthcare Stocks Higher Late Afternoon — Healthcare stocks rose late Monday afternoon with the NYSE Healthcare Index increasing 0.6% and the
Yahoo Finance 2026-09-21
Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test.
Yahoo Finance 2026-09-21
Oura Targets $15.6 Billion Valuation in Test of IPO Market — Smart ring maker Oura is seeking a valuation of as much as $15.6 billion in an IPO that could test investor appetite for a new wave of fall listings.
Yahoo Finance 2026-09-22
Novo Nordisk Partners with Anthropic to Bring AI Deeper into Drug Discovery
Yahoo Finance 2026-09-22
Moderna (MRNA) Stock Trades Up, Here Is Why — Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 9.4% in the afternoon session after positive Phase 3 INTerpath-001 trial results evaluating its personalized cancer vaccine, intismeran autogene, alongside Merck's Keytruda in high-risk melanoma patients continued to drive momentum.
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion 2026-09-22
Tempus AI Sees Pricing, Data Growth Fueling Long-Term Expansion
Yahoo Finance 2026-09-22
Twist Bioscience (TWST) Expands AI Drug Discovery Exposure With Lilly TuneLab Partnership
Yahoo Finance 2026-09-22
AlzeCure Pharma to Present at Swiss Nordic Bio 2026 in Zurich
Yahoo Finance 2026-09-22
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Children with Active Polyarticular Juvenile Idiopathic Arthritis
Stocktwits 2026-09-22
VKTX, GPCR, ALT Stocks Rise: Novo Nordisk Signals Bigger M&A As It Chases Over 5 ‘Multi-Blockbusters’ — Novo targets over $23 billion in risk-adjusted pipeline sales by 2035, excluding any contribution from future acquisitions.
Yahoo Finance 2026-09-22
European Markets Close Mixed Ahead of Trump-Xi Summit; Saudi Arabia Oil Pipeline Restarts
Yahoo Finance 2026-09-22
3 Reasons to Sell MRK and 1 Stock to Buy Instead — Over the past six months, Merck has been a great trade, beating the S&P 500 by 13.4%. Its stock price has climbed to $149.98, representing a healthy 29.6% increase.
Yahoo Finance 2026-09-22
Amgen Boasts Success In Sjogren's; Shares Charge Ahead
Yahoo Finance 2026-09-22
Novo's CagriSema Outshines Zepbound in Key Phase III Weight-Loss Study — NVO's CagriSema delivers greater weight loss than Eli Lilly's tirzepatide in T2D and 21% weight loss in obesity, strengthening its late-stage pipeline.
Eli Lilly Breaks Ground on $6.5B Generation Park Facility 2026-09-22
Eli Lilly Breaks Ground on $6.5B Generation Park Facility — A $6.5B Eli Lilly biomanufacturing facility broke ground at Houston’s Generation Park, Texas’ largest pharmaceutical investment to date.
Yahoo Finance 2026-09-22
Chronic Pain Market Poised for Growth at a CAGR of 5% During the Forecast Period (2026-2036), as Rising Patient Burden and Novel Treatment Approaches are Creating New Opportunities | DelveInsight
24/7 Wall St. 2026-09-22
His Bet On Home Depot Made Ken Langone A Billionaire. Now He Sees Eli Lilly Stock Hitting $2,000
Yahoo Finance 2026-09-22
Novo Nordisk Just Made a Surprising Move Beyond Weight Loss
Yahoo Finance 2026-09-22
Should Eli Lilly (LLY) Investors Watch Its $6.5 Billion Houston GLP 1 Buildout? — Eli Lilly (NYSE: LLY) has started construction on a US$6.5b manufacturing facility in Houston to produce its oral GLP-1 drug Foundayo.
Yahoo Finance 2026-09-22
Sector Update: Healthcare Stocks Rise Late Afternoon — Healthcare stocks rose late Tuesday afternoon, with the NYSE Healthcare Index adding 0.5% and the St
Yahoo Finance 2026-09-22
Roche's Enicepatide Shows Weight Loss, HbA1c Gains in Phase II Study
AstraZeneca and GSK warn Europe’s drug industry is ‘at risk’ 2026-09-22
AstraZeneca and GSK warn Europe’s drug industry is ‘at risk’
Yahoo Finance 2026-09-22
AbbVie (ABBV) Wins EU Approval for Rinvoq in Children. Why a Small Indication Still Matters
Stocktwits 2026-09-22
VKTX Stock Jumps 36% As Oppenheimer Hikes Target, Peers Call Data A Win
Amgen reports a Phase 3 win with Sjögren’s drug candidate 2026-09-22
Amgen reports a Phase 3 win with Sjögren’s drug candidate
Yahoo Finance 2026-09-23
Vault CRM Extends Market Leadershipas Another Top 20 Biopharma Chooses Veeva
Yahoo Finance 2026-09-23
3 Healthcare Stocks with Warning Signs — Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 38.9% over the past six months, topping the S&P 500 by 20.9 percentage points.
InvestorsHub 2026-09-23
Novo Nordisk CEO Says Company Open to Direct NYSE Share Listing
Yahoo Finance 2026-09-23
AbbVie (ABBV) Won EU Approval For RINVOQ In Pediatric Arthritis
Yahoo Finance 2026-09-23
Novo Nordisk Gets Regulatory Nod in Singapore for Wegovy Treatment of Certain Liver Ailments
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID 2026-09-23
Moderna Eyes Cancer Vaccine Filing as It Expands Beyond COVID
Yahoo Finance 2026-09-23
AMGN's Dazodalibep Meets Goal in Systemic Sjogren's Disease Study
Yahoo Finance 2026-09-23
Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial
Yahoo Finance 2026-09-23
Can Novo's Rare Disease Pipeline Add a New Growth Pillar Beyond GLP-1?
Yahoo Finance 2026-09-23
VKTX Stock Rises on Encouraging Weight-Loss Maintenance Results — Viking Therapeutics' shares jump 36% as VK2735 maintenance data show most weight loss is preserved with less-frequent dosing.
Lilly stopped showing its phase 1 pipeline. Is it playing R&D chess? 2026-09-23
Lilly stopped showing its phase 1 pipeline. Is it playing R&D chess?
Yahoo Finance 2026-09-23
Merck (MRK) Declines More Than Market: Some Information for Investors — In the latest trading session, Merck (MRK) closed at $148.08, marking a -1.88% move from the previous day.
Yahoo Finance 2026-09-23
Novo Nordisk (NVO) Falls More Steeply Than Broader Market: What Investors Need to Know — Novo Nordisk (NVO) closed the most recent trading day at $38.17, moving 3.12% from the previous trading session.
TheStreet 2026-09-23
Novo Nordisk CEO opens the door to major move for U.S. investors
Stocktwits 2026-09-23
NVO Stock On Track For Worst Week In Over 6 Months After Strategy Day — Direct US Listing Talks, Drug Approval Fail To Halt Slip — NVO stock is down 11% this week, on track for its worst week since late February if losses hold.
Yahoo Finance 2026-09-23
Novo's Oral Wegovy Just Revealed a Surprising Weight-Loss Signal — Recent weight gain was associated with a higher likelihood of losing at least 10% of body weight.
Yahoo Finance 2026-09-23
Nvidia Backed This AI Drug Startup. AbbVie Just Became a Partner Before Its IPO
Proactive Investors 2026-09-23
Merck pipeline seen driving potential re-rating as clinical catalysts approach
Proactive Investors 2026-09-23
Novo Nordisk open to direct New York listing, CEO says
Yahoo Finance 2026-09-23
Huge News For Novo Nordisk Fans
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance 2026-09-23
European big pharma unites amid ‘ringing alarm bells’ of continent’s dominance
Yahoo Finance 2026-09-24
InnoCare Announces Strategic Research Collaboration and License Agreement with Lilly to Develop New Medicines
Yahoo Finance 2026-09-24
Amgen (AMGN) Is Up 7.9% After Positive Phase 3 Dazodalibep Data in Systemic Sjögren’s Disease
Yahoo Finance 2026-09-24
EPKINLY® receives Health Canada Approval for Adults with Follicular Lymphoma
Yahoo Finance 2026-09-24
BigHat Biosciences Announces $75 Million Series C Financing to Advance AI-Designed Therapeutics and Leading Agentic Data Platform for Rapid Protein Design — SAN MATEO, Calif., September 24, 2026--BigHat Biosciences, a clinical-stage, AI-driven protein therapeutics platform company, today announced the completion of a $75 million Series C financing, bringing its total funding raised to date to $223 million.
Yahoo Finance 2026-09-24
Merck’s Remigromig, a Tri-specific Agonist of the Wingless-related Integration Site (Wnt) Pathway, Met Primary Endpoint in the Pivotal Phase 2b/3 BRUNELLO Study of Adults with Diabetic Macular Edema
Yahoo Finance 2026-09-24
ISPE Announces its 2026 ISPE Annual Meeting & Expo Keynote Speakers
Merck reveals study success, and possible safety worries, for eye drug hopeful 2026-09-24
Merck reveals study success, and possible safety worries, for eye drug hopeful — A medicine acquired in a $1.3 billion buyout came through in the first of two pivotal studies in diabetic macular edema, though language regarding the drug’s safety stirred debate among analysts.
Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare 2026-09-24
Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare
Yahoo Finance 2026-09-24
Can PGEN's AdenoVerse Pipeline Create Growth Beyond Papzimeos?
Yahoo Finance 2026-09-24
Merck (MRK), What Is Behind The Fresh Attention Now? — Merck’s recent FDA label update for WINREVAIR lands while the share price has climbed strongly over 2026, with a 90-day share price return of 18.04%, a year-to-date gain of 39.11%, and a 1-year total shareholder return of 91.32%, suggesting momentum has been...
Yahoo Finance 2026-09-24
UPLIZNA Market Poised for Growth Through 2034 as Expanding Indications and Rising Demand Drive Sales Opportunities
Yahoo Finance 2026-09-24
Eli Lilly (LLY) Stock Is Up, What You Need To Know — Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.1% in the afternoon session after The U.S.
TheStreet 2026-09-24
Novo Nordisk's CEO delivered a warning that sank its stock by 8%
Yahoo Finance 2026-09-24
Novo Nordisk (NVO) Sets Pipeline Sales Target Above $23 Billion By 2035
The Motley Fool 2026-09-24
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?
Yahoo Finance 2026-09-24
Merck Jumps as Winrevair Moves Earlier in PAH
Yahoo Finance 2026-09-24
AbbVie Stays Flat as 6,000-Property AI Hunts Better Molecules
TheStreet 2026-09-24
Medicare just handed Eli Lilly a massive weight-loss win
Yahoo Finance 2026-09-24
Lilly Jumps 3.64% While a $100 Billion Obesity Race Crowds In
Yahoo Finance 2026-09-24
Merck Says Investigational Diabetes-Related Blindness Drug at Par With Roche’s Medicine
Yahoo Finance 2026-09-24
Winners And Losers Of Q2: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
RNAi drug specialist ADARx raises $446M IPO 2026-09-25
RNAi drug specialist ADARx raises $446M IPO
Yahoo Finance 2026-09-25
U.S. FDA Approves WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) for Certain Previously Treated Adult Patients With Advanced Renal Cell Carcinoma With a Clear Cell Component (ccRCC)
Yahoo Finance 2026-09-25
Nanexa shares rocket 114% on $1.3 billion Novo Nordisk licensing deal — Investing.com -- Shares of Nanexa surged more than 110% in early Friday trading after the Swedish drug-delivery company announced a global licensing and collaboration agreement with Novo Nordisk worth up to €1.165 billion ($1.3 billion), covering technology aimed at making obesity and diabetes treatments longer-lasting.
Yahoo Finance 2026-09-25
How Investors Are Reacting To Veeva Systems (VEEV) Expanding Agentic AI And Winning New Pharma Clients
This week in charts: Novo’s rise and fall and AI biotechs’ big haul 2026-09-25
This week in charts: Novo’s rise and fall and AI biotechs’ big haul
Yahoo Finance 2026-09-25
European Markets Close Mostly Higher Friday on Hopes for US-Iran Strait Deal
Yahoo Finance 2026-09-25
Update: Nektar Wins $90 Million Jury Verdict Against Eli Lilly Over Rezpegaldesleukin Deal
Yahoo Finance 2026-09-25
Eli Lilly Did Breach Implied Covenant of Good Faith With Nektar Therapeutics, Jury Funds — (NASDAQ:NKTR) $90 million in damages, finding that Eli Lilly and Co. Nektar Therapeutics Wins $90 Million Judgment Against Eli Lilly The lawsuit, filed in August 2023, stemmed from a previous licensing agreement between the two companies for the development and commercialization of the drug rezpegaldesleukin.
Yahoo Finance 2026-09-25
LLY's Onswik Wins FDA Nod as a Once-Weekly Basal Insulin for T2D
Yahoo Finance 2026-09-25
Merck's Remigromig Meets Main Goal in Diabetic Macular Edema Study
Quartz 2026-09-25
ADARx Pharmaceuticals raises $446 million in upsized IPO — The San Diego RNA drug developer sold 26.3 million shares at $17 apiece, with AbbVie investing up to $100 million in a concurrent private placement
Yahoo Finance 2026-09-25
Novo Nordisk's $1.3 Billion Deal Targets a Big Obesity-Drug Problem
Yahoo Finance 2026-09-25
Amgen’s Deerfield office campus sold to Mesirow for $151M in sale-leaseback deal — Price with 1 Horizon Way in Deerfield (Getty, Mesirow, Google Maps)An entity tied to Chicago financial services firm Mesirow bought the Amgen office complex in Deerfield in a sale-leaseback deal for $151 million.
Yahoo Finance 2026-09-25
FDA approves Lilly's Olumiant (baricitinib) for pediatric patients 12 years of age and older with severe alopecia areata
Yahoo Finance 2026-09-25
Ifinatamab Deruxtecan Biologics License Application for Certain Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer Voluntarily Withdrawn
Yahoo Finance 2026-09-25
Viatris sues Novo Nordisk over generic Wegovy patent dispute
Yahoo Finance 2026-09-25
Sector Update: Healthcare Stocks Higher Late Afternoon — Healthcare stocks rose late Friday afternoon with the NYSE Healthcare Index increasing 0.3% and the
Yahoo Finance 2026-09-25
Sector Update: Healthcare Stocks Edge Higher in Afternoon Trading
Novo Nordisk Changed the World With Its GLP-1 Weight-Loss Drugs. Now It Wants to Help Cure Baldness. 2026-09-25
Novo Nordisk Changed the World With Its GLP-1 Weight-Loss Drugs. Now It Wants to Help Cure Baldness.
Yahoo Finance 2026-09-25
Amgen (AMGN) Rises Higher Than Market: Key Facts — In the latest trading session, Amgen (AMGN) closed at $414.61, marking a +2.11% move from the previous day.
Yahoo Finance 2026-09-25
Novo Pays Up to $1.3 Billion for Nanexa's Drug Delivery Tech
Yahoo Finance 2026-09-25
Nektar Therapeutics stock rises on $90M jury verdict vs Lilly — Investing.com -- Nektar Therapeutics (NASDAQ:NKTR) shares rose 3.6% in premarket trading Friday following a jury verdict awarding the company $90 million in damages in a contract dispute with Eli Lilly and Company (NYSE:LLY).
Quartz 2026-09-25
Merck remigromig DME trial results raise safety concerns
Yahoo Finance 2026-09-25
Sector Update: Healthcare Stocks Edge Higher Premarket Friday
Yahoo Finance 2026-09-25
Bet on These 5 Dividend Growth Stocks Amid Rising Treasury Yields
Yahoo Finance 2026-09-25
Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance 2026-09-26
Eli Lilly (LLY) vs. Novo Nordisk (NVO): Has the GLP-1 Race Changed the Moat? — Since mid-2024, Novo’s stock has fallen roughly 74%, while Lilly’s has gained about 35%.
Yahoo Finance 2026-09-26
Eli Lilly (LLY) Wins Two FDA Approvals And A $3.35 Billion Drug Alliance — Eli Lilly agreed a global drug discovery alliance with InnoCare Pharma valued at up to US$3.35b in research and licensing commitments. These combined FDA approvals and the US$3.35b InnoCare alliance deserve weighing against the rest of our Eli Lilly analysis.
Yahoo Finance 2026-09-26
Merck (MRK) Stock May Be 37% Undervalued On Fresh FDA Approval — Merck’s stock has had a strong multi year run, and with the shares closing at US$148.78 most recently, the key question for you is whether that level is supported by the cash the business can generate over time. Over the past 5 years, Merck has delivered a total return of 113.0%, which puts real weight on the question of whether the current valuation still lines up with its underlying cash flows.
Stocktwits 2026-09-26
Biotech Deal Week: Lilly, Novo And Novartis Pay Up For Platforms, Not Pipelines
Yahoo Finance 2026-09-26
What Is Novo Nordisk (CPSE:NOVO B) Getting From A €1.165 Billion Licensing Deal? — Novo Nordisk (CPSE:NOVO B) agreed a €1.165b global licensing deal with Swedish drug delivery specialist Nanexa for long-acting injectables.
Yahoo Finance 2026-09-26
What Does AbbVie (ABBV) Need To Prove With Its Latest Pipeline Moves?
Yahoo Finance 2026-09-26
Foundayo’s Early Growth Is Raising Lilly (LLY)’s Revenue Expectations. But Can It Outrun Pricing Pressure? — The brokerage increased its target to $1,284 from $1,273 while maintaining a Buy rating on the pharma stock.
24/7 Wall St. 2026-09-26
How to Build $7,250 a Month in Dividend Income Without Owning a Single Yield Trap
Yahoo Finance 2026-09-27
Why Moderna (MRNA) Is Up 29.1% After Melanoma Vaccine Success And Middle East Expansion Talks